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SUMMARY
Chemical and enzymic routes for the synthesis of a fluorinated 
analogue of NAD* were investigated. 3-Trifluoroacetylpyridine was 
successfully synthesised chemically and glycosidically linked to 
2,3,5-tri-O-benzoyT-Drribose, but débenzoylation of this product to 
give the mononucleoside proved impossible.
Enzymic synthesis of 3”trifluoroacetylpyridine adenine dinucleotide 
from 3“trifluoroacetylpyridine and NAD* in the presence of NAD* 
transglycosidase from pig brain was unsuccessful. However, the 
fluorinated analogue of NAD* was prepared by the incubation of 
3-trifluoroacetylpyridine, PRPP and ATP in the presence of nicotinamide 
phosphoribosyl transferase (Lactobacillus fructosus ) and NAD* 
pyrophosphorylase.
3-Trifluoroacetylpyridine adenine dinucleotide was found to behave as 
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IV
I N T R O D U C T I O N
— 1 —
Fluorinated analogues of natural substrates in which either a
hydrogen atom or a hydroxy group in the original compound is
replaced by fluorine have, in the past, proved to be of considerable
value in the elucidation of metabolic pathways, and as a probe at
the active sites of enzymes. In view of the wide involvement of
NAD* in enzymically catalysed oxidation-reduction reactions a
fluorinated analogue of this coenzyme could be of great use as a
19probe, particularly now that the techniques of F n.m.r. 
spectroscopy have been applied to enzyme systems.
In view of the direct involvement of the nicotinamide mioety in 
the oxidation-reduction mechanisms involving NAD*, it was decided to 
introduce fluorine, in the form of a trifluoromethyl group, into the 
nicotinamide component. Both chemical and enzymic approaches to 
such a synthesis are possible, and the methods available will be 
reviewed later in the present Introduction.
BIOLOGICAL ACTIVITY OF FLUORO-COMPOUNDS.
(a) Analogues in which fluorine replaces hydrogen.
Although the study of organic fluorine compounds began in I896 when 
Swarts described the chemistry of a series of fluoroacetates it was 
not until much later (Schrader et. al.; 1946) that the toxicity of 
these compounds, and their potential as insecticides and rodenticides 
became appreciated. Marais (1944) observed that fluoroacetate is 
the major compound present in the South African plant Dichapetalum 
cymosum, and was so able to explain the sickness and death of cattle 
which grazed on pastures containing these plants. In view of the 
economic implications of this finding research into the toxicity and 
metabolism of fluoroacetate was initiated and pursued in the following
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years,
The toxicity of fluoroacetate varies considerably from system to 
system, for instance, a dose of 60 pg/Kg is often sufficient to 
kill a dog, whereas the South African clawed toad can survive a 
dose of 500 mg/Kg (Quin and Clark; 1947), and fluoroacetate has 
been shown to have little effect on microorganisms (Kalnitsky 
and Barron; 194?) or on isolated enzymes (Bartlett and Barron: 1947).
Fluoroacetate was found to con^etitively inhibit acetate metabolism 
in Baker* s yeast (Saccharomyc es cerevisiae) and in Corynebacterium 
creatinorans, both of which microorganisms utilise acetate rapidly 
(Kalnitsky and Barron; 1947) • Martius (1949) and Liebecq and Peters 
(1 9 4 9) in simultaneous experiments showed that fluoroacetate was in 
some way interferring with citrate metabolism. Buffa and Peters 
(1 9 4 9) showed shortly afterwards that fluorocitrate arrested the 
T.C.A. cycle and caused citrate accumulation in vivo in rat and 
guinea pig, but had no effect on isolated enzyme fractions. Since 
this time it has been suggested that the inhibitary substance 
isolated from tissue homogenates after respiration in the presence of 
fluoroacetate is monofluorocitrate. Thus, synthetic samples of 
monofluorocitrate were shown to have a comparable I.R. spectrum to 
that of a fluorinated tricarboxylic acid isolated by Peters et. al. 
(1953 a and b) from kidney tissue which had been incubated with 
monofluoroacetic acid.
Lotspeich et. al. (1952) demonstrated that the * inhibitor fraction* 
isolated after incubation of kidney homogenates with fluoroacetate 
would inhibit aconitase preparations, thus implicating this enzyme
- 3 -
as a possible point at which the ^biochemical lesion* occurs
after fluoroacetate poisoning- Peters (I9 6I) has demonstrated
as much as 50% inhibition of aconitase by as little as 10~^ to 
- 910 M of enzymically, prepared fluorocitrate, and has described 
the production of the toxic fluorocitrate from the non-toxic 
precursor, fluoroacetate, as **lethal synthesis'*. (Fig. 1)
Monofluorocitric acid has been synthesised chemically (Rivettj 
1 9 5 3Î Fanshier et. al.;1964) and has been shown to consist of 
two pairs of enantiomers (Fig. 2) giving two spots on 
electrophoresis, one corresponding to the erytho pair (l and III) 
and the other to the threo pair (II and IV). On the basis of 
X-ray crystallographic studies Carrell et. al. (1970) assigned 
the slower moving (more acidic) spot to the threo configuration.
Fanshier et. al. (1964) showed that citrate synthetase catalyses 
the condensation of fluoroacetyl CoA with oxaloacetate to give 
an isomer of fluorocitrate which strongly inhibits aconitase, 
whereas the isomer formed when acetyl CoA is condensed with 
fluorooxaloacetate does not inhibit aconitase. Both of these 
isomers run as the slower spot on electrophoresis and therefore 
have the threo configurations. The isomers with the erythro 
configuration were found not to be inhibitors of aconitase. If 
it is assumed that citrate synthetase shows the same stereo 
specificity to fluoroacetyl CoA as it does to acetyl CoA then the 
inhibitory isomer must have the structure III or IV, which therefore 
leaves structure IV. The result of the lethal synthesis of 
fluorocitric acid from fluoroacetic acid is accordingly (-) - 
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Enantiomers of monofluorocitric acid.
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Other fluorinated metabolites of monofluoroacetate have been 
postulated. Miura. and Hori (I9 6I) reported evidence of a :
fluorinated ketone and Schaefer and Machleidt(1971) published 
evidence of the conversion of fluoroacetate to amino-acids in 
various mammalian tissues.
As work on the elucidation of the mechanism of fluoroacetate 
toxicity was progressing, it became apparent that other 
fluorinated aliphatic compounds were also toxic. Various groups 
of workers (Saunders; 1947: Buckle et. al. 1949: Pattison and 
Saunders; 1949: Pattison; 1959) suggested that long-chain 
lU-fluoro fatty acids with an even number of carbon atoms would be 
expected to be highly toxic whereas those with an odd number of 
carbon atoms would be relatively non-toxic. This is compatible 
with the P-oxidation mechanism accepted for fatty acid 
degradation: the even numbered acids passing through a highly 
toxic fluoroacetate stage and the odd numbered acids to the 
relatively non-toxic P-fluoropropionate. This rule was also 
applied to UJ-fluoronitriles by Pattison et. al. (I9 5 6 ) who found 
that those compounds with an odd number of carbon atoms were very 
toxic, whereas those with an even number were not. This was taken 
as indicating biodégradation via carbon-cyanide cleavage, rather 
than by a reduction of the -C s  N bond.
As a result of metabolic and enzymic studies on these various 
naturally occuring fluorine compounds it became evident that synthetic 
fluorine containing compounds could be of use in the elucidation of 
the mechanism of many biological systems.
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p-Fluoropyruvic acid, a compound of potential biological interest, 
was first synthesised by Mager and Blank (1954) who reported 
growth inhibition of Escherishia coli and Aerobacter aerogenes at 
low concentrations of the fluoroanalogue. It was also shown to 
be toxic to rats at higher levels, causing death without the high 
level of citrate accunujlatjon usually associated with fluoro­
acetate poisoning. Subsequently Gal et. al. (I956 a, b) reported 
that in the rat, a fatal dose (ca. 80 mg/Kg) of P-fluoropyruvate 
reduced the amount of ^^C-carbon dioxide eaqpired from ^^C-acetate 
in vivo, and lowered the level of pyruvate in the blood, indicating 
that pyruvate utilisation was not blocked. Some in vitro work with 
kidney particle preparations showed that P-fluoropyruvate blocked 
the formation of citrate from fumarate, but did not inhibit the 
disappearance of citrate, the inference being that aconitase was 
not inhibited and hence that fluorocitrate was not formed in 
appreciable quantities. P-Fiuoropyruvate has a powerful effect 
on the enzymes of pyruvate metabolism and was shown by Avi-Dor and 
Mager sC 1956a) to exercise its metabolic effect by behaving in a 
similar manner to iodoacetate, which blocks protein or enzyme -SH 
groups. This reaction was shown (Peters and Hall; 1957) to be 
accompanied by the splitting off of the fluorine atom,
R  SH + FCH^COCOOH-»RSCH^COCOOH + HF
and it may be that ̂  -fluoropyruvate could have a use in -SH grot# 
estimation (Avi-Dor and Mager; 1956 b).
One rationale behind the use of fluorine for the production of 
isosteres having potential biological or pharmacological importance 
has been its similarity in size to a hydrogen atom (Fig. 3). Thus, 
in the laboratories of both Bergman (I9 6I) and Kun (Kun and Dummel^
Fig.3
Parameters of various elements
Element (a)Bond length Van der Vaals 
radius
(c)Electronegativity
H 1 .0 9 1.20 2.1
0(in OH) 1 .4 3 1.40 3 .5
F 1 .3 9 1 .3 5 4.0
Cl 1-77 1 .8 0 3 .0
Br 1 .9 4 , 1*95 2.8
I 2.1 - 2.2 2 .1 5 2-5
S (in SH) 1 .8 2 1 .8 5 2 .5
Tables of interatomic distances and configuration in molecules and 
ions, The Chemical Society (London),Special publication No. 18. 
Ed. L.E. Sutton (I9 6 5).
b) The nature of the chemical bond. L. Pauling. 3rd Edition, 
Cornell University Press, Ithaca, New York, p260.
c) Ibid. p . 90
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1969) a concentrated effort has been made to synthesise 
intermediates of the T.C.A. cycle and some related amino acids 
in which fluorine replaces a hydrogen atom. The effect of many 
of these compounds is not dramatic at a metabolic level, although 
some appear to be specific inhibitors of isolated enzyme reactions. 
Thus, monofluorooxaloacetate has been found to interact with a 
number of enzymes for which oxaloacetate is a substrate ÔCun.j I9 6 9) 
while fluoroacetate is a potent inhibitor of malate dehydrogenase
for oxaloacetate) implying the reduction of oxaloacetate and 
difluorooxaloacetate (also a substrate for this enzyme) in 
mitochondria (liver and kidney) and cytoplasm (kidney but not liver) 
(Kun and Volfin; I966 a). It has been suggested that differential 
inhibition of this type may result from selective recognition of 
inhibitors by isozymes possessing differing catalytic properties.
Such tissue specific differences may be a relatively common 
phenomenum. Thus oxidation of succinate by liver and kidney 
mitochondria is unaffected by monofluorooxaloacetate even at a 
concentration of 0.2 mM, whereas in heart mitochondria, under 
similar conditions succinate oxidation is abolished (Kun and Volfin;.
1966 b).
Organ-specific differences were also demonstrated in the effects of 
monofluorooxaloacetate on the respiration of mitochondria (using 
oxaloacetate and pyruvate) from brain, liver and kidney in which 
the addition of 0.33 mM monofluorooxaloacetate caused 80 to 90% 
inhibition of oxygen uptake after 30 minutes (Fanshier et. al.; I9 6 2). 
Citrate levels were diminished to approximately 50% in liver and 
kidney, but almost unaffected in brain mitochondria. The potent 
inhibition of oxygen uptake, and lesser inhibitory effects on citrate 
levels in brain could be explained in terms of the demonstrated
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weak in vitro effect of fluorooxaloacetate on citrate formation 
from acetyl CoA and oxaloacetate coupled with the more 
pronounced effect on malate dehydrogenase. Similar experiments, 
performed under initial rate conditions in an oxygen electrode 
showed that the fluoro-acid did not initially affect oxygen uptake 
and indicated a time dependent adjustment of mitochondrial 
metabolism (Kuh and Volfin; I966 b).
An advantage of using fluoroanalogUes is that their action is likely 
to be related to the function of specific enzymes. Kun (I9 6 9) suggests 
that fluoroanalogUes in combination , for example, with uncoupling 
agents, may be able to discriminate between energy coupled and substrate 
level control mechanisms.
FluoroanalogUes can disrupt or modify cellular functions in a variety 
of ways. Incorporation of the analogue into cellular macromolecules 
has now been demonstrated in several systems and analogues already 
shown to be active in this respect include the fluorinated amino-acids 
5,5 »5~trif luoro leucine. , 2,3- and 4-fluorophenylalanine, 3-fluorotyrosine 
and 4-fluoroproline (Halvorson and Speigelman; 1952: Munier and Cohen; 
1959: Re*^nert and Anker; 1963 Richmond; I9 6 3: Gottlieb et. al.;
1 965: Munier and Sairrazin; 1964: I9 6 6).
p-Fluorophenylalanine has been shown to prevent mature polio virus 
formation (Leventaa et. al.; I9 6 2) while still permitting synthesis 
of infectious RNA. The fluoroanalogue does not necessarily inhibit 
protein synthesis, but may act by virtue of its incorporation into 
a protein which becomes functionally impaired. Thus,in the presence 
of'p-fluorophenylalanine,viral coat protein is either not formed, 
is formed but is functionally inadequate, or the maturation process 
is sensitive to the fluoroanalogue.
FluoroanalogUes sometimes reveal aspects of biochemistry which are
— 8 —
not easily detected by a non-analogue approach. Tryptic digests
of the alkaline phosphatase from E. coli yield six peptides that
contain phenylalanine (Richmond; I9 6 3), four of which contain one
phenylalanine molecule in the chain, while the others contain
two. Examination of the enzyme after biosynthetic labelling with 
14C-p-fluorophenylalanine showed that all the peptides which 
originallycontained phenylalanine now contained the fluoroanalogue, 
demonstrating that all the phenylalanine residues in alkaline 
phosphatase are accessible to replacement by the fluoroanalogue. 
The degree of replacement under conditions of direct competition 
between p-fluorophenylala^iine and phenylalanine shows no variation 
in the ratio of the two amino-acids incorporated into any of the 
six peptides, indicating that the system responsible for the 
incorporation of phenylalanine into various positions in alkaline 
phosphatase may be equivalent. Arnstein and Richmond (1964) 
demonstrated that this ^  me fluoroanalogue was incorporated into 
protein by a cell free system from rabbit reticulocytes in a 
quantitative manner similar to phenylalanine. They found that the 
incorporation of both phenylal anine and p-fluorophenylalanine is 
stimulated to approximately the same extent by the addition of 
polyuridylic acid to the reticulocyte system, indicating that at 
least one code, the UUU triplet, for phenylalanine does not 
discriminate against the p-fluoroanalogUe. If there is any 
degeneracy in the code for phenylalanine in the reticulocyte 
system the various t-RNA's must have similar specificities for 
phenylalah.ine and p-f luorophenylala ine .
Non mucoid strains of E. coli produce capsules and yield mucoid 
colonies when grown in the presence of p-fluorophenylalanine 
(Kang and Markovitz; I967 a, b). The organism reverts to the
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normal incapsulated state when subcultured in media free of the 
fluoroanalogue or when phenylalanine is added to depress its 
utilisation. Analysis revealed elevated levels of certain 
enzymes concerned with polysaccharide synthesis when the fluoro­
analogue was present in the medium. Kang and Markovitz suggest 
that synthesis of these enzymes has been de-repressed, possibly 
because p-fluorophenylalanine has been incorporated into the 
regulator protein coded for by the relevant regulator gene(s) of 
the organism, leading to the synthesis of ineffective repressor 
molecules. A report by Rennert (I9 6 9) has appeared which suggests 
that the formation of leucine - t - RNA and trifluoroleucine - 
^ - RNA during the embryonic development of the mouse is a function 
of gestational stage. Results indicate the presence of a leucine - 
t - RNA synthetase in unborn mice of gestational age less than ten 
days which is capable of açylating t - RNA with trif luoroleucine 
almost to the same extent as leucine. A second leucine - t - RNA 
synthetase, similar chemically and physically to the enzyme from a 
more mature embryonic tissue has been isolated from this embryonic 
tissue, as well as adult tissue. Trifluoroleucine - t - RNA was not 
formed if the enzyme and t - RNA were obtained from late embryonic 
tissue (gestational age greater than fourteen days),newborn mice, 
or adult organs. This investigation revealed a unique enzyme, a 
leucine - t - RNA synthetase, present in early embryonic tissue which 
disappears during the process of embryogenesis and is absent from 
adult systems.
The rewarding results obtained with fluoroacetate and its derivatives 
have motivated many workers, in both biological and medicinal chemistry 
to examine the biochemical and therapeutic effects of natural 
products in which a hydrogen is replaced by a fluorine. In the 
field of nucleic acid research, many fluorinated purine and pyrim idine
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nucleotide analogues have been synthesised (Heidelberger; I9 6 5: 
Hartmann and Heidelberger; I9 6I; Reyes and Heidelberger; I9 6 5: 
Heidelberger; 1972: Wright et. al; I9 6 9: Wright et. al.; I97O).
Some of these compounds display a type of biological activity which 
renders them useful as anti-tumour agents. It has been known for 
some time that certain tumours utilise uracil for nucleic acid 
biosynthesis to a greater extent than most normal cells (Rutraan et. 
al.; 1 954). In an attempt to exploit this and the fact that most 
cancer cells differentiate more rapidly than normal cells,
Heidelberger and his co-workers (I9 6 5) have synthesised 
fluorinated uracil analogues which could potentially interfere 
with nucleic acid biosynthesis in cancer cells. Of the compounds 
synthesised, some of the most useful chemotherapeutic agents are 
5-fluorouracil and 5-fluoro-2-deoxyuridine, the former being possibly 
the best anti-cancer drug currently available. Both compounds are 
themselves inactive and have been shown to require a metabolic 
transformation within the cell to an 'active* form (5~fluoro-2- 
deoxyuridine monophosphate). This compound is a potent competitive 
inhibitor of thymidylate synthetase (K̂  = 2.2 x 10 M) (Hartmann and 
Heidelberger; I9 6I) which is the enzyme responsible for the conversion 
of 2-deoxyuridine monophosphate into 2-deoxythymidine monophosphate. 
This, in the terminology of Peters, can be considered as another 
example of 'lethal synthesis'. Both 5-fluorouracil and 5“fluoro-2- 
deoxyuridine are thought to be converted to 5-fluoro-2-deoxyuridine 
monophosphate via pathways normally associated with the synthesis 
of 2-deoxythymidine monophosphate. On reaching the 5-fluoro- 
2-deoxyuridine monophosphate stage, the compound is not metabolised 
further, and having a high apparent affinity for thy*"idylate synthetase.
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inhibits this enzyme, and consequently nucleic acid biosynthesis 
(Fig. 4).
Considerable evidence now exists that thymidylate synthetase 
inhibition is the major antituraour mechanism of fluorouracil although 
the incorporation of the analogue into RNA cannot be completely 
eliminated (Heidelberger; 1972). An advantage of using 5-fluoro­
uracil and 5“fluorouracil-2'-deoxyuridine for chemotherapeutic 
purposes is that they are degraded in animals to the relatively 
non-toxic a-fluoro-p-alanine rather than a fluoro compound 
possessing other toxic properties (Fig. 5) (Chaudhuri et. al.; 1958), 
The pyrimidine.'analogue trifluorothymine is not significantly active 
in mammalian systems. The nucleoside of this compound, 
trifluorothymidine, was found to be highly active against tumours 
and DNA viruses. 5-Trifluoromethyl-2'- deoxyuridine 
monophosphate inhibits thymidylate synthetase in a competitive 
manner if added simultaneously with the substrate (Reyes and 
Heidelberger; I9 6 5), but non-competitively if the enzyme is 
preincubated with the inhibitor. This may mean that an alkylation 
has taken place near or at the active site. Fridland et. al. (1971) 
have now affected a 4700-fold purification of the enzyme from 
Ehrlich ascites carcinoma cells in order to elucidate whether or not 
an alkylation does take place. That thymidylate synthetase is the 
locus of antitumour activity of the nucleoside trifluorothymidine 
is suggested by the fact that very little of the fluoro-analogue 
appears in the DNA of mammalian cells. In the case of viruses such 
as the T 4 B bacteriophage, however, as much as 10% of the thymine 
in the DNA can be replaced by the trifluoroanalogues which results 
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Inhibition of thymidylate synthetase by 5-fluoro-2'-deoxyuridine
monophosphate
Fig. 5
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Degradation of 5-fTuorouracil and 5-fluoro-2'-deoxyuridine
in animals.
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pursuing the antiviral properties of trifluorothymidine Kaufman 
and Heidelberger (1964) found this compound to be extremely active 
against Herpes simplex keratitis of the rabbit cornea, being more 
potent in this respect than any other analogue previously used for 
therapeutic purposes ^ufmann; I9 6 5). To study the mechanism of 
antiviral action of this compound, Heidelberger and his co-workers 
have established a standard system for examining the effect of 
trifluorothymidine on Vaccina virus replicating in HeLa cells.
The fluoroanalogue was ten times more active as an antiviral agent 
in this system than any other compound (Umeda & Heidelberger; I9 6 9) 
and the effect was irreversible, even after a delayed thymidine 
administration. That this compound was actually incorporated into 
viral DNA was eventually demonstrated by sucrose gradient 
centrifugation experiments (Fujiwara and Heidelberger; I9 7 0).
Viral particles, after incorporation of trifluorothymidine into 
their DNA were completely non-infective, producing abnormal 
m-RNA (Oki and Heidelberger; I9 7I). Studies are continuing in 
Heidelberger's laboratory in an attempt to elucidate the complete 
mechanism of antiviral action of trifluorothymidine.
The antitumour approach that is being used by Fox and his co-workers 
(Wright et. al.; I9 6 9: 1970) is to synthesise nucleosides bearing 
fluorine in the sugar moiety rather than in the base (as Heidelberger 
did). They are, however, continually harassed by deaminase activity.
9-(2' -Deoxy-2' -fluoro-p-JD-arabinofuranosyl) adenihe(Fig- 6 ) (Wright 
et. al.; 1 969)^a potential inhibitor of nucleic acid biosynthesis,is 
rapidly metabolised to the inactive cytotoxic agent (Wright et. al.;
1970). The pyrimidine analogue l-(2’-deoxy-2»-fluoro-p-D-arabinofuranosyl) 









screening studies reveal that this compound is active against 
suspensions of L1210 leukemia cells (Wright et. al.; 1970).
Fluorination of steroid molocules frequently produces analogues 
exhibiting enhanced biological activity over that of the parent 
compound (Burger; I97O: Chen and Borrevang; 1970; Wettstein;
1972). Such analogues have many potential uses, for example as oral 
contraceptives, anti-inflammatory drugs and in the treatment of 
hormonal sexual disorders and certain types of cancer. The 
androgen, 9 !X-fluoro-ll P-hydroxyl-17 a-methyltestosterone (Fig. 7a) 
shows high androgenic and anabolic activities. These properties, 
coupled with its relatively weak action on the hypophysis render it 
useful for the treatment of certain hypogonad disorders and breast 
cancers (Talley et. al.; 1964). Some 'prototype' steroids possess 
more than one enhanced activity and this is undesirable in certain 
instances. Both the glucocorticoid and mineralocorticoid activities 
of 9 a-substituted cortisols are increased in relation to the parent 
hormone cortisol (Fig. 7b)- Further substitution, for example of a 
fluorine atom into the 6 a-position, increases the glucogenic and 
anti-inflammatory activity of the compound whilst diminishing 
possibly unwanted sodium retaining properties (Fig. 8 ). Fluorination 
of the steroid nucleus in the 60c, 6 a  and 9®., l6a, 6a and l6a, and 6a,
9a and l6a positions has proven most effective in changing a variety
of activities normally associated with the parent hormone. In this 
connection, the 6a, 9a and l6a fluoro series of prednisolone acetates 
are potent as anti-inflammatory and thymolytic agents (Fig. 5c)













(d)(X=F);9 a-Fluoro-11 a-deoxycorticosterone acetate
(e)(X=H);ll ct-deoxycorticosterone acetate.
Fig. 8.
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It is still not possible to predict the biological effect of structural 
modifications in steriod molecules. Fried and Borman (1958) have proposed 
an explanation for the enhancement of glycogenic action observed with 
9<X“SubstitutedCOrlisoles. Although, in general, the smaller the 9&- 
substituent, the greater the effect, steric factors could not account 
completely for the results obtained with all the compounds tested. For 
example, the effects of 9 ot-hydroxyl substitution were some fifty times 
less than that of the fluoro-analogue, although the groups are of 
equivalent size. It was therefore proposed that the electronegativity 
of the atoms substituted at the 9 <̂ position would, by virtue of its 
electron withdrawing • properties, increase the acidity of the 11 p 
hydroxyl group, possibly strengthening a hydrogen bond between this 
group and the receptor molecule.
9 a-fluoro-lla-deoxycorticosterone acetate (Fig. 7d) (Bergstrom and 
Dodson; I9 6 0) was found to have twelve times the sodium retaining 
properties of lla-deoxycorticosterone acetatd^Fig. 7©) (Kagawa and 
Jacobs; I9 6 0) Bergstom and Dodson (I9 6 0) have challenged Fried and 
Borman's interpretation of the influence of the 9 substituent on 
lla-oxygenated steroids (9 %-fluoro-ll a-deoxycorticosterone acetate 
has no 11 a-oxygen function) and have suggested that the 9 <x-fluoro 
group possibly interferes with metabolic 9-hydroxylation reaction.
This pathway is not, however, thought to be important in mammals. It 
is possible that the sodium-retaining properties, also observed with 
some 9&-fluoro-ll p-hydroxyl steroids, are due to a mechanism similar 
to the one underlying enhanced 9c%''"iIuoro—11—deoxy—corticosterone 
activity. A complete analysis of this problem cannot, however be 
sought until the exact nature of the receptors for various hormonal 
activities has been determined. Chemical evidence (Eschenmoser;1964) 
indicates a slower chromic acid oxidation of 9(^-fI^oro-1 1 p-hydroxy
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steroids than of the parent compounds, and he suggests that the hydroxyl 
group is stabilised by the negative inductive affect of the fluoro;atoms• 
Bush and Mahesh (1964) predicted, from the evidence of Es.chenmoser, 
that, in vivo, the ketosteroid (inactive)/hydroxy steroid (active) ratio 
will be diminished, thus effecting greater glucocorticoid activity, although 
they also suggested the possibility of competitive inhibition of the
11-carbon oxidoreductase reaction by the fluoro-analogue. Bush et. al. 
(1 968) subsequently isolated in 11 p-hydroxy steroid dehydrogenase from 
rat and guinea pig liver microsoraes. 9 a-Fluorocortico 1 was a competitive 
inhibitor of enzymic cortisal oxidation, but is itself reduced at 5 ” 10 
times the initial velocity of cortisone.
Fluorinated analogues can be used to help elucidate the mechanism of action 
and active sites of individual enzymes. Difluoro-oxaloacetate has been 
used in this way to study aspartate transaminase (Briley et. al.; 1977 a:b). 
This will be discussed in more detail later.
(b) Analogues in which fluorine replaces a hydroxyl group.
It has already been suggested (see p. 5 ) that the biologicaiactivity 
elicited by isosteres of natural compounds in which a fluorine atom 
replaces a hydrogen site results from the similarity in size between a 
fluorine and a hydrogen. It can also be seen (Fig. 3) that fluorine 
and oxygen (in, for example, a hydroxyl group) have similar bond lengths 
to carbon, similar Van der Waals radius and comparable electronegativity. 
Moreover it has been demonstrated that covalently-bound fluorine, like a 
hydroxy group can accept a hydrogen bond. (Buckley et. al.; I9 6 8:
Martin; I9 6 5: McDaniel and Brown; 1955: PaVlath and Leffler; I9 6 2).
These physico-chemical factors hâve been implicated in an explanation of 
the close resemblance in the crystal structure between 2-deoxy-2-fluoro- 
erythritol and erythritol itself (Bekoe and Powell; 1959), as determined 
by X-ray crystallographic measurements.
It is only in the last thirty years that analogues have become available
— l6 —
in which fluorine replaces a hydroxy group, and hence the ability of 
fluorine to mimic hydroxyl groups in biological systems has only recently 
been examined.
1-Deoxy-l—fluoro^D—glycerol and 1—deoxy—l-fluoro^L—glycerol were 
synthesised stereospecifically using independent routes from ÎD- 
mannitol (Lloyd and Harrison; 1971: 1973)- The enantiomers were also 
interconverted by a route which was also used to prepare 1-deoxy-D- 
glycerol from its enantiomer 1-deoxy-L-glycerol.
Together with 2-deoxy-2-fluoroglycerol and propan-1, 3-diol (2- 
deoxyglycerol) the above compounds constitute a series of analogues in 
which each hydroxyl group of glycerol is successively replaced by 
fluorine or hydrogen. These analogues were examined as inhibitors or 
substrates of glycerol kinase (Eisenthal et. al.; 1972) using steady 
state kinetics. The behaviour of 1-deoxy-l-fluoro-sn-glycerol as a 
substrate and 3-deoxy-3-fluoro-sn-glycerol as a competitive inhibitor 
allowed a reasonably precise location of the fluorine atoms within the 
enzymes active site. However, distinction between the two alternative 
orientations of the fluorine atom at C-2 could not be made on the kinetic 
data alone. However, it was later shown (Briley et. al.; 1975) that 
glycerol kinase catalyses the phosphorylation of the symmetrical 
substrate 2-deoxy-2-fluoroglycerol by ATP to an assymetric product,
2-deoxy-2-fluoro-ai -glycerol-3-phosphate.
This conclusion was based on the nmr. spectroscopic data obtained for 
chemically prepared racemic 2-deoXy-2-fluoroglycerol phosphate. The 
signals for the methylene groups at the phosphorylated and 
unphosphorylated ends of the molecule are well defined and by a study 
of the splitting patterns and comparison with the spectra of the synthetic 
precursors these signals were assigned to the appropriate enantiomers.
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Briley et. al. also chemically synthesised 2-deoxy-2-fluoro-sn-glycerol 
labelled at C-1 with deuterium, enzym - ically phosphorylated this compound 
using glycerol kinase, and purified and isolated the crystalline product 
using ion-exchange chromatography. On the basis of the nmr spectroscopic 
data the phosphate group in this compound was assigned to the non- 
deuterated end of the molecule.
Phosphorylation of the monodeoxy-and monodeoxy-monofluoroglycerols gave 
a series of analogues of sn-glycerol-3-phosphate. These analogues were 
investigated as substrates or inhibitors of a-glycerophosphate 
dehydrogenase from intact and solublised flight muscle mitochondria from 
Locusta migratoria. (Lloyd and Harrison; 1974). sn-Glycerol-3-phosphate 
and its analogues in which the C-1 hydroxyl group was replaced by either 
hydrogen or fluorine all exhibited jsubstrate activity and Michaelis-Menton 
kinetics, whilst substrate analogues in which the C-2 hydroxyl group is 
in the ̂ -configuration or has been replaced by hydrogen or fluorine lack 
substrate activity but behave as competitive inhibitors of the oxidation of 
sn-glycerol-3-phosphate using either the intact or solublised 
mitochondrial enzyme preparations. The C-1 and C-2 deoxyfluoro analogues 
of sn-glycerol-3-phosphate and of its enantiomer have similar kinetic 
parameters to the corresponding deoxy analogue in both enzyme preparations. 
The conclusions from these experiments using monofluoro monodeoxy glycerols 
and their phosphates were that, whereas replacement of a hydroxy group by 
fluorine led to an enzyme-substrate analogue complex closely mimicking the 
unfluorinated hydroxy containing complex, the kinetics of the fluoro-analogue 
were similar to those of the deoxy analogue rather than those of the 
original substrate.
The majority of synthetic analogues in which fluorine replaces a hydroxyl 
group are monodeoxymono-f luoro sugars and their related compounds. Among 
sugars that have already been reported are the complete glucose series.
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( Bar ford et. al. ; 19/ 1 : Bessel 1 et. al. ; 1971 : Foster et. al. ; 1967-‘Pacak et.
al. ; 1 9 6 9*. Micheel and Klemer; I9 6 I) , f luoropentoses (Codington et. al.; I9 6 6 :
Wright and Taylor; I9 6 7 : Wright et» al.; I9 6 9 : Wright and Fox; 1970), various
other fluorinated hexoses (Adamson et. al.;l97l: Taylor et» al»; 1972b : Kent
et. al.; I9 6 0 ) and glycosyl fluorides generally (Micheel and Klemer; I9 6 I),
Extensive studies have been reported in which fluorinated sugars of these
types have been incorporated into a range of metabolic systems (Taylor; 1972),
and their interactions with isolated enzymes have also been studied (Thomas
et. al»; 1974). Furthermore, comparison of the properties of deoxyfluoro
analogues with those of the corresponding hydroxy compounds have been made in
studies of membrane transport (Barnett; 1972: Riley and Taylor; 1972). In
only a few cases have systematic comparisons shown that deoxyfluoro compounds
act as a hydroxy analogue. In most cases the apparent activity of a fluoro
substituent as a hydroxy group can be explained in terms of the profound
effects fluorine is known to have upon neighbouring groups.
In view of the central role of NAU^ in enzymically catalysed oxidation/
reduction reactions it was thought that a fluorinated analogue of this coenzyme
19could be of great use as a probe, particularly by using F n.m.r. spectroscopy. 
SYNTHETIC METHODS
There are several positions in the NAD^ molecule (Fig 9, R = CONH^) into 
which fluorine could be substituted. It is theoretically possible to 
introduce fluorine into either of the ribofuranosyl rings, as well as into 
the adenine or nicotinamide rings. However, the nicotinamide ring is possibly 
the most attractive site in view of its involvement in oxidation-reduction 
reactions of the coenzyme, and on this ring the substitution of a 
tri1luoroacetyi grouping for the amide moiety seemed to offer potentially 
the most accessible and useful analogue.
19With a view to the use of F n.m.r. spectroscopy, the trifluoroacetyl group 
offers the advantage of three fluorines in an identical environment giving
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Formula for NAD and its analogues.
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as the concentration of the analogue in enzyme systems would be low. 
Hence it was decided to prepare 3-trifluoroacetylpyridine ade.hine 
dinucleotide (Fig. 9, R = COCF^).
INTRODUCTION OF FLUORINE
There are two basic methods for the synthesis of fluoro-analogues of 
macro molecules. Either a fluorine is introduced directly into the 
macro molecule or a small part of the macromolecule is synthesised and • 
then incorporated.
Bergstrom et.al. (I9 6 3) synthesised 9&-fluoro- 21-dihydroxy-
4-pregnene-3, 20-dion-21-acetate by treatment of the 9» 11-olefinic 
derivative with 74% HF in pyridine at 2^0, although in poor yield 
(Fig. 10a).
This reaction exemplified the addition of HF to a double bond. 
Hirschmann et. al. (195&) made 9 ot-fluoro-p-hydroxypregnenes, in 
high yield by opening an anhydro ring with anhydrous HF in tetra- 
hydrofuran and chloroform (Fig. 10b). Similar compounds have been 
synthesised (Pike et. al.; I9 6 3) which have a pronounced anti­
inflammatory activity.
Codington et. al. (I9 6I) demonstrated the opening of a five-raembered 
oxygen ring with hydrogen fluoride when they synthesised 2'-deoxy- 
2*-fluorouridine by the action of HF in dioxan on 2, 2'-anhydro-1- 
(P*3p-arabinofuranosyl) uracil (Fig. 10c).
Halides or sulphonate esters can be replaced by fluorine by the action 
of a metal fluoride. Potassium fluoride has, in the past, been the 
metal fluoride most widely used as a fluorinating agent, although the 
fluorides of caesium and r (rubidium are often more active in this respect 
Sodium fluoride has a low solubility, and lithium fluoride is a poor 
nucleophile because of its strongly ionic crystal lattice and large 
hydration shell.
Fig. 10.
0 C H 2O C O C H 3 0 ^  CH 2Q C O C H 3 
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74 % H F i n  ^
pyridine (2“C)
(a) Preparation of 9 ot-fluoro-l? P,21-dihydroxy-4-pregnene-3»20- 
dion-21-acetate.
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Potassium fluoride can be used to displace other halogens from 
acyl halides, a-haloesters, amides, nitriles and primary alkyl halides 
in polar solvents. Dry potassium fluoride in polar solvents has also 
been used to replace oxygen-bonded groups, particularly p-toluene 
sulphonyl and methanesulphonyl esters, which are excellent leaving 
groups, easily replaced when in a primary position. This is a mild 
method of replacement, particularly valuable for molecules containing 
sensitive groups, and allows for the conversion of an alcohol to a 
fluoride via a sulphonate ester (Fig. 11).
Application of fluoride exchange reaction using p-toluene sulphonate 
within ring systems had proven difficult until Henbest and Jackson (I9 6 2) 
described the action of tetra-n-butyl ammonium fluoride in acetone or 
butanone on C-3 and C-I7 p-toluenesulphonylsubstituted steroids. The 
reactions proceeded with very high yield and inversion of configuration, 
and thus these workers were able to demonstrate useful routes to 3&- 
and 3P-fluorocholestane (Fig. I2a) and 17oc-fluorotestosterone (Fig I2b). 
The suitability of tetraalkyl ammonium fluorides as fluorinating agents 
is reflected in the fact that they are highly dissociated and extremely 
soluble in organic solvents. With the aid of suitable blocking groups, 
this reaction was adopted for use in the synthesis of secondary 
fluorocarbohydrates. Foster et. al. (I9 6 7) converted 1, 2; 5î 6-di-O- 
isopropylidene-3-O-p-toluenesulphonyl-^-allofuranose to 3-deoxy-3- 
fluoro-1,2; 5»6-di-0-isopropylidene-a-_D-glucofuranose in 74% yield 
using tetra-n-butylammonium fluoride in acetonitrile. 3-Deoxy-3- 
fluoro^L—idose (Brimacombe et. al.; 1970) and 4-deoxy-4-fluoro-^- 
galactose (Marcus and Westwood; 1971) have since been synthesised by 
similar routes.
When a smaller molecule is fluorinated, and then incorporated into the 
macromolecule any of the methods used for the direct fluorination of 












Fluorination using a. metal fluoride and a leaving group.
Fia. 12.




R= Remainder of steroid molecule.
b) OTs
0
Ts = p-Toluenesulphonyl group
0
Fluorinations using tetra-n-butyl ammonium fluoride
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(Fig. 13).
One other method of fluorination that is of particular interest in the 
field of the synthesis of biologically active molecules is the replacement 
of hydrogen in a reactive methylene group using perchloryl fluoride.
Inman et. al. (1958) have described the fluorination of diethyl malonate 
in ethanol, to yield diethyl difluoromalonate in 84% yield. However, 
reinvestigation of this method by Gershon et. al. (I9 6 6) has shown that 
a mixture of five components is present, diethyldifluoromalonate only 
accounting for 36% of the theoretical yield. Gershon et. al. (I9 6 7) 
also investigated the action of perchloryl fluoride on substituted ethyl 
cyanoacetate and studied the toxicity of the products.
The general method for the introduction of fluorine into a compound with 
an active methylene group using perchloryl fluoride is described below.
The compound to be fluorinated is stirred in an inert solvent under 
nitrogen, a base added, and perchloryl fluoride bubbled through the cooled 
solution. The range of compounds which has been made by this method is 
great (Fig. 14) but that prepared by Inman et. al. (1958) is of particular 
interest from a biochemical point of view. They prepared diethyl 
difluorooxaloacetate, a potential precursor for difluorooxaloacetate, 
itself a useful probe for the active site of malate dehydrogenase 
(Smith et. al.;l977) and aspartate transaminase (Briley et. al.; 1977)*
There have been many mechanisms proposed for the action of perchloryl 
fluoride as an active methylene group, but that proposed by Sheppard 
(1969) fits the observed facts. He proposed, as a simple mechanism for 
the reaction of anions with perchloryl fluoride, that the most nucleophilic 
centre in the anion always attacks the chlorine, and never the fluorine, 
which is more electronegative . With localised nucleophiles, such as 
alkoxides, fluoride ion is displaced, but with mesomeric ions an 
intramolecular, cyclic transfer of fluoride ion can occur in the 
intermediate to form a carbon-fluorine bond. The strong driving force
Fig. 13
(a) Addition of HF to an alkene.
R C H = C H 2  + H * RCH— CH3 » RCHF— CH3















(d) Displacement of sulphonate esters by tetraalkylammonium fluoride
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Mechanism of fluorination with perchloryl fluoride.
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for this reaction is the high energy gained by the formation of a 
carbon-fluorine bond, and the fact that fluorine never has to achieve 
that highly unfavourable energy state in which it has a positive charge 
This mechanism also explains the reaction of perchloryl fluoride with 
organometallic reagents, such as that described by Schlosser et. al. 
(1 9 6 9) (Fig. l4c). It explains the fact that phenyl1ithium gives 
perchloryl benzene rather that fluorobenzene, whereas 2-lithiothiophene 
gives 2-fluorothiophene.in high yield (Schuetz et. al.; I9 6 3)- The 
mechanism also forecasts the formation of by-products such as ethyl 
perchlorate when the reactions are performed in ethanol, as was 
described by Gershon et. al. (I9 6 6) (Fig. 15)• As can be seen ethyl 
perchlorate is capable of reacting with both starting material and 
intermediates and the final reaction mixture contains numerous by­
products, as well as the desired compound. Hence it can be seen that 
the choice of solvent for perchloryl fluoride reactions is crucial.
Such difficulties may be overcome by using a solvent system of toluene 
and dioxan (3:1) which was, for example, used by Briley et. al. (1977a) 
in their preparation of diethyl difluorooxaloacetate.
Synthetic modifications to pyridine compounds
In view of the proposed mechanism for fluorination reactions involving 
perchloryl fluoride, and the expertise gained at Bath University in the 
use of this reagent, it was decided to attenç)t the preparation of 
trifluoroacetylPyridine from ethyl nicotinoylacetate using perchloryl 
fluoride as the fluorinating agent. There are many methods published 
for the preparation of ethyl nicotino ylacetate (Koelsch; 1945), and a 
reaction sequence was accordingly proposed using this as the starting 
material (Fig. I6 ). As can be seen the proposed reaction sequence is 
compatible with the mechanism suggested by Sheppard, and the reactions
Fig. 15.
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Synthesis of 3-trifluoroacetylpyridine using perchloryl fluoride.
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other than the fluorination steps,are well documented.
Salvador and Saucier (1971) developed a method for the preparation of 
a series of trifluoroacetylpyridines from the corresponding lithio- 
pyridine derivative. They based their method on that of Zaitseva 
et. al. (1961), and it involves the reaction of N, N-diethyltrifluoro- 
acetamide with the appropriate lithiopyridine derivative (Fig. I7 ). 
Information was also given by Salvador and;Saucier concerning the 
spectroscopic data of these compounds, which became hydrated to form 
some of the few stable gem-dio Is which have been isolated in the pure 
state. The gem-dio1 of thenoyltrifluoroacetone (Fig. I8a) was one of 
the few cojnpounds of this type which had previously been isolated. Its 
stability is attributed to intramolecular hydrogen bonding.
Similarly, the four gem-dio is reported by Salvador et. al. (Fig. l8b) 
are also stablised by hydrogen bonding. Their remarkable stability 
is exemplified by a number of properties. The 2- and 4- pyridyl gem 
dioIs are, for example, recrystallisable from anhydrous organic 
solvents, while the 4-pyridyl compound can be sublimed at 120°C 
without loss of water. This stability can be accounted for by the 
inductive effects of the trifluoromethyl group on the acidity of the 
hydroxyl groups. Middleton and Lindsey (1964) showed that fluoro- 
alcohols form extremely strong hydrogen bonds (ca. 6 Kcal/mole) with 
electron rich atoms. This enables them to form stable 1:1 complexes 
with a series of bases. The stability of these complexes is a function 
of the acidity of the alcohols and the basicity of the bases involved. 
Like the fluoroalcohols, the hydroxyl function of some trifluoromethyl 
ketone gem-diols have been estimated (Stewart and Van der Linden; I96O) 
to be quite acidic, and they should thus form strong bonds with basic 
atoms.
Fig. 17
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Stabilising effect of hydrogen bonding in gem - diols
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The pyridyl gem-diols all contain basic nitrogen atoms and hence 
would be susceptible to both intra- and inter-molecular hydrogen 
bonding. As expected, the 3-pyridyl compound is less stable than either 
the 2- or 4-pyridyl compounds because of the mesomeric effects of the 
pyridine ring.
*H N.rn.r,spectroscopy showed a singlet for the hydroxyl groups in each 
of the pyridyl compounds, ruling out the possibility of strong, 
intramolecular hydrogen bonding, Leaving interraolecular hydrogen 
bonding as the main stabilising influence.
3“Lithiopyridine , the starting material for the synthesis of
3-trifluoroacetylpyridine , may be prepared by the method of Vibaut 
et. al. (1951).
Nucleoside synthesis
Nucleotides and their analogues have been synthesised by both chemical 
and enzymic methods, the first stage in a chemical synthesis being the 
preparation of a nucleoside.
A natural nucleoside was first synthesised by Todd et. al. (1947) 
using the method of Hilbert and Johnson (1930) who had found that a 
dialkoxy pyrimidine reacts at room temperature with one mole of an 
alkyl halide to give N(3)-alkylpyrimidine (Fig. 19a). (i.e. the new
alkyl group is bound to the same nitrogen as that to which the sugar 
is attached in a nucleoside) On treatment with acid the pyrimidine 
is converted to an uracil, and with alcoholic ammonia the corresponding 
cytosine is formed.
With acetobromoglucose, a halo sugar, in place of an alkyl halide, a 
completely analogous series of reactions takes place, and the 
P-D-glucopyrahosides of uracil and cytosine were obtained by Hil bert and 
and his co-workers ( 1930^1 ; I9 3 6). In the synthesis of cytidine 
(Todd et. al.; 194?) the reactants were diethoxypyrimidine and
triacetylribofuranosyl bromide, déacylation of the product with
Fig. 19-
(a) Reaction of pyrimidines with alkyl halides.
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An N(3)~alkyl pyrimidineDialkyl pyrimidine
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An uracil A cytosine
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(c) Mechanism of the reaction.
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alcoholic ammonia giving cytidine (Fig. 19b).
The mechanism of the reactions of dialkoxypyrimidines with halogeno 
compounds, and with acids is fundamentally the same. The first step 
is the addition of a proton, alkyl or glycosyl group to the nitrogen, 
followed by attack by the halide ion on the alkoxy grouping (Fig. 19c) 
A modification of this method, developed by Iwia et. al. (1964), has 
distinct advantages over the original method; the principal one being 
that sil.ylated derivatives may be prepared in excellent yields 
directly from pyrimidines such as cytosine, uracil or thymine. 
Silylation may be readily accomplished with either chlorotrimethyl- 
silane, hexamethyldisilazane or trimethyTsilyl-N-(trimethylsilyl) 
acetdmidate, the latter of which is reported to be a very powerful 
silylating agent.
As compared with the Hilbert-Johnson synthesis, in which alkoxy 
derivatives are employed, silylated pyrimidines react sluggishly 
with 0-acylglycosyl halides, and more rigourous conditions, such as 
heating the reactants together at high temperature, are required.
The residual trimethylsilyl groups thus formed are readily cleaved 
by water or simple alcohols, and the completely protected nucleoside 
is never isolated as such. Instead, they are usually dissolved in 
either methanol or ethanol which affords the acylated derivatives 
directly. Thus the reaction step in the Hilbert-Johnson synthesis, 
in which a residual alkoxy group of the glycosylated pyrimidine 
is separately cleaved has been eliminated.
The trimethylsilyl procedure frequently affords a mixtute of anomeric 
nucleosides (Fig. 20) (the Hil bert-Johnson synthesis gives 
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Synthesis of pyrimidine nucleosides using silylated derivatives.
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The method has been extended to the preparation of uracil nucleosides 
containing jD-arabinofuranose or _D-lyxofuranose residues, thymine 
nucleosides containing JD-arabinofuranose, ^-lyxofuranose or 
^-ribofuranose residues, and an adenine and a hypoxanthine nucleoside, 
both containing a ̂ -glucopyranose residue (Nishimura et. al.; 1964a 
and b: I9 6 5: I9 6 8).
Fusion of an 0-acylglycoside halide with a silylated purine or 
pyrimidine at high temperature (ca. 190°C) as in the previous 
synthetic routes is destructive to the halides involved. However, 
by using more reactive per-O-acyl-2-deoxyglycosyl halides milder 
conditions may be used. Durr et. al. (I9 6 7) fused 2-deoxy-3, 4, 6- 
tris-0-( 4-nitrobenzoyl)-a-^-arabinohexosyl bromide with 3 ,5-bis- 
(trimethylsiloxy)-as-triazine (prepared by the silylation of 3 >5“* 
dioxo-2 , 3> 4, 3-tetrahydro-as-triazine with hexamethylsila.zane) at 
85°C to give the acylated derivative in 35% yield. Déacylation yielded 
3 , 3-dioxo-2-(2f-deoxy-p-JD-arabino-hexopyranosyl)-2,3,4,3-tetrahydro-as- 
triazine (l-(2-deoxy-P^D-glycopyranosyT)-6-azauracil). The synthesis 
is not complicated by the formation of the undesired N-4 isomer, as was 
the case when the alkoxy derivatives were used. In a similar eaqperiment 
Shen and his co-workers (I9 6 8) synthesised 3»5~dioxo-2-(2-deoxy-P*^- 
erythropentafuranosyl)-6-trifluoromethyl-2 , 3 >4,3*“tetra-hydro-as- 
triazine (2 ’-deoxy-5*“trifluoromethyl-6-azauridine) by reacting 6- 
trifluoromethyl“3 ,5“t>is (trimethylsiloxy)-as-triazine with 2-deoxy- 
3,5-bis-0-(4-n.itrobenzoyl)-D-erythropentosyl chloride at l^O^C for 
30 minutes.
A significant improvement in the trimethylsilyl method was made by 
Wittenberg et. al. (I9 6 8) who eliminated the necessity for high 
tenq)eratures in the condensation, by dissolving an 0-acylglycosyl
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halide and a triraethylsilylated pyrimidine in a solvent, such as 
benzene, and subsequently adding silver perchlorate- The reaction is 
very exothermic and appears to proceed via.a highly reactive 
0-acylglycosyl perchlorate (Birkho.fer et. al.; 1964). The condensation 
is also facilitated by the addition of mercuric oxide and mercuric 
bromide to the reaction mixture, although in this case heating is 
required before the reaction will proceed. Alternatively, silver 
perchlorate and mercuric oxide/mercuric bromide may be used to prepare 
acylated thymine nucleosides derived from P-^-gàlactopyranose, a-L- 
arabinopyranose and p-^-ribofuranose in 45 to 48% yield. Thymine 
nucleosides containing 2-deoxy-D-erythro-pentafuranose, 2-deoxy-^- 
erythro-pentapyranose or 2-deoxy-D-threo-pentapyranose residues and 
1 -( 2-deoxy-D-erythro-pentopyranosyl ) uracil have also been prepared 
by a similar method (Wittenberg; I9 6 8: Wittenberg et. al.; I9 6 8). 
Winkley and Robins (I9 6 8; I9 6 9) used the trimethylsilyl method to 
prepare 2,4,6-trisubstituted pyrimidines which were difficult to 
prepare by other methods. The conditions of the condensation were 
modified by dissolving the trimethylsilylated pyrimidine and the
0 -acylglycosyl halide in dry acetonitrile, and allowing the reaction 
to proceed at room temperature for several days. Although time 
consuming, this variation of the method eliminates the necessity for 
either heating or using other reagents, and is undoubtedly the least 
destructive procedure, as shown by the high yields of acylated 
nucleosides- 516-D imethylur idine, . 6-methyl cytidine and 1 ?-JD- 
ribofuranosyl-barbituric acid have been prepared by this method. 
However, with silylated derivatives of 6 -aminouracil, ̂ -methyluracil 
and 6-(methylthio)-uracil glycosylation takes place at N-3 rather 
than N-1.
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It was shown by Fischer and Helferich (1914) that purine 
nucleosides may be synthesised by the reaction of the silver salt 
of 2, 8-dichloroadenine with a halogeno-sugar. Todd et. al. (1948) 
reacted the silver salt of 2 ,8-dichloroadenine with l-bromo-2 ,3 ,5- 
triacetylribofuranose, deacylated the product, then catalytically 
dehalogenated the nucleoside to yield adenosine (Fig. 21). The reason 
for using 2 , 8-dichloroadenine is that adenine itself is sufficiently 
basic to dehydrohalogenate the sugar derivative.
Davoll (1948; 1951) found that it was simpler to acylate the amino 
group and use, for exan^le, N-benzoyladenine. Further he showed that 
better yields were obtained using purine mercuric chloride rather than 
silver salts. The reaction,with these modifications, which still 
constitutes the best general method for synthesising purine nucleosides 
is illustrated by the synthesis of guanosine from the diacetylaminopurine 
mercuric chloride (Fig. 22).
The fusion method, developed by Sato and his co-workers (I9 6I) is a 
procedure for the synthesis of purine nucleosides, and is simply the 
fusion of an acylated sugar with a purine in the presence of an acidic 
catalyst under reduced pressure. The method is applicable to purines, 
and further substitution of the purine to provide protecting groups for 
such functions as amino, 0x0 or thio, which might already be present, 
is not necessary. The use of per-O-acylglucose is of distinct advantage, 
eliminating the necessity for transforming it into the corresponding, 
relatively unstable 0 -acyl glycosyl halide, hitherto the main 
intermediate used in the synthesis of purine nucleosides. A wide 
variety of purine nucleosides have been prepared by this method, in 
yields of up to 80% (Sato; I9 6 8: Sato et. al.; I9 6 5: Pan et. al.;
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The synthesis of 2-bromoadenosine (Montgomery and Hewson; 1964: I9 6 8) 
illustrates the procedure, and sefrves to show how a substituted 
purine may lead to a nucleoside that is readily transformed into 
another nucleoside with the same sugar residue (Fig. 23).
Imai and his co-workers (I966. ) have shown that the fusion of
1—CHacetyT-2,3i5-tri-0-benzoyl^D-ribose with various purine 
derivatives in the presence of iodine affords a somewhat better 
yield of benzoylated nucleosides than when acidic catalysts are 
employed. More recently, the superiority of iodine over p- 
toluenesulphonic acid as a catalyst is demonstrated in the preparation 
of 7“(3*» 45 6-tri-0-acetyl-^-deoxy-P“_D-arabinohexosyl) theophylline, 
6-chloro and 2,6,8-trichloro-9-(2*,4',6Vtri-0-acetyl-3“deoxy-p-^- 
xylosyl)-9H-purine and ?-(2%4%6-tri-0-acetyl-3-deoxy-p-^-xylosyl) — 
theophylline (Antonakis and Leclercq; I9 6 8).
The Glycal-Mercuri method consists of dissolving an acylated glycal 
in an inert solvent such as benzene and saturating the solution with 
anhydrous hydrogen chloride or bromide. The resulting product, a 
mixture of anomeric 0-acyl-2-deoxyglycosyl halides,is freed from excess 
hydrogen halide and, without further purification, is added in solution 
to a suspension of a monopyriraidinyl mercury salt dissolved in 
dimethylformamide. The resulting product is a mixture of acylated 
anomeric 2 '-deoxynucleosides, which are deacylated without resolving 
them at this point, affording a mixture of the a- and p- anomeric 
forms of the nucleoside. Often the anomers are then resolved by 
chromatography and recrystallisation.
The conversion of thymine into the anomers of l-(2-deoxy-^-arabino- 
hexopyranosyl)-thymine (Etzold and Langen; I9 6 8) illustrates this 
procedure (Fig. 24).
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pentapyranosyl or 2-deoxy—D-threo—pentapyranosyl residues, as well 
as to 2-deoxy-JD-^abinohexopyranosyl nucleosides of uracil, 
5-bromouracil, 5“fluorouracil and 5~iodouracil (Etzold et. al.;
1 9 6 6: 1 9 6 8; 1968a; Fox et. al.; I9 6 3: Zorback et. al.; I9 6 5: I9 6 8).
As a mixture of the anomeric 0-acyl-2-deoxyglycosyl halides is 
employed in the condensation the formation of both the a-D- and 
P^D-anomers is inherant in the method.
The mercuric cyanide/nitromethane procedure introduced by Helferich 
and Weis (195&) is a modification of the Koenigs - Knorr synthesis 
of glycosides and involves the substitution of mercuric cyanide for 
either silver carbonate or silver oxide, both of which have been 
employed as routines acceptors in the synthesis of 0-glycosyl 
derivatives (Koenigs and Knorr; I9OO: I9OI). By substituting 
nitromethane for the more usually used inert solvents the reaction 
may be performed in the homogeneous phase, thus leading to improved 
yields of acylated glycosides.
In the initial application of the mercuric cyanide/nitromethane 
procedure to the synthesis of nucleosides (Yamoaka et. al.; I9 6 5) 
outstanding yields of per-O-acylated nucleosides derived from 
N-benzoyladenosine, N-benzoylcytosine,6-chloropurine, 2 ,6- 
dichloropurine, theophylline and 2,4,8-trichloropurine were 
obtained using 2,3,4,6-tetra-O-acetyl-a-D-glucosyl bromide or 
chloride.
With the exception of amino-substituted pyrimidines, pyrimidines 
such as thymine and uracil may be directly subjected to the reaction, 
without prior conversion to the mercury derivative. In the case 
of bases such as adenine and cytosine it is advantageous to protect 
the amino group by acylation prior to coupling. However, it has been 
shown that 2-thiocytosine may be used directly in the reaction. Coupling 
of this compound with 2,3,5-tri-O - acetyl-D-ribosyl bromide affords
the acetylated nucleoside in 29% yield (Rogers and Ulbricht; I9 6 9).
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Many purines and pyrimidines are not very soluble in nitromethane 
and so these compounds are suspended in a solution of glycosyl 
halide in nitromethane in order to facilitate the reaction, which, 
as it proceeds, becomes homogenous. This procedure is applicable 
to the preparation of per-O-acylated-l-a-L-arabinofuranosyl -N- 
benzocytosine(Yamao!ca et. al.; I9 6 8) and N-acetyl-l-(2,3,5-tri-Q- 
benzoyl-4-O-methanesulphonyl-p-^-galactosyl)-cytosine (Watanabe and 
Kotick; I9 6 9); the latter in 100% yield. The ready preparation of a 
number of pyrimidine nucleosides employing this method has been 
reported (Fox and Watanabe; I9 6 9) and it was observed that 
exceptionally high yields of acylated products were obtained from 
pyrimidines containing highly electronegative groups at C-5« By 
this method the following nucleosides were prepared;- 
acylated p-D-glucopyranosyl (di or tetra-hydro) pyrimidine 
nucleosides derived from 6-oxo-l,6- dLhydro-pyrimidine, thymine, 
5-ethoxycarbonyl- and 5-fluorouracil; benzoylated-p-D- 
ribofuranosyl (di-and tetra-hydro) pyrimidine nucleosides derived 
from N-benzoylcytosine, thymine, uracil or derivatives of uracils 
containing ethoxycarbonyl, cyano, fluoro or nitro substituents at 
C-5» The formation of 2* ,3 ' »5'~tri-0-benz-oyluridine (77% yield) is 
particularly noteworthy because in the standard "mercuri" synthesis 
uracil fails to give nucleoside products.
By far the simplest method for the synthesis of nucleosides in which 
a glycosyl-nitrogen bond is formed was developed by Schramm and his 
co-workers (I9 6 2) and takes the form of the condensation of a sugar 
with a base in the presence of phenyl polyphosphate. In this 
procedure unprotected sugars and unsubstituted purines can be used 
directly, thus eliminating the necessity to prepare intermediates. 
Because of its simplicity this method is potentially the most
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powerful synthesis of nucleosides, being less time-consuming and 
laborious than most other methods. A further advantage is that the 
stereo chemical restrictions of acylated sugars or acylated glycosyl 
halides are avoided, and that anomers, not readily accessible by 
other methods, can be prepared in satisfactory yield.
The method consists of heating an acidified solution of a purine, 
phenylpolyphosphate and a pentose in dimethylformamide at 50°C for 
5 minutes to give a mixture of anomeric nucleosides.
The procedure has been employed in the preparation of 2*- 
deoxyadenosine and 9 ( p-D-arabino-f uranosyl) adenine ( Carbon ; 1963: 
Cohen; I9 6 6). However, the results are difficult to reproduce.
In order to develop the procedure into a useful preparative method 
extensive studies have been carried out with adenine and ̂ -ribose 
or 2-deoxy-D-erythro-pentose (2-deoxy-D-ribose). Thus, optimal 
reaction conditions were worked out and a structure for the 
intermediate polyphosphate ester suggested.
The synthesis of adenine and its anomer (Fig. 25) illustrates the 
reaction sequence. Adenine reacts with phenyl polyphosphate to 
afford a phosphorylated intermediate which then couples with 
ribofuranose to give the intermediate A. In acidic solution the 
phosphate ester residue is transferred from the 9-position of the 
purine to the hydroxyl group at 0 -1  of the pentose, thus enabling 
nucleophilic attack of N-9 on C-1' probably by means of a concerted 
reaction. The phosphoramide bond is subsequently cleaved in 
aqueous solution to yield equal amounts of adenosine and its 
anomer with a total yield of approximately 20%.
The method is applicable to the condensation of adenine with 2-deoxy- 
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anomer with a yield of 40% (Schramm et. al.; I9 6 7) in which the 
a-form predominates slightly. Similarly heating adenine and 
^-arabinose for 5 minutes at 50°C in the presence of phenyl 
polyphosphate gives a 25% yield of 9 {^“arabinofuranosyl).adenine, 
with the a-and p-anomers in a ratio of 4:3. This method represents 
a simple method for the synthesis of biologically active 9 (P-D- 
arabinofuranosy^adenine.
Todd and his co-workers (1947b; 1950: 1957) prepared NMN with a 
view to the total synthesis of NAD^ in order to verify the structure of 
various nicotinamide based co—enzymes. Adenosine-5'-phosphate 
had already been prepared (Baddiley and Todd; 1947) and so their 
first step was the synthesis of dihydro-nicotinamide riboside. The 
first synthesis of a glycosyl-pyridinium salt was that of N-{2’,3'»
4* ,6*-tetra-acetyl-^-glu'Cosyl)pyridinium bromide (Fischer and Raske; 
1910) which was prepared by the reaction of (%-acetobromo-glucose and 
pyridine in the presence of phenol-
Karrer and his co-workers (1937) investigated the structure of NAD* 
and designated the nicotinamide ring as the moiety reduced during its 
coenzymic action, T hey extended the work of Fischer and Raske to the 
preparation of several related compounds and acetobromoglucose, 
acetobromoarabinose and acetobromoxylose were all condensed with 
nicotinamide in dioxan solution. These quarternary ammonium salts 
showed oxidation-reduction properties similar to those exibited by 
NAD*. It was later shown that the nicotinamide-ribose linkage in 
NAD* was similar to that present in the synthetic materials. This 
was done by the enzymic hydrolysis of NAD* using sweet almond press 
cake, which yielded adenosine and nicotinamide nucleoside which, 
although devoid of co-enzymic activity exhibitedproperties similar to 
those shown by Karrer's model nucleosides (Schlenk; 1940: 1941: 1942:
1 9 4 3: Schlenk and Gingrich; 1942: 1944).
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Todd further extended Fischer's work to include the preparation of 
quarternary ammonium salts from nicotinamide and acetohalogeno- 
derivatives of ̂ -mannopyranose,, JD-galactopyranose and JD-ribofuranose, 
as well as repeating the work of Karrer.
The general method used by Todd was to condense the acetylated 
halogenosugar with nicotinamide in dry acetonitrile at 0°C. The 
crude product was purified by dissolving in chloroform and 
reprecipitation by the addition of diethyl ether. The quarternary 
ammonium salt was dissolved in saturated aqueous sodium hydrogen 
carbonate and the solution was saturated with carbon dioxide and 
sodium dithionite added. The product was extracted with chloroform 
and isolated by the addition of petroleum spirit, finally being 
deacetylated by dissolution in dry ammonia-saturated methanol. (Fig.26). 
Because of the great instability of N-(_D-ribofuranosyl)-1,2- 
dihydronicotinamide obtained from the reaction of nicotinamide and
l-bromo-2 ,3 ,5-tri-0-acetylribofuranose this glycoside was unsuitable 
as the starting point of the synthesis of NAD*. Hitherto ammoniacal 
déacylation of the quarternary glycosides had not been regarded as a 
satisfactory step in nucleoside synthesis because of the instability 
of the nucleoside under alkaline conditions.
Consequently acidic hydrolysis was widely used until Todd discovered 
that ammoniacal hydrolysis of quarternary ammonium salts could be 
performed with care. Todd improved the preparation by using l-chloro-2, 
3 ,5""tri-0-behzoylribofuranos^ . as the glycoside, condensing this with 
nicotinamide to form N-(2',3',5'-tri-0-benzoyl-^-ribofuranosyl)-3- 
carbamoylpyridinium chloride which was debenzoylated by dissolution in 
dry ammoniacal methanol to give N-(^-ribofuranosyl)-3~carbamoyl- 
pyridinium chloride, the intermediate compound in the synthesis of 
NMN (Fig. 27)- It would seem that this method could be adapted to the 
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Synthesis of nicotinamide nucleoside
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The effect of acylated a-bromosugars giving exclusively glycoside with 
p-configuration is readily explicable on the assumption that the reaction 
proceeds with a single, normal inversion at C-1 of the sugar. However, 
the synthesis of the natural p-nucleosides described all used syrupy 
ribofuranosyl halides which are almost certainly a mixture of the 
a- and P- forms. However, in the synthesis of puromycin (Baker et. al.; 
1 955) a crystalline halogenosugar known to have the P-configuration 
also gave only the p-nucleoside. Baker (1957) suggested that the 
condensation of a heavy metal salt of a purine with an acylated 
glycosyl halide will form a nucleoside with a 1,2-trans configuration 
in the sugar(i.e. usually a P-configuration) regardless of the original 
configuration at C1-C2. If the halogenosugar has the 1,2-cis-configuration, 
the purine will enter a single SN2 reaction with inversion at C-1, 
giving a nucleoside with the 1,2-trans configuration, which may be 
a- or p- depending on the sugar (Fig. 28a).
Halogenosugars with a 1,2-trans configuration undergo two SN2 reactions, 
the first of which is intramolecular with the participation of the 
2-acyloxy group (Fig. 28b).
Thus the formation of P-ribosides from p-ribose is seen to depend on the 
neighbouring group participation of the 2-acyloxy group. If such a 
group is missing or sterically hindered a mixture of products is to 
be expected. This was found, for example, in the adenosine synthesis 
using 5-0-benzoyl-JD-ribofuranosyl bromide-2,3-cylic carbonate, which 
gave the a- and p- anomers (Wright et. al.; 1958) and in the synthesis 
of 2'-deoxyribosides from 2-deoxyribose.
The Synthetic NMN prepared by Todd and his co-workers had an optical 
rotation ( [ot]p ) of-38^ which was compatible with the/p-anomer, 
whilst the optical rotation of the a-anomer, obtained from an
Fig. 28.
(a) Glycoside formation when the halosugar has a C1-C2 cis configuration,
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impurity in NAD , has an optical rotation of+58 .̂
Nucleotide synthesis
The last stage in the preparation of a nucleotide is the phosphorylation 
of the nucleoside. A great range of reagents have been used with 
varying degrees of success. In their phosphorylation Todd and his 
co-workers encountered several difficulties, the first being that 
nicotinamide riboside is insoluble in most organic solvents and 
sufficiently unstable to render impractical any protection for the 
2* and 3* hydroxyWith, for example, an isopropylidene residue. A 
solution would be to prepare the nucleoside from a ribofuranose 
containing a reactive group, such as iodo, or a protected phosphory1 
residue in the 5'“ position. However, Todd (working in collaboration 
with R L Hinman) met with little or no success, and so this approach 
was abandoned.
Todd then turned to direct phosphorylation of the nucleoside using, 
firstly, phosphoryl chloride in moist pyridine, a reagent that had 
been used successfully in the field of riboflavin chemistry (Forest and 
Todd; 1950). However, despite initial success it was found that 
nicotinamide nucleoside had a half-life of only eighteen hours in 
moist pyridine, being converted into another nucleoside later identified 
(by paper chromatography) to be quarternary pyridine ribofuranoside 
(indicating a transglycosylation between pyridine and nicotinamide).
The nicotinamide nucleoside was, however, stable when dissolved in 
anhydrous m — cresol or dimethyl formamide, or when suspended in 
acetonitrile or nitromethane. Nitromethane was found to be the best 
medium for phosphorylation, although acetonitrile was almost its equal. 
The nucleotide was isolated by passage down anion and cation exchange 
resins. It was found that the nucleoside had been phosphorylated to 
an extent of 20%, and was exclusively the 5*-phosphate. This was proven 
by hydrolysis with snake vemon ^'-nucleotidase (which caused the complete
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breakdown of the nucleotide), periodate titration and both 
chromatography and electrophoresis on paper in the presence of 
borate ions. Moreover, the paper chromatographic behaviour was 
identical to that of an authentic sample of NMN obtained by enzymic 
degradation of NAD*. The optical rotation ( [a]p = -24^) showed that 
the anomers were present in the ratio of a; p:: 4 :1 , and this was 
later confirmed by further synthetic work.
A phosphorylating agent, to be of general use must be available on a 
large scale, stable for long periods, very reactive and such that the 
unprotected intermediates can be converted into the desired products 
under mild conditions. Many reagents have been suggested as useful 
phosphorylating agents, but few fulfill all the above criteria.
0-Benzyl phosphorus-O,0-diphenyl phosphoric anhydride, in the presence 
of 2 ,6-lutidine as a catalyst, reacts with the free hydroxyl groiç> of 
a sugar to form a benzyl phosphate, which can be chlorinated with 
N-chlorosuccinamide. Hydrolysis gives the benzyl hydrogen phosphate, 
and the benzyl group can then be removed by catalytic hydrogenation 
(Brown et. al.; 1954) (Fig. 29).
2-Cyanoethylphosphate, prepared by the reaction of phosphorus 
oxychloride and 1-cyano-2-hydroxyethape, has been used for the 
synthesis of phosphPraonoesters of alcohols, particularly of 
nucleotides (Tener; I9 6I). It is coupled to the alcohol using 
dicyclohexylcarbodiimide (DCC) as the condensing agent and pyridine as 
the solvent, as exemplified by the preparation of 3 '-0 -tritylthymidine 
(Fig. 3 0). The protective trityl group may be removed by acid 
hydrolysis, and very mild alkaline hydrolysis will yield the desired 
phosphate ester. 2-Cyanoethyl phosphate also has the advantage of being 
stable in aqueous conditions.
Dibromomalonamidç prepared by reaction of malonamide and bromine in 




CH + (C^H^O lgPOPO CHÿ^Hg




C H 0P 0C H 2C ^H













[ OH Ac = acetyl group
OAc
or
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with a twofold excess of triethyl phosphite to phosphorylate hydroxy 
compounds (Mukaiyaraa et. al.; I9 6 3).
Dioxan diphosphate, prepared by the reaction of one mole of dioxan 
and two moles of 88% aqueous orthophPsphoric acid (Baer; 1944), has been 
used by Chambers and his co-workers (I9 6 0) to prepare nucleoside 
diphosphates (Fig. 31)» A nucleotide is converted into the 
5'-phosphor ami date by reaction with a mixture of ammonium and DCC, and 
the amidate is treated with dioxan diphosphate in o-chlorophenol for 
three hours at O^C. The diphosphate is precipitated by the addition 
of petroleum ether and purified as the ammonium salt. However, dioxan 
diphosphate is very hygroscopic and readily decomposed by water.
A series of diacyl phosphorochloridates (Fig. 32a) have also been used 
as phosphorylating agents (Brigl and Muller; 1939: Zeile and Meyer; 1938: 
Zervas; 1939: Atherton et. al.; 1943: Zervas and Dilaris; 1955: Witzel 
et. al.; I96O). These compounds may all be used to prepare phosphate 
ester by the same general method (Fig. 32b). Diphenylphosphorochloridate 
is the most widely used of these compounds and has been used in the 
preparation of DL-glyceraldehyde-3-phosphate (Baer; 1931)» However, 
all the diacylphosphorochloridates have some disadvantages. They are, 
with the exception of the diphenyl compound, difficult to prepare on a 
large scale or are unstable in the presence of moisture.
Metaphosphoric acid, which is prepared by heating 83% phosphoric acid 
(Fig. 33a), has been used in the synthesis of pyridoxal-3 *-phosphate, 
which was isolated as the calcium salt. Nitric acid is used in the 
hydrolysis step to destroy the N,N-dimethyl-glycyl hydrazine (Viscontini 
et. al.; 195D (Fig. 33b).
o -Phenylene phosphorochloridate is prepared from catechol and phosphorus 
pentachloride, the product being reacted with acetic anhydride (Fig. 34a). 
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(b) Phosphorylation using the above compounds.
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pyridine) to give a phosphotriester, which is easily hydrolysed to 
the o-hydroxvphenol phosphate ester which, when treated with excess 
bromine water, is converted into the monophosphate in good yield 
(Khawaja and Reese; I9 6 6) (Fig 34b). These conditions are mild and 
the reactions proceed in good yield; the reagent is easily made on 
the molar scale, and is stable when kept in a sealed tube. Hence all 
criteria for a good phosphorylating agent are apparently satisfied 
and the reagent looks like a good one for the conversion of nucleosides 
into nucleotides. Khawaja and Reese (I9 7I) have investigated the 
reaction between _o-phenylene phosphorochloridate and the 2 ,3- 
isopropylidene derivatives of N^, N^-dimethyl adenosine and uridine and 
found the products, after isolation, to be the corresponding 
hydro3cyphenol phosphates, the reaction proceeding in good yield.
Acidic hydrolysis, followed by treatment with bromine in aqueous sodium 
carbonate oxidised the products to the corresponding 5*-nucleotide. 
However, complications may occur at the oxidation stage when unsaturated 
alcohols are phosphorylated.
Phosphorodimorpholidic chloride, prepared from morpholine and 
phosphoryl chloride in benzene, has been used to phosphorylate 
alcohols (Montgomery and Turnbull; 1958)i A mixture of the alcohol, 
phosphorodimorpholidic chloride and 2 ,6-lutidtne are refluxed, and the 
aryl diethylpho$phorodimorpholidate ’ produced is extracted with 
ether, and purified (Fig. 35)- Hydrolysis to the dihydrogen phosphate 
is facilitated with a protonated ion-exchange resin. When 
phosphorodimorpholidic bromide, a much more reactive compound than 
phosphorodimorpholidic chloride, is used the reaction proceeds at 
room temperature.
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pentoxide in 85% phosphoric acid, has been used as an alternative 
to phosphoryl chloride in the phosphorylation of pyridoxamine 
dihydrochloride (Wilson and Harris; l95l)(Fig. 3 6).
Polyphosphoric acid was used by Cherbuliez and Rubinowitz (1956; I9 3 8) 
to prepare the monophosphates of various aminoalcohols and 
hydroxy esters, while Hall and Khar ana (1955) used it for the 
preparation of uridine-5 '-phosphate.
Pyrophosphoryl tetrachloride is prepared in 30% yield by heating 
phosphoryl chloride with phosphorus pentoxide in a sealed tube, and 
fractionating the mixture of products (Grunz;e; I9 5 8). A second method 
involves the reaction of phosphoryl chloride and water (Besson; 1897: 
Becke-Goehring and Sambeth; 195?) (Fig. 37a). At low temperatures 
and without solvent, the reagent reacts with the primary alcohol group 
of 2 *,3 '-isopropylidene nucleosides to give the 5 '-dichlorophosphate 
which, on treatment with water gives the 5'-monophosphate (Koransky 
et. al.: I9 6 2). Yields are in the order of 80% and the method avoids 
base catalysis and the removal of organic residues (Fig. 37b). Gruber 
and Lynen (I9 6 2) found that in the presence of triethylamine the reagent 
reacts with the free alcoholic group of 2 ',3 *-isopropylidene adenosine 
to give the pyrophosphate ester. Hydrolysis and removal of the 
isopropylidine group with formic acid gave a material containing 22%
ADP (Fig. 37c). They also showed that the reagent may be used for
preparation of unsymmetrical diesters of pyrophosphoric acid and suceeded 
in the synthesis of coenzyme A, although the reaction only proceeded in 
low yield.
Pasternak (I95O) used silver diphenylphosphate to synthesise 
a-D-glucose-l-phosphate (Fig.3 8). Tetra-O-acetyl-a-D-glucopyranosyl 
bromide is usually phosphorylated with inversion at C-1, but it reacts 
with silver diphenylphosphate with retention of configuration. The 
product is isolated as the crystalline potassium salt.
Fig. 37.
(a) Synthesis of pyrophosphoryl tetrachloride.
2  POCI3 + H2O
Î !
C I2P — 0 — PCI2 + 2 HCl
(b) Phosphorylation of alcohols by pyrophosphoryl tetrachloride,
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Tetra-p-hitrophenyl pyrophosphate is prepared in situ by the reaction 
di—p—^^trophenyl hydrogen phosphate with di—p—tolylcarbodiimide in 
anhydrous dioxan (Moffatt and Khorana; 1957). It reacts with an 
alcohol to give the neutral di-p-nitrophenyl ester without basic 
catalysts. One of the p-nitrophenyl groups is removed under mild 
alkaline conditions, the second by heating with alkali (Fig. 39). The 
p-nitrophenyl groups may also be removed by hydrogenolysis, the first in 
neutral medium, and the second in the presence of an acid catalyst. 
Guanosine-5*- phosphate was prepared in a yield of 70% by this method 
(Chambers et. al.; 1957).
As can be seen from the forgoing observations there would appear to be 
no single phosphorylating agent which fulfills all the criteria set out 
for the perfect phosphorylating agent and hence choice of a reactant for 
a particular synthesis is difficult. Hence it was decided to use o- 
phenylene phosphorochloridate in the synthesis of the nicotinamide 
riboside 5 '-phosphate and if this did not succeed to follow the synthesis 
set out by Todd and his co-workers who, as already stated, used 
phosphoryl chloride at the phosphorylation step.
Chemical Methods of Pyrophosphorylation
In the original chemical synthesis of NAD by Todd and his co-workers 
(Hughes et. al. 1957) the pyrophosphorylation step was facilitated using 
dicyclohexylcarbodiimide in aqueous pyridine, although NAD^ had
been reportedly detected enzymicly in a mixture produced by the action 
of trifluoroacetic anhydride on NMN and AMP.(Shuster et. al.; 1955). 
Dicyclohexylcarbodiimide had previously been used in the synthesis of 
nucleotide pyrophosphates in anhydrous pyridine or dimethylformamide 
(Christie et. al.; 1953), but it had also been reported (Khorana; 1954) 
that aqueous pyridine could be used provided that a large excess of
— 4t2 —
dicyc lohexylcarbodiijnide was used.
The expected products (Fig, 4o) were obtained from the reaction, and 
were separated by anion exchange chromatography. The product was 
isolated as an amorphous powder which had the correct elemental 
analysis and was shown to be 70% pure p—NAD (by reaction with yeast 
alcohol dehydroSGnase). The yield of product at this stage of 
purification was 46%, an excellent yield for a reaction of this type. 
Subsequently dicyc-lohexylcarbodilmide, usually in aqueous pyridine, 
has proved to be a very useful method for the synthesis of dinucleotides, 
particularly in the field of NAD^ analogues (Fig. 41). As can be seen, 
the reaction has not been used to prepare analogues in which the nico­
tinamide moiety has been replaced. This is because of the ease with 
which these analogues may be prepared using NAD* transglycosidase from 
pig brain. However, there is no reason why such NAD* analogues 
may not be prepared by this method.
One disadvantage with this method is that when two different 
nucleotides are condensed more than one product will be obtained 
(Fig.40 ). For example when the reaction to condense NMN and AMP was 
investigated by Hughes, as well as NAD*, the desired product, the 
condensation product between two molecules of NMN, as well as the 
product from the condensation of two môlecules of AMP were isolated. 
Hence, after a lengthy synthesis to prepare a dinucleotide analogue 
considerable product may be lost when these unwanted by-products are 
formed.
However, Moffatt and Khorana (I9 6I) reported N, N*-dicyclohexyl-4— 
morpholinocarboxamidine, the condensation product between morpholine 
and dicyclohexylcarbodiimide will condense with an equimolar amount
of one of the nucleotides to give the morpholidate, and then this will 
condense with an equimolar amount of the second nucleotide (Fig. 42).
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R' ss ribofuranose R' * = guanine
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( Honjo et. al. ; I9 6 2. )
R* ss ribofuranose R* • ss thiopurine
R' ss ribofuranose R» ' methylthiopur
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( Pfleiderer et. al. ; 19^3» 1964. )
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purified by ion-exchange chromatography.The reactions proceed in good 
yield,but it is possible that the 3 ',3 'ribosyl cyclic phosphate may be 
prepared from the morpholidate in the presence of excess dicyclohexyl­
carbodiimide, although elevated temperatures are generally required for 
the reactions to proceed via this pathway (Moffatt and Khorana; I96la) .Another 
advantage of this method is that the morpholidates are usually soluble 
in anhydrous pyridine, whereas the unsubstituted ^'-nucleoside 
phosphates are not, anhydrous pyridine being the solvent in which the 
reaction proceeds with the best yield (Smith et. al.; I9 6I).
Enzymic synthetic methods.
Dinucleotide synthesis.
Of the enzymic methods for the synthesis of analogues of NAD^ the most 
attractive is that of Kaplan and his co-workers (1954) who investigated 
the effect of isonicotinic acid hydraz;ine (INH) on NAD* transglycosidase 
from beef spleen, and later isolated the INH analogue of NAD*. The 
ability of NAD* transglycosidase from beef spleen to catalyse an 
exchange reaction between the nicotinamide moiety of NAD* and added 
nicotinamide was noted (Zatman et. al.; 1953) and it was proposed that 
this enzyme might catalyse group transfer reactions of a more general 
nature, that is the transfer of the ADHl group of NAD* to compounds 
structurally related to nicotinamide. Depending on the nature of the 
acceptor molecule the resulting analogue may, or may not, be active in 
oxidation-reduction reactions. Using purified NAD* transglycosidase 
INH (1 X  10 ^M) was found to cause 50% inhibition in the rate of
disappearance of NAD*, whereas with nicotinamide a ten-rfold increase 
in concentration was required to cause a similar inhibition. This 
effect of INH is relatively specific, such compounds as nicotinic acid 
hydrazine, N'-raethylisonicotinic acid hydrazine, nicotinic acid and 
isonicotinic acid having little effect. The only other compounds found
— 44 —
to inhibit the enzyme were isonicotinamide, the N-isopropyl 
derivative of INH, imidazolecarboxamide and thioazolecarboxamide.
In further experiments NAD*transglycosidases from other animal 
tissues were used under similar conditions with varying results 
(Fig. 43). On the basis of these results, Zatman divided NAD* 
transglycosidases into the categories of INH sensitive and INH 
insensitive enzymes, depending on whether the enzyme was inhibited 
by INH. He then looked for evidence of analogue formation in both 
systems, and was able to detect it in only the INH insensitive enzymes 
which included those from human spleen and prostrate, and horse and 
pig brain.
In a subsequent investigation Zatman and his co-workers (1954) 
reported that, using NAD* transglycosidase from pig brain,the 
INH analogue cf NAD* was isolated in 73% yield. It was analysed 
chemically and the results were compatible with the analogue's having 
a structure similar to NAD*, but with the nicotinamide moiety replaced 
with INH. Physical and enzymic properties of the analogue were reported, 
the analogue being found to be more than twice as potent an inhibitor 
as free INH of the INH-sensitive NAD* transglycosidases. No inhibitory 
action on any of the NAD*-linked dehydrogenases was noted. In this 
paper it was also suggested that the mode of action is via an ADPR— 
enzyme intermediate (Fig. 44). The non-competitive nature of the 
inhibition of NAD* transglycosidase from beef spleen can readily be 
accounted for in this formulation by including complexes between the
ADPR-enzyrae complexes and the ribosyl acceptors (ADPR-enzyme---
nicotinamide and ADRP-enzyme  INH). In the "insensitive" enzyme
system the latter complex would break down to form the analogue 
(Fig. 44a), whereas in the case of "sensitive" enzyme systems the reaction 
would not proceed in either direction. Zatman believed this to account 
for the inhibition of NAlf breakdown by INH and its dépendance on NAD 
concentration; the inhibition, by INH, of the incorporation of
Fig. 43.
Effect of various inhibitors on NAD^transglycosidases from various
sources.




41Rabbit brain 1 X 10
Horse brain 1 X  10
-2Beef spleen 1 X  10
CONHNHCH
2 X 10 50
Duck brain
-2Human prostrate 2 X 10
-2Pig brain 2 X  10
ONHNH
2 X 10Beef spleen
-2Pig brain 2 X  10
-2Beef brain 1 X  10
-2COOH Pig brain
-2S O 2 O H Beef brain 1 X 10
-2Pig brain 2 X  10
HNH -22 X  10Beef spleen
-2Pig brain 2 X  10
Fig. 44.
N AD^ + E nzym e
i  N i c o t i n a m i d e
A D P R  Enzyme
± IN H
AD PR (INH )
t
Enzyme




A DPR-------- E n z y m e  IN H ADPR(INH) + Enzyme
Formation of NAD* analogues using NAD* transglycosidase.
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radioactively labelled nicotinamide into NAD* the failure to form 
detectable amounts of analogue and the failure to hydrolyse added 
analogue, all of which are properties of the ’’sensitive” enzyme 
system. He also reported that the INH analogue of NAD* is a stronger 
inhibitor of NAD transglycosidase than INH itself. This finding 
strengthened the view that the inhibition caused by INH is due to its 
conversion into the analogue, which, once formed, even in minute 
amounts, remains attached to the enzyme, beirg neither hydrolysed 
by the enzyme or released into the bulk of the medium. He also 
found, surprisingly, that the analogue, apart from its inhibitory 
action on NAD transglycosidases, is not a general inhibitor of NAD* 
requiring enzyme systems.
Kaplan and Ciotti (1954) reported that the NAD*transglycosidase prepared 
from pig brain catalysed the formation of the 3-acetylpyridine- analogue 
of NAD* from 3-acetylpyridine and NAD*. This analogue was of particular 
interest, as it was the first pyridine substituted analogue of NAD* 
which was shown to be active as a coenzyme in a number of dehyd­
rogenase reactions and 3-acetylpyridine had been shown to be an 
antagonist of nicotinamide in animals (Woolley; 1945î McDaniel et. al. 
1955: Kaplan et. al.; 195^)* In a later paper Kaplan and Ciotti (195&) 
compared the properties of this analogue with those of NAD*, as well 
as giving the details of the synthetic method which were later shown 
to be general. The spectrum of the reduced form of the analogue has a 
\nax 365 nm with a molar extinction coefficient of 7*8, whereas
NADH itself has a at 340 nm with a molar extinction coefficient of
6.3- The analogue is also reduced with bisulphite, and this reduced 
compound has an identical ultraviolet/visible spectrum to that of 
the enzymically reduced compound. Yarmolinsky and Colowick (1956) 
reported a yellow intermediate, formed during the bisulphite 
reduction of NAD*. This was not thought to be the half-reduced
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intermediate, but the sulphoxylate addition product, which has a
A between 355 and 36O nm. The analogue also forms a similar max
intermediate, which is intensely yellow, and has a distinct peak 
at 385 nm-
The 3-acetyl pyridine, analogue of NAD* forms an addition product with 
cyanide ions, as does NAD* itself, the analogue, however, forming
the product much easier than does NAot The X for the analogue—■ max
cyanide compound is at “ikO nm whereas for NAD* it is 325 nm. The 
analogue also forms addition compounds with dihydroxyacetone and 
bisulphite, as does NAD*, again the compounds adding more easily to 
the analogue than to NAD*. Changes were noted in the ultra-violet/ 
visible specta of both the analogue and NAD* when they were dissolved 
in dilute alkali. Subsequently Kaplan and his co-workers produced 
a series of 3-substituted pyridine analogues of NAD* and 
investigated the addition of cyanide and their reduction with 
yeast alcohol dehydrogenase and bisulphite. They found that, of 
the analogues which they investigated, only the 3-acetylpyridine 
and the pyridine-3-aldehyde analogues reacted with cyanide, yeast 
alcohol dehydrogenase and bisulphite in a manner similar to that of 
NAD*. Other analogues react with none or some of these compounds.
(Fig. 4 5)
As previously stated the method developed by Kaplan and his co-workers 
for the production of analogues of NAD* in which the nicotinamide 
moietyis substituted has proved to be a fairly general one. (Fig. 46) 
One analogue of particular interest is the 3-chloroacetylpyridine 
analogue which was prepared, via, the 3-diazoacety]pyridine analogue, 
by Biellmann et. al. (197^)- If the 3-fluoroacetylpyridine analogue 
could be prepared information obtained using this analogue would 
complement information obtained from reactions involving the
3-tr if luoroacetylpyr idine analogue.
The 3-chloroacetylpyridine analogue, claimed to be an alkylating agent
Fig. 43.
Comparison of the reactions of NAD with some 3-substituted pyridine
analogues of NAD*.
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Nicotinamide substituted NAD^ analogues prepared using NAD^ 
transglycosidase from pig brain.
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can be used to detect the presence of functional amino-acid residues 
at the catalytic sites of dehydrogenases. As basic residues are 
involved in the mechanism of enzymic dehydrogenation of hydroxy 
compounds alkylation of these basic groups by an alkylating agent 
such as this analogue should yield useful information on dehydrogenation.
NAD tpansglyqosidases from animal tissue other than pig brain have been 
used to prepare analogues of NAD*. For instance the NAD* trans- 
glyeosidase from beef spleen has been used by Nishizuka et. al.
(1 963) and Hanjo et. al. (1964) to prepare nicotinic acid adenine 
dinucleotide. The transglycosidation proceeds at pH 7-5 in 
tfis-chloride buffer and is monitored by determining the total 
dinucleotides by forming the cyanide adduct and then determining the 
NAD* which remains unconverted using alcohol dehydrogenase from yeast, 
the analogue not being reduced under these conditions.
Mononucleotide preparation
An alternative method for the preparation of analogues of NAD* is to 
first prepare the nicotinamide mononucleotide analogue by using a 
phosphoribosyl transferase and then to join this analogue to 
adenosine monophosphate by either chemical or enzymic means.
The principle of this method is that the ribose-5-phosphate moiety 
of 5“phosphoribosyl-l-’pyrophosphate (PRPP) is transferred enzymically 
onto the base (Fig. 47 )» inorganic pyrophosphate being liberated.
The source of the phosphoribosyl transferase can be from either 
animal tissue or microorganism, and are generally specific in their 
base requirement.
Lactobacillus fructosus was reported by Kodama (1956) to require 
nicotinamide for growth and mainte nance but not to use nicotinate.
The biosynthetic route to NAD* in this microorganism was subsequently 
shown by Ohtsu et. al. (I9 6 7) to contain a phosphoribosyl transferase 
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Synthesis of NAD* or a NAD* analogue using a phosphoribosyl
transferase.
(3~Trifluoroacetylpyridine is used as the substituted pyridine
in this example.)
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The purified enzyme is stable for several months without detectable 
loss of activity in phosphate buffer at pH 7* The optimum activity 
is found to be at pH 6 to pH 7 and values for nicotinamide,PRPP and
ATP were found to be 2 x 4 x lo“^M and 6.7 x 10"^M
respectively.
The enzyme activity is inhibited to 20% of the original activity by a
concentration of 0.1mM of NMN, and to 60% by a similar concentration of
NAD*. These inhibitors eire competitive in nature and have K. values
_4approximating to 7-5 x 10 M. Nicotinamide appears to a specific 
substrate for this enzyme, neither nicotinate of quinolinate 
phosphoribosyl transféras©. activity being detected in either the 
crude or purified enzyme preparations.
The purified enzyme catalyses the conversion of nicotinamide and PRPP 
to stoichemetric quantities of nicotinamide mononucleotide and 
pyrophosphate. The enzyme has an almost absolute specificity for ATP 
under the assay conditions employed.
Similar enzymes have also been isolated from animal tissues, for example, 
rat liver (Dietrich; 1971)» It also has a dépendance for ATP and 
nicotinamide. However, ATP is not a substrate, but acts as an 
allosteric modifier of NMN pyrophosphorylase. The enzyme is inhibited 
by nicotinamide analogues such as 6-aminonicotinamide, thionicotinamide 
and 3-acetyt>yridine, , the inhibition being competitive in nature, but 
not by nicotinic acid, 6-chloronicotinamide, 6-hydroxynicotinamide, 
aminoisonicotinamide, or ethyl nicotinate.
At least two of these nicotinamide analogues serve as substrates,
thionicotinamide being utilised as well as nicotinamide, and exhibiting
kinetic properties very similar to those of nicotinamide.
-53-Acetylpyridine, however, has a of 2 x 10 M, ten times that of
nicotinamide, and a value of some five times that of nicotinamide,
6-aminonicotinamide, on the other hand, inhibits the enzyme, but does 
not act as a substrate.
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The enzyme is also inhibited by nicotinamide riboside, NMN, 
a-NAD*, p-NAD* and several analogues of NAD* (Dietrich et. al.; 1968). 
Nicotinic acid mononucleotide, a naturally occuring analogue of 
NMN, has been prepared from nicotinate phosphoribosyl transferase 
from various sources. Preiss and Handler (1958) have for example 
prepared the enzyme from human erythrocytes, whilst Honjo et. al.
(1966) prepared a similar enzyme from bakers yeast. The enzyme is 
specific for nicotinate, nicotinamide being totally inert as a 
substrate.
Quinolinate phosphoribosyl transferase has been isolated from various 
animal tissues (Iheda et. al.; I9 6 5) and the microorganism 
Astasia longa (Blum and Kahn; 1971)»
It is possible that one, or more of the enzymes may accept 3“ 
trifluoroacetylpyridine as a substrate, and so catalyse the 
phosphoribosylation of 3~trifluoroacetylpyridine under reaction conditions 
similar to those employed in the various assay procedures for the 
enzymes mentioned.
An interesting enzyme is nicotinate ribonucleotide : benzimidazole 
phosphoribosyl transferase isolated from Clostridium sticklandii 
(Friedmann; I9 6 5: Fyfe and Friedmann; I9 6 9)» This enzyme catalyses the 
exchange of ribose-5-phosphate from nicotinic acid mononucleotide to 
another base, in this case benzimidazole (Fig. 48).
Nicotinate mononucleotide: dimethylbenzimidazPle phosphoribosyl transferase 
activity is also found in the enzyme preparation.
The enzyme has the disadvantage that it is relatively unstable in 
aqueous solution, losing 9^% of its activity on storage at -13°C for 
32 days. However, the stability is improved by using glycerol, 
ethylene glycol, or dithiothreitol during purification and storage.
The enzyme exhibits maximal activity at pH 8.6 to 9-2.
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The enzyme is highly specific for a ribose-phosphate donor which 
contains nicotinic acid, and not nicotinamide. Hence the enzymic 
activity with NMN is greatly reduced, and no activity is found in the 
presence of NAD*. Nicotinic acid adenine dinucleotide is less active 
with the enzyme than is nicotinic acid mononucleotide. Nicotinic 
acid ribonucleoside, nicotinamide ribonucleoside, PRPP and ribose-5-* 
phosphate are also inactive with the enzyme and most of the activity 
noted with NMN is due to a deaminase which is contained in the enzyme 
preparation.
The enzyme is much less specific for the free base than it is with the 
ribose-phosphate donor. Benzimidazole, $^6-dimethylbenzimidazole, 
5,6-dichloro-benzimidazole and 5-nitrobenzimidazole have been shown to 
be active with the enzyme, the rate of the reaction being followed 
by means of radiotracers. The analogous enzyme from Propionibacterium 
shermanii has also been shown to catalyse phosphoribosyl transfer to other 
bases. (Friedmann; 1 965)»
The products obtained are the a-glycosidic-5'-ribonucleotides of the 
respective bases, and hence if the naturally occuring p-anomer is required 
the starting material would need to be the a-anomer. Owing to the lack 
of specificity in base requirements, this enzyme may catalyse the 
phosphor ibosylat ion of 3-trif luoroacetylpyridine.
Enzymic pyrophosphorylation
Enzymic pyrophosphorylation is facilated by NAD* pyrophosphorylase 
which can again be obtained from either microorganisms or animal tissue. 
For example, during the preparation of nicotinamide phosphoribosyl 
transferase from Lactobacillus fructosus a NAD* pyrophosphorylase 
is precipitated on the addition of protamine sulphate. The enzyme may 
be used in the crude state or may be purified by homogenising and 
























Action of nicotinate ribonucleotiderbenzimidazole phosphoribosyl
transferase.
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is eluted from the pellet with 0.2M dipotassium hydrogen phosphate, 
the procedure giving a 10 fold increase in purity with a yield of 
10%.
The enzyme is specific for NMN and does not react with nicotinic acid
ribonucleotide, the final preparation being practically free of
nicotinamide phosphoribosyl transferase activity. The K valuesm
-4 -3for NMN and ATP being 6*7 x 10 and 2.7 x 10 M respectively, the 
maximal activity being observed at pH $.8.
The pyrophosphorylation proceeds at pH $.8 in tris-acetate buffer. The 
enzyme requires ATP and magnesium ions, the extent to which the 
reaction occurs being monitored by either reacting the dinucleotide 
with a dehydrogenase, or by incorporating a radioactive tracer into 
the reaction mixture, separating the components of the reaction mixture 
byt.l,c,and measuring the radioactivity due to each component- 
Another method, based on the procedure, of Kornberg (1950) utilises 
a pyrophosphorylase from various rat tissues. This enzyme accepts both 
NMN and nicotinic acid mononucleotide as substrate, although Kornberg 
has reported that the equalibrium constant of the reaction does not 
favour the formation of NAD*.
Investigation of analogue properties.
The extent to which any fluorinated analogue can mimic the natural
substrate can be examined by either classical enzyme kinetics or by 
19Fn.m^, spectroscopy.
Enzyme kinetic methods.
Fluorinated analogues can act either similarly to the natural substrate 
( that is as an enzyme substrate) or as an inhibitor of the enzymes 
action on the natural substrate. The work of Eisenthal et. al. (1972) 
on the activity of fluoro- and deoxy- analogues of glycerol as subs frètes.
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and inhibitors of glycerol kinase provides examples of both types of 
analogue activity. As earlier stated (p. 16 )it was shown that the 
analogues of glycerol in which the hydroxy groups at C-1 and C-2 were 
replaced by fluorine proved to be substrates, whereas that in which the 
C-3 hydroxy was replaced was an inhibitor.
Briley et. al. (1977 a:b) reported that difluoro-oxaloacetate behaves as 
a competitive inhibitor of 2-oxoglutarate and as a non-competitive 
inhibitor with respect to aspartate with cytoplasmic aspartate 
transaminase. Initially steady state kinetics were used to investigate the 
enzyme and rate equations for the inhibitions formulated. Subsequently 
kinetic analyses of both the initial fast and the overall slow reaction 
with -the aminic form of the enzyme were made using repeated spectral 
scanning and stop-flow techniques, allowing the formulation of a basic 
reaction mechanism involving at least two intermediate enzyme complexes.
A molecular reaction scheme involving a ketimine Schiffs base intermediate 
was also proposed.
Any technique used to investigate natural enzyme substrates can also be
used vith fluorinated analogues of these substrates. The above examples
illustrate just some of the techniques which have been used.
19F Ntclear magnetic resonance spectroscopy.
N.m,r, studies have shown that, in general, fluorine coupling constants and 
chemical shifts are at least an order of magnitude greater than those of the 
corresponding hydrogen containing compound (Emsley and Philips; 1971 ), 
while at a given magnetic field the sensitivity of the fluorine nucleus 
is second only to that of the proton. These facts, coupled with the minimal 
perterbation caused by the small fluorine nucleus when it is incorporated
19into a test molecule suggests that F should act as an ideal n.m.r. probe 
of intermolecular interactions.
When studying enzyme systems with fluoro-compounds two approaches have
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been used, firstly the fluorine may be introduced covalently onto the
enzyme and the changes in the spectrum noted when an inhibitor is
added. In principle this is very similar to observing the proton 
resonances of an enzyme in which all but a few selected protons have 
been deuteriated. The advantage of using a fluorine probe in these 
cases is that there are potentially larger changes in chemical shifts 
and coupling constants when the inhibitor binds.
The second approach is to use a fluorinated substrate as a.probe. The
chemical shift, line width and other characteristics all could alter
X
when the substrate analogue binds to the enzyme and the environment 
of the fluorine atom(s) changes. The relatively low concentration of 
bound substrate combined with the fact that, in the bound state, the 
signal is very broad leads to difficulties in its detection and 
measurement. There are, however, ways of obtaining information about 
the bound site. If there is fast chemical exchange between the free 
(in bulk) and bound substrate, then the observed signal is a weighted 
(time) average of that in each environment, , and so carries information 
about the bound site.
Fluorine has been used as a covalent probe to investigate the 
conformational transitions in h æmoglobin, which had been investigated 
in terms of ligand dependent induced fit (Koshland; 1953) and 
allosteric effects (Koshland et. al.; I9 6 6). The use of fluorine as a 
probe at a specific site in haemoglobin (Raftey et. al.; 1971) affords 
in principal an easier method of monitoring conformational changes 
than does Si n.m.r. (Vurtrich; 1971) since any changes in chemical shift 
will be larger than those in the corresponding proton containing 
compound. A 3,3,3“trifluoroacetonyl group was bound covalently and 
specifically to the -SH group of cysteine-p-93, thus placing the probe
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close to the region of intersubunit contact (Raftery et. al.;1971). .
The binding of oxygen to the modified haemoglobin was essentially the 
same as that to natural haemoglobin. The chemical shifts of the oxy 
and deoxy trifluoroacetonoyl-haemoglobin complexes are shown in figure 
4 9 , together with those of the liganded forms, the small differences 
in chemical shift caused by the various ligands suggesting similar
19but not identical environments for the F probe in each case. The
pH dépendance of the trifluoroacetonoyl-haemoglobin complex implicates
a group with a pK^ value of 7-4 and crystallographic results (Perutz;
1970 ) show that the p-histidine residues at 146, 143,or 92 are possible
sites. Due to the environments of the various groups this pK wasa
assigned to histidine-p-l46. This argument also implies that the probe 
will be primarily sensitive to conformational changes in the P-chain. 
Raftery and his coworkers also used this probe to show that,contary 
to previous experiments on dye binding and crystal form,
methyl iron (III)-haemoglobin is different from oxy iron(III)-haemoglobin
19because the curve for the pH dependence of F probe chemical shift is 
different. The X-ray structure does not yield precise information as the 
oxy-haemoglobin used in this study contained some methyl-haemoglobin.
In the above example of the use of fluorine as a covalent probe precise 
interpretation of the chemical shift changes depends substantially on 
a detailed knowledge of the crystal structure. The few small enzymes 
for which the crystal structure is known provide a means of trying out 
the technique and making progress in understanding the factors which 
cause the chemical shifts. In larger enzymes the slower tumbling times 
mean that covalent probe resonances will be broader because the dipolar 
interactions with other nuclei will no longer be averaged out. In such 
cases the use of substrate probes has to be considered.
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may be possible to obtain information on the fluorine resonance of 
the substrate or inhibitor when it is bound to the enzyme. This may 
result in either the observation of a weighted average resonance 
signal because of 'rapid chemical exchange' of the substrate between 
the enzyme site and the bulk, or, under conditions of'slow chemical 
exchange' two signals corresponding to the bound and the free substrate 
will be observed.
An example when conditions of 'slow exchange' prevail is the binding of 
fluoro
the trijacetylated analogue of chitotriose to lysozyme(Raftery et. al. ; 
1 971). The signal of a one to one ratio of enzyme to trisaccharide 
(each at 3mM), at which concentration the concentration of the complex 
is close to 100%, is shown at 3 pH values (Fig. 50 ). The sharp peak at 
the highest field represents the trifluoroacetate anion, which is used 
as an internal reference. From the spectrum at pH 4.5 the resonances 
of the bound inhibitor were identified on the basis of experiments at 
high temperature, at pH 4 under conditions of 'fast exchange' with ex­
cess oligarosaccharide present, and by comparison with the spectrum 
of the pure trisaccharide. The effect of pH on the trifluoroacetyl 
group varies with the position of the group in the molecule.
The interaction of chitotriose with specific groups on the enzyme was 
determined by X-ray spectroscopy (Perutz ;19?0). If the binding of the 
fluorinated analogue is similar to the natural compound the formation 
of a hydrogen bond between aspartate-101 and the trifluoroacetyl group
19 . .would result in a change in the F chemical shift of this group. From 
this model it is apparent that the trifluoroacetyl group at the reducing 
end of the trisaccharide is the furthest trifluoroacetyl group from 
aspartate-101, and yet, unlike the central trifluoroacetyl group it 
experiences an evident chemical shift. The effect is unlikely to be 
electronic, as is that for the trifluoroacetyl group at the 
non-reducing end of the sugar. An explanation which agrees with the
Fig. 50,
pH 7 25
pH 4  50
pH 3 00
h  150  Hz
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19F N.m.r. spectra of solutions of 3mM-trifluoroacetylated chitotriose 
and 3n>M-lysozyme at 3 pH values (T= 10°C). The resonance at the 
highest field is due to the trifluoroacetate anion.
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kinetic observations using n.rajr.methods (Dahlquist and Raftery; 1972) 
is that the formation of the aspartate-1 0 1 hydrogen bond at the 
reducing end of the trisaccharide causes an isomérisation of the 
complex which alters the position of the end trifluoroacetate group 
with respect to the aromatic ring of tyrosine-1 0 8 and therefore the 
effect of the ring current on the fluorine nuclei.
For most inhibitors or substrates binding to enzymes conditions of 
'slow exchange* do not prevail, and this is, in general, fortunate for 
in larger enzymes the resonances obtained would be to broad to 
detect.
However, under conditions of "rapid chemical exchange* this problem 
does not arise. For example, it has been shown that a state of 'fast 
chemical exchange* exists in the binding of N-acetyl-D,L-p-
19fluorophenylalanine to chymotrypsin. The Fn,m.r. spectrum of the 
inhibitor corresponds to an AA'BB'X multiplet (Spotswood et.al. ;
191 967)» No difference between the F spectra of the optical isomers
was observed, but the addition of chymotripsin resulted in two sets of
resonances, corresponding to the 2  ^  isomers. Addition of the pure
resolved isomers indicated that the 2  isomers resonance is shifted to
low field, while that of the 1, isomer is not significantly altered.
19If, under conditions of "rapid chemical exchange", the F n.mji spectrum 
of a substrate or inhibitor changes on binding to an enzyme it is 
possible to obtain the binding parameters for the system. Thus, the 
binding constant for the binding of N-acetyl-^-^-fluorophenylalanine 
(S) to chymotripsin (E)may be determined.The binding may be represented 
thus ;-
E + S ES
and hence ; — K = [ e ] [ s]
[ES]
If the chemical shift of the fully bound substrate is represented as
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A , and the fraction of substrate bound to the enzyme as then the
observed chemical s h i f t w i l l  be given as:-
t f  = b^.A
Also, assuming that is considerably greater than [ES]:-
B = [ Es] where[S 1 is the total concentration
[So]
of substrate. Also:-
[So] = [Eol- A
cF
Thus, a plot of [ s j  against^ allows A to be determined from the slope 
and from the intercept of the x-axis. In the above example it was 
found that A =83Hz. (at 56.4KHz.) and K^=6mM.
This equation can be modified to take into account the effects of 
competition by a second sustrate:-
i  = - J -A s  + [=o] + Mi]
O A  .E \  K.O N  1
where and [sj are the binding constant and total concentration of 
the competing substrate respectively.
It has been suggested that the low field shift observed when
N-acetyl-p-fluorophenylalanine binds to chymotripsin is evidence for
the binding of the aromatic ring and acetyl group of the probe into
the hydrophobic "pocket* at the active site. Although this is possibly
the case there are many other factors, for example pH, temperature and
19through-space interactions that can contribute to F chemical shifts, 
and which cannot be elucidated from a single determination of a 
chemical shift. The effect of pH on the chemical shift of the bound 
substrate may lead to further information about binding sites, if it 
is remembered that a detailed interpretation will depend on a 
knowledge of the crystal structure of the enzyme.
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In their earlier investigation Briley et. al. (I977a^b) had postulated 
that a complex was formed between difluoro-oxaloacetate and the 
aldimine form of aspartate transaminase, and determined its dissociation
19constant spectrophotometrically and by F n.m.r, spectroscopy. They later
19investigated the Fn.m,r, line width-pH and chemical shift-pH profiles
of this enzyme system and found that both show inflexion points in
the pH 5 and pH 8 regions and suggested that these arose from the
variations in the binding of difluoro-oxaloacetate as specific groups
on the enzyme are protonated (Briley et. al.; 1977c). Difluoro-
oxaloacetate was also found to interact with the apoenzyme to form a
19complex, the dissociation constant of which was determined by F n.m.r. 
spectroscopy along with the line width-pH and chemical shift-pH profiles, 
each of which showed a single inflexion point at approximately pH 8.
The absence of the inflexion point at pH 5» which is present in the 
aldimine form enzyme system, indicates that this results from the 
ionisation of an enzyme group associated with the pyridoxal phosphate 
cofactor.
19Compared with the magnitudes of F chemical shifts frequently observed 
the changes in chemical shift in the enzyme complexes so far discussed
19are small. In general F chemical shifts are large when the effects 
giving rise to them are transmitted through chemical bonds. For example 
in fluoromonosaccharides the chemical shift of the equatorial fluorine 
at C-3 differs by about 5p.p.m,for the ot- and P- forms. When the shifts 
arise from through-space interactions, such as ring currents and 
electric field effects, they are much smaller. In the forgoing exan%)le 
additions of the inhibitors or ligands may result in a change in the 
enzyme structure and the small shifts observed are a consequence of 
through-space interactions. It is possible that several of these 
interactions produce shifts in different direction, giving a small net 
chemical shift. In most experiments using enzymes, shifts will result
from through-space interactions and thus, although fluorine appears
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to be a highly attractive probe in enzyme systems because of the large 
shifts which may be expected, the smaller shifts which occur in practice 
are still relevent.
19In larger enzymes, in which the crystal structure is unk^iown F  n.m.r. 
spectroscopy finds a great use in the mapping out of bound substrates 
around . a paramagnetic probe, preferably one at the active site. The 
experiments used involve two techniques, observation of the high 
resolution spectrum of the substrate, and the determination of the 
proton relaxation behaviour of the bulk water protons. By a combination 
of these measurements it is possible in principle to calculate the 
distances of individual nuclei from the paramagnetic probe. The 
relaxation times are related to this distance by the Solomon-Bloemberger 
equations. The calculation of the distances requires a knowledge of the 
correlation time; a parameter difficult to determine without detailed 
relaxation time measurements as a function of magnetic field and 
temperature. However, the use of proton relaxation enhancement 
measurements suggests a fairly straightforward way of obtaining 
reasonable estimates of correlation time(Dwek; 1972).
The study of the proton relaxation of the water molecules around .the 
paramagnetic ion in the presence of different amounts of macromolecule 
or ligand allows the determination of the stability constant for the 
paramagnetic ion-linked binary complexes. The addition of substrate to 
form the metal ion-macroraolecule-substrate complex gives ternary 
complexes, whereas the addition of further substrate will form a 
queurternary complex.
In addition to allowing the determination of binding constants the 
binary, ternary and quarternary enhancement parameters of the fully 
formed complexes may be obtained and these are believed to be 
characteristic for a given state or conformation of an enzyme.
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loSummarising, F relaxation times are increased by the addition of 
paramagnetic metal ions^ which have relatively long electron spin 
lattice relaxation times. The increase in the relaxation times is a 
function of the distance between the metal ion and the observed 
nucleus and of the correlation times for then.mjr. relaxation behaviour 
of the complex. The introduction of metal ions such as Mn (II) and 
Gd (III) into enzyme systems thus allows molecular conformation 
determinations of inhibitor-enzyme complexes with respect to the metal 
site.
An example of the use of paramagnetic metal ion is the binding of methyl 
N-fluoroacetyl-P-JD-glucosamine, and of N-fluoroacetylglucosamine to 
lysozyme. The addition of lysozyme to the methyl compound (Butchard 
et.al.; 1 972) results in a downfield chemical shift, which can be used 
to determine the binding constant and chemical shift of the bound 
substrate by means similar to those shown above(p 57)- The paramagnetic 
probe chosen was Gd (III), since X-ray crystallography had shown this 
ion to bind at the active site. Also the chemistry of the lanthanides 
parallels that of the actinides, so that if the position of a heavy 
metal atom is known from X-ray work it is likely that the corresponding 
lanthanide ion (Gd (III) in this case) binds at the same site.
The addition of Gd (III) results in a broadening of the resonance shown 
by the pure substrate and a much greater broadening when the enzyme is 
present. The broadening for the pure substrate probably arises from 
dipolar interactions, or the formation of a very weak complex. The 
coordination number and dissociation constant were determined from 
the proton relaxation enhancement experiments, as well as the . 
internuclei distances.
Similar experiments on the binding of N-fluoroacetylglucosamine to 
lysozyme also enabled the internuclei distances to be found for both
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the a- and p- anoraers and allowed the postulation that the chemical 
shift of the p- anomer is the result of the influence of tryptophen-1 0 8, 
whereas that of the a- anomer is due to the influence of tryptophen-6 3  
in lysozyme.
This example .illustrates that with the use of distance information from 
line broadening studied, complemented by the geometric information 
obtained from chemical shift studies caused by through-space,dipolar 
interactions it is possible to accurately locate the position of the 
nuclei studied.
From the above examples it can be seen that fluorinated analogues can,
19by using F n.mj: spectroscopy, yield a considerable amount of 
information about enzymes and the way in which they act. In view of the 
central role played by NAD* in biochemical processes it was considered 
that a fluorinated analogue of this compound would prove of wide use 
as an enzyme and metabolic probe.
E X P E R I M E N T A L
a n d
R E S U L T S
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MATERIALS
All chemicals, except where stated in the text, were obtained from 
British Drug Houses, and were, where available, of 'AnalaR* quality. 
Solvents were, where necessary, dried over sodium wire, except that
(a) alcohols were dried by refluxing them with magnesium turnings and 
iodine, followed by distillation and (b) chloroform and the toluene/ 
dioxan mixture (used in perchloryl fluoride fluorinations ) were dried 
over molecular sieve. Enzymes and other biochemicals were, except where 
stated in the text, obtained from the Boehringer Corporation. 
Radiochemicals were obtained from the Radiochemical Centre, 
INSTRUMENTATION
Infra-red spectra were measured (over the range 4000 to 67O cm ^.) 
using a Perkin-Elmer Vyi spectrophotometer.
Gas liquid chromatography was performed on columns (2m x 6mm ) of 
coiled stainless steel, packed with 3% silicone gum-rubber ( SE-3OI ) 
on High performance Chromosorb W (8 0 to 100 mesh ). Samples were 
chromatographed isothermally, at 100°C, using a Perkin-Elmer Fll gas 
chromatograph equipped with a flame ionisation detector. Concentrations 
were calculated on the basis of peak area.
Ultra-violet/visible spectra and enzyme kinetic measurements were 
recorded using a Pye-Unicara SPI8OO spectrophotometer using 1 cm silica 
cells.
Nuclear magnetic resonance spectra were recorded on a Jeol PS-100 n.m.r. 
spectrometer, and where necessary the signal to noise ratio was enhanced 
by means of repeated scans using a Jeol JNB SB-3 signal-to-noise booster. 
P r o t o n c h e m i c a l  shifts are quoted inp.p.m,downfield from
19tetraraethylsilane, whereas F n.m.r, chemical shifts are given in p.p.m. 
from trifluoroacetic acid.
Mass spectra were recorded using an A.E.I. M.S. 12 spectrophotometer 
( at 70 eV. ), and are quoted in graphical form.
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DETECTION OF FLUORINE
The compound under investigation (ca. 50mg ) was fused with sodium 
( 0.2 g ) and the reaction mixture was quenched in distilled water 
( 5 ml ). The inorganic salts were dissolved by boiling with glacial 
acetic acid (0.5 ml ) and the solution concentrated to low volume 
( ca. 1 ml ). A few drops of this solution were added to 2 ml of 
a 50% mixture of alizarin red S (saturated in ethanol ) and zirconoyl 
chloride ( 5% in 50% HCl ). A change in colour from red to yellow 
indicated the presence of fluorine.
DETECTION OF CHLORIDE
A few drops of a solution of the compound under investigation in 5% 
nitric acidwere added to an aqueous solution of silver nitrate. A 
white precipitate indicated the presence of chloride.
DETECTION OF CARBOHYDRATE
The Molisch test was used to detect carbohydrates. The compound under 
test ( 5 mg ) was dissolved in water ( 0.5 ml ), and 2 drops of 
1-naphthol solution ( 10% in ethanol ) were added. Concentrated sulphuric 
acid (1 ml) was added carefully, a red ring at the interface between the 
layers indicated the presence of a carbohydrate.
CHEMICAL SYNTHESES OF PRIMARY INTERMEDIATES 
Ethyl nicotinate hydrochloride.
Ethyl nicotinate ( 0.33 moles )was dissolved in dry diethyl ether 
( 200 ml ) and dry HCl was passed through the solution. The crystals 
which formed were recovered by filtration and purified by • 
recrystallisation from ethanol: diethyl ether (l:l).
The product was isolated as white needle crystals in 95% yield, and 
had the following spectroscopic data:- 
I R spectrum.(Nujol mull )
Major absorptions:- 30^0, 1740 (ester ^ C =  0 ), 1620, 1600, 1525, 1450
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-1and 1320cm
N.m.r. spectrum (in deuterium oxide ).
1.47p.p.m. (triplet, 3 protons, CH^ of the ethyl group, J = 7Hz.), 
4.54p.p.m. (quartet, 2 protons, CH^ of the ethyl group, J = 7Hz*), 
and 8.22 to 9*42p.p.m. (multiplet, 4 protons, protons on the pyridine 
ring).
The above data confirms that the product was ethyl nicotinate 
hydrochloride.
Ethyl nicotinoylacetate hydrochloride.
Three methods for the synthesis of this compound were examined, 
although each was a variation of the same basic method:-
A  CH3COOC2H5
J . 0  InuOCjH; 0 3
_  — TH^COOCoHr ,^ v /n C -C H o C 00C2Hc:
COCH2COOC2H5 HCl o COCH2COOC2H5
Cl
(a) Burns and Powell (1945). H
The product was obtained as pale yellow crystals (m.p. I52 to 154°C) 
in 66% yield. Burns and Powell quote a 37% yield of cream crystals 
(m.p. 140°C (decomposition), then melting at 154 to 155°C).
(b) Strong and McElvain (1933).
The product was obtained as pale yellow crystals (m.p. 155 to 156°C) 
in 75% yield. Strong and McElvain quote a 70% yield of cream crystals 
(m.p. 156 to 1 5 7.5°C).
(c) Gilman et. al. (1948).
The above method was followed, except that the product was isolated
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as the hydrochloride, whereas Gilman isolated ethyl nicotinoylacetate 
itself. The product was isolated as yellow crystals (m.p. 152 to 
157°C) in 29% yield. Gilman isolated ethyl nicotinoylacetate as a 
straw coloured liquid (b.p. 121 to 123^0(0.4 mm Hg)) in 67% yield.
The spectroscopic properties of the product obtained from each of 
the three preparations were similar, and showed that the product was 
the desired compound, ethyl nicotinoylacetate hydrochloride.
I.R. spectrum (Nujol mull).
Major absorptions;- 3050 (aromatic — H), 1740 (ester ^ C = 0 ) ,
1695 (ketonic ̂ = = 0 ), 1635, I6 0 0, 1530, 1455 and 1335 cm“ .̂
N.m.r. spectrum (in D^-DMSO).
I.l6p.p.m. (triplet, 3 protons, CH^ of the ethyl group, J = 7Hz.),
4.06p.p.m. (quartet, 2 protons, CH^ of the ethyl group, J = 7Hz.),
4.35P"P.m.* (singlet, 2 protons, methylenic -CH^- group), 7*96 to 
9.37P"P.m. (multiplet, 4 protons, protons on the pyridine ring) and 
9.5lp«p.m.* (singlet, 1 proton , ^ N — H).
* These resonances disappeared on the addition of D^O.
N.m.r. spectrum (in deuterium oxide).
1.27p.p.m. (triplet, 3 protons, CH^ of the ethyl group, J = 8Hz.),
4.27p.p.m. (quartet, 2 protons, CH^ of the ethyl group, J = 8Hz .) and
8.20 to 9"40p.p.m. (multiplet, 4 protons, protons on the pyridine 
ring).
No resonances due to ethyl nicotinate hydrochloride were found.
Mass spectrum.
The interpreted mass spectrum is shown in figure 3"̂ ,
Ethyl nicotinoylacetate. (
Ethyl nicotinoylacetate hydrochloride (O.O5 moles ) was dissolved in 
water (5 0 ml ), diethyl ether (200 ml) was added and the aqueous layer was 
neutralised with Na CO . The ether layer was separated and the aqueous2 J
Fig. 51.
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layer was extracted with further ether (2 x 50 ml )• The 
ether layer and the extracts were combined and dried (MgSO^ ) and the 
ether was removed in vacuo (at ca. 30°C /300 mm Hg) to give a pale 
yellow viscous liquid (63% yield )-
The product was distilled under reduced pressure at 33 Nm ^(0.25 mm Hg) 
to give four fractions and a residue. The major fraction (89% of the 
distillation input) had a boiling point of 115°C /3 3  Nm ^ (0.25 mmHg) 
and the spectroscopic data was consistent with the product having the 
desired structure.
I.R. spectrum (Liquid film ).
Major absorptions:- 296O (^C— H stretch), 1740 (ester ̂ = 0 ) ,  1695 
(ketonic / C = 0 )  ,1650, I6 2 5, I5 8 5, 1420, I3 2 0, I2 6 5, 1210, 1020, 803 
and 704 cm
N.m.r. spectrum (in CDCl^).
1.20 p.p.m. (triplet, 3 protons, CH^ of the ethyl group, J = 8 Hz.), 
3 .9 9 p.p.m. (quartet, 2 protons, CH^ of the ethyl group, J = 8 Hz.), 
4.40 p.p.m.* (singlet, 2 protons, methylenic -CH^- group) and 7 *3 0  
to 8 .6 2  p.p.m. (multiplet, 4 protons, protons on the pyridine ring).
* This resonance disappeared on the addition of D^O.
Mass spectrum.
The interpreted mass spectrum is shown in figure 52.
Gas liquid chromatography.
Several compounds were eluted. The two major components had retention 
times of 2 .5I minutes ( 3%î ethyl nicotinate ) and 12.42 minutes ( 95%» 
ethyl nicotinoylacetate ).
Fractions from the vacuum distillation which had a lower boiling point 
than the main fraction were shown, by I.R. spectroscopy, to contain a 
mixture of the product, ethyl nicotinoylacetate, and the starting 
material, ethyl nicotinate. The residue was shown to contain only a 
little product.
Fig. 52.
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The fluorination method used by Briley et» al. (1977a ) to prepare 
diethyl difluorooxaloacetate from diethyl oxaloacetate was used in the 
preparation of the above compound.
Ethyl nicotinoylacetate (O.O5 moles ) in dry toluene ;dioxan (2:1 ) was 
stirred under an atmosphere of dry nitrogen. The mixture was cooled to 
(the temperature of the reaction mixture was kept at between O and 
throughout the fluorination ) and dry perchloryl fluoride (Pennsalt 
Chemical Corporation ) was passed through the reaction mixture at a flow 
rate of 1 1 hr ^ for 30 minutes. A suspension of sodium hydride (0.12 
moles, obtained as a 50% dispersion in mineral oil from The Aldrich 
Chemical Company) in dry toluene :dioxan (2:1) (I5 ml) was added to the 
reaction mixture over a period of one hour, during which time the flow 
of perchloryl fluoride was continued. Gas was evolved, and the solution 
became yellow.
The flow of perchloryl fluoride was continued, and the extent of the 
reaction was monitored by analysis of samples using ultra-violet 
Spectroscopy, the starting material having a at 288 nra and the
product at 277 nra. When the reaction appeeired to be complete the flow 
of perchloryl fluoride was stopped and the residual gas was flushed 
from the system by dry nitrogen. Water (10 ml) was added to the reaction 
mixture in order to decompose the excess sodium hydride and to dissolve 
the inorganic salts, followed by saturated NaCl (100 ml ) and diethyl 
ether (25O ml ). The organic layer was separated and successively 
washed with water (200 ml ) and saturated aqueous NaCl (100 ml ). The 
washings were retained. The aqueous layer was sequencially washed with 
diethyl ether (3 x 250 ml ) and benzene (2 x 250 ml ). Each of the 
extracts was washed with the water and the saturated NaCl retained from 
washing the original organic layer. The organic layers were combined.
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dried (MgSO^) and the solvents removed in vacuo (at ca. 30°C /400 mm Hg) 
to give two layers, one, a colourless layer, presumably being derived 
from the NaH /mineral oil dispersion, and the other, a dark brown, 
viscous liquid, possibly being the product.
The brown layer (48% yield) was distilled under reduced pressure at 
20Nm ^ (0 .1 5  mm Hg ) yielding three fractions and a residue. The main 
fraction (84% of the distillation input; b.p. 95 to 98^C /20 Nm ^
-(0 .1 5  mm Hg ) ) was shown to be mainly the required product, ethyl 
difluoronicotinoylacetate.
I.R. spectrum (Liquid film).
Major absorptions:- 296O (?C— H stretch ), 1770 (ester ̂ C = 0  ), I705
(ketonic ), I58O, 1415, 1310, 1260, II60 (^C— F ), 1122 (^C— F ),
-1
922 and 700 cm
N.m.r. spectrum (in CDCl^ ).
:- 1 .2 3 p.p.m. (triplet, 3 protons, CH^ of the ethyl group, J »
10 Hz. ), 4.02 p.p.m. (quartet, 2 protons, CH^ of the ethyl group,
J ST 10 Hz. ), 4 .3 5  p.p.m. (doublet, O.I5 protons, ~C — H of the -CHF- 
group of the monofluoro compound ?, J = 56 Hz. ), 4.40 p.p.m.
(singlet, 0.2 protons, methylenic -CH - group from ethyl 
nicotinoylacetate ), 7*90 to 8 .7O p.p.m. (multiplet, 4.1 protons, 
protons on the pyridine ring ).
^^F :- 7*1 p.p.m. downfield (singlet, 1 fluorine, CF^ group from the 
desired product ) and 5*43 p.p.m. downfield (doublet, O .0 5 fluorines,
F of the -CHF- group in the monofluoro compound ?, J = 5^ Hz. )
Mass spectrum.
The interpreted mass spectrum is shown in figure 53*
Gas liquid chromatography.
Five compounds were eluted. These had retention times of 2.50 minutes 
(1%, ethyl nicotinate ), 3 .0 9 minutes (1%, unknown ), 6 .1 9 minutes 
(80%, ethyl difluoronicotinoylacetate ), 9*59 minutes (10%, ethyl
Fig. 5 3 .
















—  69 —
fluoronicotinoylacetate ? ) and 12.40 minutes (8%, ethyl 
nicotinoylacetate ).
Fractions with a higher boiling point were shown, by I.R. spectroscopy, 
to contain a mixture of ethyl difluoronicotinoylacetate and the starting 
material. The residue was hydrocarbon in nature.
The results quoted above represent the best yield of ethyl 
difluoronicotinoylacetate which was obtained. Subsequent fluorinations, 
which were monitored by means of g.l.c. rather than ultra-violet 
spectroscopy, gave very little ethyl difluoronicotinoylacetate, the 
reaction only proceeding to give ethyl fluoronicotinoylacetate in most 
cases. Catalytic amounts (O.l ml ) of water or ethanol, as well as 
additional sodium hydride, were added to the reaction mixture in an 
attempt to obtain a greater yield of ethyl difluoronicotinoylacetate. 
n-Butyllithium (Gilman et. al.; 1949 ) was used as the base in place 
of sodium hydride in one preparation, but the isolated product appeared, 
by I.R. spectroscopy, to contain mainly ethyl nicotinoylacetate, the 
starting material.
Difluoronicotinoylacetic acid hydrochloride.
Ethyl difluoronicotinoylacetate (0.013 moles ) and 25% HCl (40 ml ) 
were heated under reflux for 4 hours, the solution was reduced to low 
volume in vacuo, and the residual water was removed as the benzene 
azeotrope. The residue was recrystallised from diethyl ether ; ethanol 
(1:1 ) to give yellow crystals of difluoronicotinoylacetic acid 
hydrochloride (32% yield ).
I.R. spectrum (Nujol mull ).
Major absorptions: — 3300 (hydrogen bonded -OH ), 1715 (ketonic ̂ C = z O  ), 
1685 ( carboxylic acid ^ C =  O ), I6OO, I56O and I090 cm (—C— F ).
The above spectroscopic data suggests that difluoronicotinoylacetic 
acid hydrochloride was formed.
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3~Difluoroacetylpyridine.
Difluoronicotinoylacetic acid hydrochloride (0.002 moles ) was
dissolved in water (10 ml ), the pH of the solution was adjusted to
7 .5  with Na CO and IN-NaOH (2 ml ) was added. The mixture was heated ^ 3
under reflux for 2^ hours, cooled, and the solution was extracted with 
diethyl ether (4 x 10 ml ). The extracts were dried (MgSO^ ) and the 
ether was removed in vacuo to give a pale yellow powder (m.p. 30 to 
32°C ) which was thought to be 3“difluoronicotinoylacetic acid (yield 
8% ).
I.R. spectrum (Liquid film ).
Major absorptions:- 3300 (hydrogen bonded -OH ), I7 IO (ketonic ̂ 0 = 0  ), 
1695 (carboxylic acid ^ 0 = 0  ),1590, I56O, 1485 and II85 cm"^ (-“C— F ). 
The above spectrum is inconsistent with the product obtained being 
3-difluoroacetylpyridine. The most likely structure for the product is 
3-difluoronicotinoylacetic acid. However, the spectroscopic data 
obtained for this compound and for difluoronicotinoylacetic acid 
hydrochloride was insufficient to make a positive identification of 
these substances.
N , N-Diethyltr if luoroacetamide .
This compound was prepared by the reaction of diethylamine and 
trifluoroacetyl chloride (Henne et. al.;1948 ) according to the methèd 
of Zaitseva et. al. (I9 6I ). The product was purified by distillation 
under reduced pressure to give a major fraction (b.p. 84 to 85°C /
6650 Nm ^ (5 0 mm Hg))in 52% yield, the properties of which were 
consistent with its identification as the desired product, 
N,N-diethyltrifluoroacetamide. Zaitseva quotes a 48% yield of a 
colourless liquid (b.p. 74 to 75°C / 5 0  mm Hg ).
I.R. spectrum (Liquid film ).
Major absorptions:- 2990 (^C— H stretch ), I685 (amide ̂ C = 0  ),1460,
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a group of five peaks from 1230 to 1120 (-̂ C— F ), 878 and 760 cm 
N.m.r. spectrum (in CDCl^ ).
^  :- 1 .2 3 p.p.m. (triplet, 3 protons, CH^ of one of the ethyl groups,
J = 7*2 Hz. ), 1 .2 9 p.p.m. (triplet, 3 protons, CH^ of the other ethyl 
group, J s 7 .2  Hz. ) and 3*60 p.p.m. (quartet, 4 protons, CĤ  ̂of both 
ethyl groups, J = 7.2 Hz. ).
^^F :- 8 .9 4  p.p.m. downfield (singlet, CF^ group ).
Mass spectrum.
The interpreted mass spectrum is shown in figure 54.
X
other fractions from the distillation were shown, by I.R. spectroscopy, 
to contain no significant amount of the desired product.
3-Trifluoroacetylpyridine.
3-Bromopyridine (Aldrich Chemical Company ) and ii-butyllithium (Gilman 
et. al.; 1949 ) were reacted to form 3-Iithiopyridine (Vibaut et. al.; 
1951 ) and the product from this reaction was reacted with 
N,N-diethyltrifluoroacetamide according to the method of Salvador and 
Saucier (1971 ) to give a dark brown viscous liquid (80% yield ). The 
product was purified by distillation under reduced pressure, when a 
main fraction (75% of the input to the distillation, b.p. 7 I to 73°C/ 
5320 Nra ^ (41 mm Hg )) was obtained, the properties of which were
consistent with those reported and showed the product to be the desired 
compound, 3“trifluoroacetylpyridine.
Salvador and Saucier quote a boiling point of 98 to 100°C /6 8  mm Hg
and a frequency for the carbonyl absorption (CCl^ solution ) of 
-1
1725 cm
I.R. spectrum(CCl^ solution ).
\  -1^ C = = 0  absorption at 1723 cm
I.R. spectrum (Liquid film ).
Major absorptions:- I72O (ketonic ^ C = = 0  ), 1590* 1475* 1415* 1205
Fig. 34.









(^C— F ) , 1173 — F ) , 1143 (l̂ C— F ) , 940 and 695 -1cm
The three peaks at 1205 j 11?5', sind 1143 cm ^ are at similar frequencies 
to peaks found in the spectra of other compounds containing a 
trifluoroacetyl group, and may be attributed to this grouping (Aldrich 
Libary of Infra-red Spectra ).
N.m.r. spectrum (in D^-acetone ).
Si:- 7*2 to 9*1 p.p.m. (multiplet, protons on the pyridine ring ).
19F:- 6 .3 6 p.p.m. upfieId (singlet, CF^ of the trifluoroacetyl group ). 
Mass spectrum.
The interpreted mass spectrum is shown in figure 53*
Gas liquid chromatography.
Two compounds were eluted. These had retention times of 6.92 minutes 
(9 3*3%* 3“trifluoroacetylpyridine ) and 1 0 .08 minutes (6 .5%, 
3-bromopyridine ). In subsequent preparations the purity of the 
product was improved to 9 8.1%.
3-Trifluoroacetylpyridine gem-diol.
This compound was prepared by leaving 3“trifluoroacetylpyridine in a 
moist atmosphere overnight, according to the method of Salvador and 
Saucier (1971 )* 3“Tritluoroacetylpyridine gem-diol was obtained as 
white crystals (m.p. 92 to 93°C ) in 93% yield. Salvador and Saucier 
quote a yield of 69*4% (from 3“bromopyridine )and a melting point of 
93 to 9&°C* They also quote/that the I.R. spectrum contains a broad 
-OH absorption at 3^80 cm ^ and that in the n.m.r. spectrum the 
protons of the -OH groups have a chemical shift of 7*38p.p.m.. The 
product had the following spectroscopic data, which is consistent with 
that quoted by Salvador and Saucier:- 
I.R. spectrum (Nujol mull ).
Major absorptions:- 3^30 (hydrogen bonded -OH ), I6OO, 1460, II80  
(~C— F ), 1070 ( ^ — F ), 9 3 0, 813 and 710 cm“ .̂
Fig. 33-















N.m.r. spectrum (in tetrahydrofuran ).
7*3 to 9*0 p.p.m. (multiplet, 4 protons, protons on the pyridine 
ring ) and 7*40 p.p.m.* (singlet, 2 protons, protons of the -OH 
groups )•
* This resonance disappeared when D^O was added.
19F:- 6 .3 0  p.p.m. upfield (singlet, CF^group ).
3-Trifluoroacetylpyridine-2,4rdinitrophenylhydrazone.
3-Trifluoroacetylpyridine (O.OOl moles ) was added to a solution of 
2 ,4-dinitrophenylhydrazine (0 .5  g ) in methanol (5 ml )and sulphuric 
acid (0 .5  ml ). The solid which formed was separated by filtration, 
washed with aqueous methanol, then with dilute sodium hydrogen 
carbonate solution and recrystallised from aqueous methanol (75% ) 
to give red crystals in 75% yield.
Ultra-violet spectrum.
^max (CHCl^ ) =375nm (£ = 3 .0 I x 10^ c m V ^ )
3-Diazoacetylpyridine.
This compound was prepared by the method of Dornow (1940 ) from 
nicotinoyl chloride and diazomethane. 3“Diazoacetylpyridine was 
obtained as colourless prisms (m.p. 72 to 73°C )in 19% yield. Dornow 
quotes a 20%*yield and a melting point of 7^^C.
o-Phenylene phosphorochloridate.
Phosphorus pentachloride and o-dihydroxybenzene were reacted to form 
2,2,2-trichloro-l,3»2-benzodioxaphosph(Y)ole which was then reacted 
with acetic anhydride according to the method of Khwaja et. al. (1970 ) 
to give the above compound,which was isolated as yellow crystals (m.p. 
56 to 38°C; b.p. 130 to 131°C /266O Nm ^ (20 mm Hg )) with a yield of 
42%. Khwaja quotes a melting point of $8 to 59^C, a boiling point of 
122^0 (12 mm Hg ) and a yield of 63%.
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1-0-Acetyl-2,3i3“tri-0-benzoyl-D-ribofuranose.
The above compound was prepared by one series of operations involving 
the méthylation, benzoylation, déméthylation and acétylation of
2-ribose according to the method of Kissmann et. al. (1955 )• The 
product was isolated as white crystals (m.p. 127 to 128°C ) in 79% 
yield. Kissmann et. al. quote a 37% yield of white crystals which had 
a melting point of 126 to 129°C. The product had the following 
spectroscopic data which was consistent with its being the desired 
product, 1-O-acetyl-2 ,3 ,5-tri-O-benzoyl-^-ribofuranose.
I.R. spectrum (Nujol mull ).
Major absorptions:- 1743 (ester ̂ C = 0  of the acetyl group ), 1723 
(ester ^0 = 0  of the benzoyl groups ), 1430, 1270 ( — 0 stretch of
the benzoyl ester groups ), 1223 ( "̂ C O stretch of the acetyl ester
group ), 1 120, 1022, 9 7 0, 952 and 701 cra"̂ .
N.m.r. spectrum (in CDCl^ ).
The protons on the ribofuranose ring are given alphabetic assignments 
in figure 3 6. These assignments are used in the following table.
2 .0 2  p.p.m. (singlet, 3 protons, CH^ of the acetyl group ), 4.42 to 
4 .9 2  p.p.m. (multiplet, 3 protons, ribofuranosyl protons *a*, *b* and 
*c* ), 3-79 to 6.01 p.p.m. (multiplet, 2 protons, ribofuranosyl 
protons *d* and *f* ), 6.47 p.p.m. (singlet, 1 proton, ribofuranosyl 
proton ’e* ), 7 *2 8 to 7 .6 8 p.p.m. (multiplet, 9 protons, m- and £- 
protons of the benzoyl groups ) and 7*86 to 8.20 p.p.m. (multiplet,
6 protons, £- protons of the benzoyl groups ).
Mass spectrum.
The interpreted mass spectrum is shown in figure 37*
l-Chloro-2,3,5-tribenzoyl-D-ribofuranose.
The above compound was prepared, according to the method of Davoll
Fig. 56.
Alphabetic assignments given to the protons on the ribofuranose
ring and used in the interpretation of the n.m.r. of the
compounds listed below.0
II







0  = benzoyl group
(a) (R = CH^CO):- l-0-acetyl-2,3»5~tri-0-benzoyl-jD-ribofuranose,
(b) (R = Cl):- l-chloro-2,3,5-tri-O-benzoyl-^-ribofuranose.
(c) (R = nicotinamide):- N-(2%3%5-tri-O-benzoyl-^-ribofuranosyl) 
3-carbamoylpyridinium cation.
(d) (R = 3-trifluoroacetylpyridine):- N-(2%3%5-tri-O-benzoyl-;D- 
ribofuranosyl)-3“trifluoroacetylpyridinium cation.
Fig. 37.













et. al» (1 9 4 8 ), by treating l-0-acetyl-2,3,5-tri=0-benzoyl-D= 
ribofuranose with HCl in dry diethyl ether. The product was isolated 
as a straw-coloured syrup (99% yield ) and had the following 
spectroscopic data, which showed the product to be the desired 
compound, l-chloro-2,3,5-tri-0-benzoyl-^-ribofuranose•
I.R. spectrum (liquid film ).
Major absorptions;- 1735 (ester ^ C = 0  of the benzoyl groups ), 1475»
1450, 1315» 1265 ( --0 stretch of the benzoyl groups ), 1110, IO9O,
702 and 678 cm ( -pC— Cl ) •
N.m.r. spectrum (in D^-acetone ).
The protons on the ribofuranose ring are given alphabetic assignments 
in figure 5 6. These assignments are used in the following table.
4.68 to 5-12 p.p.m. (multiplet, 3 protons, ribofuranosyl protons *a*, 
*b* and *c* ), 5 -7 6 to 6 .I3 p.p.m. (multiplet, 1 proton, ribofuranosyl 
proton *f* ), 6 .3 5  p.p.m. (singlet, 1 proton, ribofuranosyl proton 
•d* ),6 .8 7 p.p.m. (doublet, 1 proton, ribofuranosyl proton *e' ),
7 .2 8  to 7 -6 2 p.p.m. (multiplet, 9 protons, m- and p- protons of the 
benzoyl groups ) and 7»92 to 8 .2 2  p.p.m. (multiplet, 6 protons, 2 "" 
protons of the benzoyl groups ).
No resonances were observed at a chemical shift of 2.02 p.p.m. (the 
chemical shift of the acetyl group in the starting material ).
Mass spectrum.
The interpreted mass spectrum is shown in figure 5 8.
CHEMICAL SYNTHESIS OF NUCLEOSIDES AND NUCLEOTIDES.
N-(2*,3 *,3'-Tri-O-benzoyl-D-ribofuranosyl)-3-trifluoroacetylpyridinium 
chloride.
The above compound was prepared by a method similar to that used by 
Haynes et. al. (1957 ) in their synthesis of NMN.
Fig. 58.

















0 - C O C H i .
O 













-  76 -
l-Chloro-2 ,3 ,5~tri-0 -benzoyl-^-ribofuranose (0 .0 2 5 moles ) in
acetonitrile (3 0 ml ) and 3"trifluoroacetylpyridine (O.O3 moles ) in
acetonitrile (100 ml ) were mixed at 0°C and allowed to stand at this
temperature for 48 hours. The precipitate was removed by filtration
and the filtrate was evaporated to dryness in vacuo (at^l5°C /400 mm
Hg ) to yield a foam which was washed with dry diethyl ether. The
residue was purified by dissolution in chloroform (I5 ml ) followed by
reprecipitation with diethyl ether (200 ml ) to give product A.
The precipitate, which had been removed from the reaction mixture by
filtration, was dissolved in water and neutralised by the addition of
saturated aqueous Na CO . The product was isolated by extraction with“ 3
diethyl ether, dried (MgSO^ ) and concentrated to dryness to give 
product B.
Product A was obtained as a buff-coloured powder (42% yield ) the 
properties of which were consistent with its identification as the 
desired product, N-(2‘,3'»5*“tri-O-benzoyl-^-ribofuranosyl)-3- 
trifluoroacetylpyridinium chloride•
I.R. spectrum (Nujol mull ).
Major absorptions:- 1730 ( / C = 0  of the benzoyl groups and the ketonic
^ 0 = 0  ), 1 6 0 0, 1450, 1365, 1260 ( -- 0 of the benzoyl groups ),
1210 (-̂ C— F ), 1180 (-Jc— F ), 1120 (“ C— F ) and 710 cm"^.
N.m.r. spectrum (in CDCl^ ).
The protons on the ribofuranose ring are given alphabetic assignments 
in figure 5 6 . These assignments are used in the following table.
Si:- 4 .3 0  to 5 »l(t p.p.m. (multiplet, 3 protons, ribofuranosyl protons
*a*, *b* and *c* ), 5 *3 2 to 5 *7 6 p.p.m. (multiplet, 2 protons, 
ribofuranosyl protons *d* and 'f ), 6 .O6 p.p.m. (singlet, 1 proton, 
ribofuranosyl proton *e* ), 7 » 10 to 7 *6 2 p.p.m. (multiplet, 9 protons, 
m- and p- protons of the benzoyl groups ), 7 ,7 4  to 8.16 p.p.m.
Fig. 39.
Mass spectrum of N"( 2 ' , 3 ' , 5 ' “tr I-O-benzoy 1-U-r ibo furanosy 1 )-'3-
tri fluoroacetylpyr iclitiiurn chlor ide
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3 .5 2 p.p.m.* (singlet, 1 proton ), 3.02 p.p.m.* (singlet, 4 protons ) 
6 .1 7 p.p.m.* (singlet, 1 proton, ribofuranosyl proton *e' ), 7-02 to 
7 .6 2  p.p.m. (multiplet, 9 protons, m- and p- protons on the benzoyl 
groups ), 7 *7 8 to 8 .3 6 p.p.m. (multiplet, 8 protons*, o- protons on 
the benzoyl groups and the protons on the amidic -NH^ group ) and 
8.48 to 9 *6 3 p.p.m. (multiplet, 4 protons, protons on the pyridine 
ring ).
*The spectrum was very poorly resolved, the resonances being very 
broad, and hence a detailed interpretation could not be made. However, 
the combined number of protons attributed to these resonances was 
equal to the number of protons on the ribofuranosyl ring.
* On the addition of D^O the integral of this resonance decreased to 
the equivalent of 6 protons, the protons of the amidic =NH^ grouping 
having been deuteriated.
Mass spectrum.
The interpreted mass spectrum is shown in figure 6 0.
Product B (isolated as for product B above ) was shown, by I.R. 
spectroscopy, to be nicotinamide.
N-(P-Ribofuranosyl)-3-carbamoylpyridinium chloride.
The above compound was prepared from the benzoylated nucleoside by 
treatment with methanolic ammonia according to the method of Haynes 
et. al. (1 9 3 7 )• The required product, N-(jD-ribofuranosyl)-3-carbamoyl• 
pyridinium chloride, was obtained as a pale yellow, hygroscopic powder 
(70% yield ), and had the following spectroscopic data. Haynes et. al. 
quote a yield of 73%- 
I.R. spectrum (Nujol mull ).
Major absorptions:- 3^00 (broad, hydrogen bonded -OH ), I68O (amidic 
2 Z C = 0  ), 1390, 1340, 1230 and 96O cm“ .̂
Fig. 60.
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N.m.r. spectrum (in D^-DMSO ).
The n.m.r. spectrum was a series of unresolved, broad resonances, and 
hence a detailed interpretation could not be undertaken. However, the 
following general observations may be made:-
3 .2 0  to 6 .6 0  p.p.m. (multiplet, 9 protons,-— C— H and ̂ C—-OH protons 
on the ribofuranosyl moiety ) and 7 .8O to 9 -7 0 p.p.m. (multiplet,
6 protons, protons on the pyridinium ring and the protons of the amidic 
-^Hg group ) .
On the addition of D^O the integrals of the ribofuranosyl protons: 
pyridinium protons:HDO changed to 6:4:5* This is consistent with the 
protons of the -OH groups and the amidic -NH^ group having been 
deuteriated, as would be expected.
Aiest for carbohydrate proved positive.
N-(P-Ribofuranosyl)-3-trifluoroacetylpyridinium chloride.
Three methods were investigated in an attempt to debenzpylate
N-(2',3* -tri-0-benzoyl-jD-ribofuranosyl)-3“trifluoroacetylpyridinium
chloride in order to obtain the above product.
(a) A similar method to that used to debenzoylate N-(2‘, 3 * -tri-O- 
benzoyl-_P-ribofuranosyl)-3-carbamoylpyridinium chloride was used.
N-(2',3 *,5'-Tri-O-benzoyl-^-rib ofuranosyl)-3-trifluoroacetylpyridinium 
chloride (0.004 moles ) and dry ammonia saturated methanol were allowed 
to stand for I8 hours. The solvents were removed in vacuo (at ^ 10°C / 
400 mm Hg ) to yield a yellow oil, which was dissolved in dry methanol 
(5 ml ). The product was precipitated by the addition of ethyl acetate 
(2 2 0 ml ), isolated by filtration (under a stream of nitrogen ) and 
dried under vacuum to give a pale yellow hygroscopic powder (8% yield ) 
I.R. spectrum (Nujol mull ).
Major absorptions:- 3IOO (broad, hydrogen bonded -OH ), 1720 (ketonic
%ZCz= 0  ) ,  1595 , 1530, 1490, 1220, 1190 ( 0 C ~ F  ) ,  1165 ( ->C— F ) ,
— 8o —
1120 (0 C— F ) and 730 cmT^.
N.m.r. spectrum (in D^-DMSO ).
The n.m.r. spectrum was a series of unresolved resonances, and 
hence a detailed interpretation could not be undertaken. However the 
following general observations may be made:—
3 .7 1  to 6.20 p.p.m. (multiplet, 9 protons,-^C— H and— C— OH protons 
on the ribofuranosyl moiety ) and 7 -9 0 to 9 *5 0 p.p.m. (multiplet, 4 
protons, protons on the pyridinium ring ).
On the addition of D^O the integrals of the ribofuranosyl protons: 
pyridinium protons:HDO changed to 6:4:3- This is consistent with the 
protons on the ribofuranosyl -OH groups having been deuteriated.
19F : - 1 6 .1 p.p.m. downfield (singlet ).
Tests.
The product was tested for fluorine, carbohydrate and chloride, all 
of which proved positive.
(b) Sodium ethoxide (O.O3 moles ) in dry ethanol (200 ml ) was reacted 
with N-(2*,3*,5'-tri-O-benzoyl-^-ribofuranosyl)-3-trifluoroacetyl­
pyridinium chloride (O.Ol moles) at O^C for 48 hours; Dry 5% methanolic 
HCl (10 ml) was added to the reaction mixture and the solvents and excess 
HCl removed in vacuo (at ̂  10°C/400 mm Hg). The resultant gum was
extracted with dry methanol (2 x 5 ml ) and added to ethyl acetate 
(2 0 0 ml ). Filtration (under an atmosphere of dry nitrogen ) and drying 
yielded an off-white hygroscopic powder (25% yield ), the infra-red 
spectrum of which was different from that of the product from 
preparation (a) in that it showed no ^C— F absorptions. Chemical 
analysis for fluorine proved negative.
(c) N—(2 * ,3*, 5 ' -Tri-0-benzoyl-^—ribofuranosyl ) —3- trif luoroacetyl 
-pyridinium chloride (O.OO5 moles ) was stirred with dry saturated 
methanolic HCl at 0°C for 24 hours. The solvents and excess HCl were
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removed in vacuo (at^lO°C /400 mm Hg ), the resultant gum was extracted 
with dry methanol (2 x 3 ml ), the solution filtered and the product 
precipitated by the addition of ethyl acetate (200 ml ). The precipitate 
was isolated by filtration and dried in vacuo to give product A.
The mother liquor from the precipitation was evaporated to dryness to 
give product B.
Product A , obtained in 10% yield, was a yellow amorphous solid, the 
infra-red spectrum of which was similar to that of the product from 
method (b) above. The n.m.r. spectrum had no resonance due to 
fluorine, and a chemical test for fluorine also proved negative.
Product B , obtained in 15% yield,as a brown paste was shown, by 
infra-red spectroscopy, to contain 3“trifluoroacetylpyridine and its 
gem-diol, although these were not the only compounds present. 
Phosphorylation of N-(P-ribofuranosyl)-3-carbamoylpyridinium chloride 
using o-phenylene phosphorochloridate.
A solution of o-phenylene phosphorochloridate (1.1 m-moles ) in 
acetonitrile (2 ml ) was added to a stirred suspension of 
N—(D-ribofuranosyl)-3-carbamoylpyridinium chloride (1 m-mole ) and 
2,6-lutidine (3m-moles ) in acetonitrile (2 ml ) at room temperature 
(20°C ) and the mixture was stirred for 3 hours, after which time water 
(1 ml ) was added and the solvents removed in vacuo (at ^ 25°C ). The 
residue was dissolved in 0.2M-triethy1ammonium bicarbonate, pH 7-5 
(5 0 ml ) and 2% aqueous bromine was added. The solution was shaken for 
20 minutes and then extracted with diethyl ether (10 ml portions ) 
until the extracts were colourless. Air was bubbled through the aqueous 
layer, which was then concentrated to low bulk in vacuo (at^ 25^C ).
An aliquot (5 0 ^1 ) of the reaction mixture was chromatographed on 
paper (Whatman No. 1 ) using an eluent of IM-amraonium acetate,pH 5: 
ethanol (3:7). Several compounds were separated.which absorbed
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ultra-violet light, but one (R^ = 0 .2 9 ) had the same as did 
NMN.
ENZYME ISOLATION AND ASSAY.
NAD* transglycosidasé from pig brain.
This enzyme was isolated from whole pig brain using the method of 
Kaplan et. al. (195^ )«
Assay.
The enzyme solution (25 pi ), 6 mM-WAD* solution (0.1 ml ) and 
0.1 M-KHgPO^ buffer, pH 7-3 (0.3 ml ) were incubated at 37°C for 7-3 
minutes. The decrease in NAD* concentration was measured by preparing 
the cyanide adduct (Colowick et. al.; 1931 ) and by assay using yeast 
alcohol dehydrogenase (Kaplan and Ciotti; 193^ ). By both methods the 
enzyme was found to contain 16 units ml  ̂ (1 unit » 1 p-mole of NAD* 
destroyed in one hour ).
Nicotinamide phosphoribosyl transferase from Lactobacillus fructosus.
This enzyme was isolated by a modification of the method of Ohtsu 
and Nishizuka (I967 )-
Cells of Lactobacillus fructosus were grown in a medium of glucose 
( 2  % ), polypeptone (O.5 % ), yeast extract (O.5 % ), nicotinamide 
(10 mg 1~^ ) and fructose (1 % ) in 0.01 M-potassium phosphate 
buffer, pH 7, at 26°C, harvested by centrifugation and washed with 
0.14 M-KCl (2 X 50 ml ). The cells were homogenised with cold acetone 
(40 ml ) at -15°C and filtered rapidly on a Buchner funnel. The cell 
cake was brought to room temperature, crushed and dried under vacuum 
for two hours. The powder thus obtained was sufficiently stable to 
be stored at -15°C for an extended period.
The enzyme was purified for use by suspending the acetone powder
(1 g ) in 0 .0 5 M-potassium phosphate buffer, pH 7 (20 ml ) by stirring
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for 15 minutes. The cells were disrupted in a sonic occillator for 
20 minutes, and the resulting suspension was centrifuged at 
12,000 X g and 4°C for 20 minutes. An equal volume of 0.4 %-protamine 
sulphate, pH 7» v̂ as added, the mixture was stirred for 30 minutes and 
the precipitate was removed by centrifugation (12,000 x g; 4°C). 
Ammonium sulphate (12 g ) was slowly added to the supernatent and 
the precipitate was again removed by centrifugation (12,000 x g; 4°C ). 
The pellet was dissolved in O.O5 M-potassium phosphate buffer, pH 7 
(10 ml ) and dialysed against O.O5 M-potassium phosphate, pH 7:
20 % aqueous polyethylene glycol (1:1 ) for 20 hours. The resultant 
solution was stored at -18°C until use, which was within 2 weeks.
Assay.
0 .2 5  M-Tris acetate buffer, pH 7 (0.2 ml ), 50 mM-PRPP (O.O5 ml ),
50 mM-ATP (0 .0 5 ml ), 50 mM-MgCl^ (O.O5 ml ), 50 mM-nicotinamide 
(0 .0 5  ml ), 50 m M - 7 n i c ot in a mi de  (5 pi, 50 mCi m-mole ^ ), water 
C o.05 ml ) and the enzyme preparation (O.O5 ml ) were incubated 
together at 37°C for 30 minutes. After this period the enzyme was 
denatured by the addition of ethanol (0 .5  ml ), and the protein was 
removed by centrifugation. An aliquot (200 pi )of the incubation 
mixture was analysed by t.l.c. on CM cellulose. Aliquots of NMN and 
nicotinamide solutions were also * spotted* on to the plate to act as 
markers and the plate was developed by butan-l-olrmethanol;water:0 .8 8 0  
ammonia (60:20:20:1 ). The plate was dried, the nicotinamide *spot* 
was visualised under ultra-violet light (R^ = O .9 ) and the plate was 
redeveloped to R^ O .85 with 1 M-acetic acid. The plate was dried, 
examined under ultra-violet light and the position of the NMN 'spot*
(R^ = 0.8 ) was noted. The silica at the positions of nicotinamide 
and NMN on the sample chromatograph was scraped into scintallatioh
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vials and 1.6 M-LiCl (0.4 ml ) and scintallation fluid (2.5 ml ) 
were added. The radioactivity due to each 'spot* was measured, and 
from this the activity of the enzyme was calculated, having determined 
the protein concentration by the method of Lowry et. al. (195^ )- 
The specific activity of the enzyme was found to be 0.0092 units mg 
Ohtsu and Nishizuka quote a specific activity of 0.0122 units mg 
ENZYMIC SYNTHESIS.
3-Acetylpyridine adenine dinucleotide.
This compound was prepared by the method of Kaplan and Ciotti (1956 ), 
which used an exchange reaction between NAD* and 3-acetylpyridine, 
catalysed by NAD* transglycosidasé from pig brain. The extent of the 
reaction was monitored by the reduction of the analogue and the 
residual NAD* by alcohol dehydrogenase from yeast. The reduced
analogue had a A at 3^5 nm compared to 3^0 nm for NADH itself.
The maximal ratio of absorbance at 3^5 nm:340 nm (reduced analogue:
reduced NAD* ) was reached after 3-5 hours and was 1.42:1.
3-Acetylpyridine adenine dinucleotide was isolated as a pale yellow
amorphous powder (45 % yield ). Kaplan and Ciotti quote a 40 % yield
and a X of 3^5 nm for the reduced analogue, max
Attempted preparation of 3-trifluoroacetylpyridine adenine dinucleotide. 
It was attempted to prepare this compound in a manner similar to that 
used to prepare 3-acetylpyridine adenine dinucleotide.
NAD* transglycosidasé from pig brain (ca. 2500 units ), NAD* (2 g.
Sigma Chemical Co. ), 3-trifluoroacetylpyridine (1.5 9 ) and
1 M-potassium phosphate buffer, pH 7-5 (6.25 ml ) were incubated 
at 20°C for 4 hours. The reaction was monitored by reaction with 
alcohol dehydrogenase from yeast or by the formation of the cyanide 
adduct. The peaks attributable to NADH or the NAD*-cyanide adduct
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decreased in size as the reaction proceeded, but no new peaks were
observed. The protein was denatured by the addition of trichloroacetic
acid (to 5 % ) and was then removed by centrifugation. Acetone (5
volumes ) was added to the supernatent and the precipitate was
removed by centrifugation, dissolved in 0.1 N=sodium acetate (25 ml )
and reprecipitated by the addition of acetone (125 ml ). The
precipitate was removed by centrifugation, washed with acetone (5 0 ml)
and dried in vacuo to give a pale yellow amorphous powder (7 0 0 mg )
19which showed no Fn.ra. r.signal, nor was fluorine detected by a 
chemical test.
Chromatography on Whatman No. 4 paper using an eluent of ethanol:
0.1 M-acetic acid (1:1 ) showed that the product had an of 0.55i 
which is the sàme as ADPR under these conditions.
In further attempts to prepare the analogue by the above method the 
pH of the buffer used was varied between 2 and 9 pH units, by 
preparing 2M-phosphoric acid and adding sufficient KOH to adjust the 
pH, and diluting the buffer to give a final concentration of 1 M. In 
no case was a fluorine-containing nucleotide isolated.
Inhibitory effect of 3*“trifluoroacetylpyridine on NAD* transglycosidase 
from pig brain.
When an equal amount of 3"trifluoroacetylpyridine and 3-acetylpyridine 
were incubated with NAD* transglycosidase from pig brain in the same 
manner as above 3-acetylpyridine adenine dinucleotide was only formed 
at 35 % of the rate at which it was formed in the control experiment 
(with 3-acetylpyridine only ).
3-Diazoacetylpyridine adenine dinucleotide.
This compound was prepared by an exchange reaction involving NAD ,
NAD* transglycosidase and 3-diazoacetylpyridine by the method of
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Biellmann et. al. (1974 ), except that the excess NAD* was not 
destroyed by the addition of NAD* glycohydrolase from Neurospora 
Crassa.
The product was isolated as an off-white powder (23 % yield ). The
cyanide adduct had a of 3^5 nm. Biellmann quotes a yield of 13 %
and a X for the cyanide adduct of 3^5 nm. max
Assay with alcohol dehydrogenase from yeast showed that the product 
contained some 18 % residual NAD* (the analogue is not reduced by 
alcohol dehydrogenase from yeast ).
3-Chloroacetylpyridine adenine dinucleotide.
This compound was prepared by the action of chloride ions on
3-diazoacetylpyridine adenine dinucleotide according to the method
of Biellmann et. al. (1974 ). The product was obtained as an amorphous
powder (73 % yield ) which, when reduced with alcohol dehydrogenase
from horse liver, had a X of 375 nm. Biellmann quotes a X formax max
the reduced analogue of 374.5 nm.
Attempted preparation of 3-fluoroacetylpyridine adenine dinucleotide.
3-Diazoacetylpyridine adenine dinucleotide (250 ̂ -moles ), lithium
fluoride (2 0 m-moles ) and hydrogen fluoride (2 m-moles ) were stirred
in water (10 ml ) for 4 hours. The excess lithium and fluoride ions
were removed by cation and anion exchange chromatography respectively.
The eluent was liophilised to give an amorphous powder (25 mg ) which 
19gave no Fn,m.r, signal. Fluorine could not be detected chemically. 
Investigation of the effect of 3-trifluoroacetylpyridine on nicotinamide 
phosphoribosyl transferase from Lactobacillus fructosus.
0.25 M-Tris acetate buffer, pH 7 (0.2 ml ), 50 mM-PRPP (0.05 ml ),
50 mM-ATP (0.05 ml ), 0.25 M-MgCl^ (O.O5 ml ), water (O.O5 ml ) and 
the enzyme preparation (O.O5 ml ) were incubated with:-
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(a) 50 mM-nicotinamide (O.O5 ml )
(b) 50 mM-3-trifluoroacetylpyridine (O.O5 ml )
(c) 50 mM-nicotinaraide (0.023 ml ) + 30 mM-3-trifluoro­
acetylpyridine (0 .0 2 5 ml )
(d) as in (a) but with 7“^^C-nicotinamide (2 ^1 )
(e) as in (b) but with 7“^^C-nicotinamide (2 ^1 )
at 37°C for 4 hours, after which time the enzyme was denatured by 
the addition of ethanol (0 .5  ml ) and removed by centrifugation.
The samples were analysed by t.l.c. under the same conditions as were 
used in the assay of the enzyme, and the radioactivity due to the
starting material and the product was counted for incubations (d) and
(e). It was found that in all the incubations a compound with 
a similar to NMN had been formed. Additionally the proportion of 
the radioactivity associated with the NMN 'spots* of incubations (d) 
and (e) was approximately the same, the ratio of nicotinamide;NMN
being O .3 2 in incubation (d) and 0.28 in incubation (e).
19An aliquot of incubation mixture (b) was examined by F n.m.r.
19spectroscopy and a new F resonance was noted, the signal being a 
singlet and 8 .7O p.p.m. upfield from trifluoroacetic acid. A signal 
attributable to 3-trifluoroacetylpyridine was also noted.
Enzymic pyrophosphorylation.
A mixture of 0.25 M-tris acetate buffer, pH 5»8(0.2 ml ), 100 mM-ATP
o(0 .0 5 ml ), 2- H-ATP,ammonium salt(2 ̂ 1, supplied in 50 % aqueous 
ethanol, activity ^ 15 to 30 Ci m-mole ^), 0.1 M-MgClg(0.05 ml ), 
water(0.05 ml ),NAD* pyrophosphorylase(0.05 ml, from hog liver ), 
and inorganic pyrophosphatase(5 /il, from bakers yeast, supplied by 
the Sigma chemical company ) were incubated with:-
— 88 —
(a) 50 mM-NMN(0.05 ml )
(b) 50 mM-3-trifluoroacetylpyridine mononucleotide (0,05 ml, 
crude, obtained as above )
at 37°C for 90 minutes, and after this time the protein was denatured 
by the addition of ethanol(O.5 ml ) and removed by centrifugation»
The supernatent was analysed by t.l.c. on PEI cellulose using 
0.1 M-acetic acid as the eluent. The compounds which were eluted were 
visualised under ultra-violet light and those attributable to ATP and 
NAD*(or its analogue ) were scraped into scintallation vials,
1.6 M-lithium chloride(0.4 ml ) and scintallation fluid(2.3 ml ) were 
added and the radioactivity of each sample measured.
Incubation (a) showed zones corresponding to NAD*(R^ = 0.41 ) and 
ATP(R^ as 0.04 ) with radioactivities of I3I3 c.p.m. and 54,414 c.p.m. 
respectively. This is equivalent to 0.14 ̂ -moles out of a possible 
2 .5  ^-moles of NAD* having been formed.
Incubation (b) showed zones corresponding to 3“trifluoroacetylpyridine 
adenine dinucleotide(R^ = 0.39 ) and ATP(R^ = 0.04 ) with 
radioactivities of 10,048 c.p.m. and 6 5 ,2 0 9 c.p.m. respectively. This 
is equivalent to 1.04 -moles out of a possible 2.5 j^-moles of 
3-trifluoroacetylpyridine adenine dinucleotide having been formed. 
One-stage enzymic synthesis of 3-trifluoroacetylpyridine adenine 
dinucleotide and NAD*.
A mixture of 0.25 M-tris acetate, pH 7(0*2 ml ), 50 mM-PRPP(0. 05 ml ), 
100 mM-ATP(0 .0 5 ml ), 0.25 M-MgCl2 (0 .0 5 ml ), 2- H-ATP, ammonium salt 
(5 pi ), nicotinamide phosphoribosyl transferase (O.O5 ml, from 
Lactobacillus fructosus ), NAD* pyrophosphorylase (O.O5 ml, from hog 
liver ), inorganic pyrophosphatase (5 ̂ 1, from bakers yeast ) and:-
(a) 50 mM-nicotinamide (O.O5 ml )
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(b) 3-trifluoroacetylpyridine (0.05 ml ) 
were incubated together at 37°C for 4 hours, after which time the 
enzymes were denatured by the addition of ethanol (0 .5  ml ) and 
removed by centrifugation.
An aliquot of the supernatent (50 ̂ 1 ) was analysed by t.l.c. on 
PEI cellulose plates. In order to facilitate a good separation of the 
nucleotides the plate was developed 2 cm past the origin with 
0.2 M-LiCl, for a further 3 cm with 1.0 M-LiCl and then the plate was 
fully eluted with 1.6 M-LiCl. The plate was divided into strips at 
^ cm intervals along the solvent path and each of these strips was 
placed into a scintallation vial along with 1.6 M-LiCl (0.4 ml ) and 
scintallation fluid (2 .5  ml ) and the radioactivity of each was 
measured. From graphs of radioactivity (c.p.m. ) against distance 
up the t.l.c. plate (cm ) (figs. 61 and 62 ) it was calculated that 
1.59 p*^oles of NAD* and 1.72 -moles of 3-trifluoroacetylpyridine 
adenine dinucleotide had been formed, out of a possible 2 .5  71-moles 
in each case.
Investigation into the base-specificity of nicotinamide phosphoribosyl 
transferase from Lactobacillus fructosus.
The specificity of this enzyme was investigated by incubating;-
(a) 50 mM-nicotinamide (O.O5 ml )
(b) 50 mM-3-trifluoroacetylpyridine (O.O5 ml )
(c) 50 mM-nicotinic acid (O.O5 ml )
(d) 50 mM-3-acetylpyridine (O.O5 ml )
(e) 50 mM-ethyl nicotinoylacetate (O.O5 ml )
(f) 50 mM-pyridin-3-al (O.O5 ml )
(g) 50 mM-3-bromopyridine (O.O5 ml )
in a similar manner to that used in the initial investigation of this
Fig. 62.
Radioactivity profile of the one-stage enzymic synthesis of 










enzyme (see page 86 ), aliquots (3 0 )il ) of the reaction mixture 
being analysed by t.l.c. as before. The remainder of the products 
were lyophilised and retained for use in the next experiment.
It was found that incubations (a), (b), (d) and (f) contained a 
compound with a similar to NMN under the conditions of assay 
which were used.
Specificity of enzymic pyrophosphorylation.
The enzymic pyrophosphorylation of the products from the previous 
experiment was attempted in a similar manner to that used before 
(see page 87 ) and t.l.c. analysis of the products again undertaken. 
Incubations (a), (b), (d) and (f) were found to have incorporated
2-^H-ATP into a product with a similar to NAD*.
Speed of formation of 3-trifluoroacetylpyridine adenine dinucleotide.
A mixture of 0.25 M-tris acetate, pH 6.5 (0.4 ml ), 50 mM-PRPP 
(0.1 ml ), 100 mM-ATP (0.2 ml ), 0.25 M-MgCl^ (O.l ml ),
50 mM-3“trifluoroacetylpyridine (O.l ml ), NAD* pyrophosphorylase 
(0 .0 5  ml, from hog liver ), inorganic pyrophosphatase (5 pi, from
o
bakers yeast ) and 2- H-ATP, ammonium salt (5 pi ) were equilabrated 
to a temperature of 37*̂ C. An aliquot (5 0 pi ) of the mixture was taken 
(to act as T = O ) and ethanol (5 0 pi ) was added, the mixture being 
stored under refridgeration until analysis. Nicotinamide phosphoribosyl 
transferase (O.O5 ml, from Lactobacillus fructosus ) was added to 
initiate the reaction and further aliquots (5 0 pi ) taken at times of 
0 .2 5, 0 .5 , 0 .7 5, 1, 1.5 , 2, 2 .5 , 3, 4, 6 and 10 hours and treated 
in a similar manner to the original aliquot.
The aliquots were analysed by t.l.c. on PEI cellulose with an eluent 
of various concentrations of lithium chloride, as described previously 
(see page 89 ). The results obtained are expressed graphically in the 
form of concentration against time for ATP, ADP, AMP,
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3-trifluoroacetylpyridine adenine dinucleotide and adenosine (Fig.
63 ).
FINAL PROCEDURES . ADOPTED FOR THE PREPARATION AND PURIFICATION OF THE 
3-TRIFLUOROACETYLPYRIDINE ANALOGUES OF NMN AND NAD*.
3-Trifluoroacetylpyridine mononucleotide.
A mixture of 0.25 M-tris acetate, pH 7 (4 ml ), 100 mM-ATP (1 ml ),
50 mM-PRPP (1 ml ), 50 mM-3-trifluoroacetylpyridine (1 ml ),
0 .2 5  M-MgClg (1 ml ), water (1 ml ) and nicotinamide phosphoribosyl 
transferase (1 ml, from Lactobacillus fructosus ) were incubated at 
37°C for 2 hours, after which time the protein was denatured by the 
addition of ethanol (10 ml ) and removed by centrifugation. The 
solution was lyophilised, the solids were washed with ethanol (I5 ml ),
the insoluble material was dissolved in water (8 ml ) and 
chromatographed on a Dowex lX8-acetate form column (2 cm x 2.5 cm dia., 
BioRad Ltd. ). The column was washed with water (5 0 ml ) to remove the 
inorganic salts and the product, 3-trifluoroacetylpyridine
mononucleotide was eluted from the column with O .5 M-acetic acid (50ml) and 
lyophilised to give a white amorphous powder.
3-Trifluoroacetylpyridine adenine dinucleotide.
A mixture of 0.25 M-tris acetate, pH 6 .5  (4 ml ), 0.25 M-MgCl^ (1 ml ),
50 mM-trifluoroacetylpyridine (1 ml ), I50 mM-ATP (1 ml ), 50 mM-PRPP 
(1 ml ), 2“ H-ATP (25 )il ), nicotinamide phosphoribosyl transferase 
(1 ml, from Lactobacillus fructosus ),NAD* pyrophosphorylase (O.5  ml, 
from hog liver ) and inorganic pyrophosphatase (5 0  ̂ 1, from bakers 
yeast ) was incubated at 37°C for 4 hours, after which.time the 
protein was denatured by the addition of ethanol (10 ml ) and removed ̂
by centrifugation. The mixture was diluted with water (5 0 ml ) and 
lyophilised. The residue was dissolved in 0.1 M-potassium phosphate
Fig. 63.
Speed of formation of 3“trifluoroacetylpyridine adenine dinucleotide 
in its one-stage enzymic synthesis.








buffer, pH 7 (10 ml) and incubated with alkaline phosphatase (5 ^1,
from calf intestine) at 37^0 for 15 minutes. T.l.c. on PEI cellulose
using an eluent of lithium chloride under the same conditions as
before (see page 8 9) showed that all the AMP had been destroyed in
this reaction (Fig. 64). The reaction mixture was applied to a Dowex
IXB-acetate form column (5 cm x 2.5 cm dia.) which was washed with
water(I50ral). The product, 3-trifluoroacetylpyridine adenine
dinucleotide, was washed from the column with 1 M-acetic acid (I50 ml)
and the eluent was lyophilised to give a white amorphous powder. (It
was shown in later experiments that 90% of the product was eluted
with 100 ml of 1 M-acetic acid and 98% with I50 ml.)
3It was shown, by the amount of incorporation of 2- H-ATP into the
product, that the yield of 3-trifluoroacetylpyridine adenine
dinucleotide was 75%» based on 3-trifluoroacetylpyridine. This yield
was confirmed spectroscopically, based on a measurement of the relative
absorption at 260 and 266 nm, assuming, as was later confirmed, the
analogue to have a similar A and extinction coefficient to NAD*.max
ANALYSIS OF 3-TRIFLUOROACETYLPYRIDINE MONONUCLEOTIDE AND. 
3-TRIFLUOROACETYLPYRIDINE ADENINE DINUCLEOTIDE.
The fluoro-analogues of NMN and NAD* thus prepared were analysed by 
the following methods, the results for assays (a) to (d) being given 
in Figure 6 5.
(a) 3-Trifluoroacetylpyridine content.
The glycosidic bond of the analogue under investigations (10 p-moles)
was cleaved by reaction with 2 N-NaOH (5 ml) and the 3-trifluoroacetylpyridine
liberated was extracted with diethyl ether (5 x 5 ml). The extracts
were dried (MgSO^), evaporated to dryness in vacuo and the
2, 4-dinitrophenylhydrazone formed as before (see page 73) except
Fig. 64.
Radioactivity profile of the one-stage enzymic synthesis of 










Analytical data on 3-trifluoroacetylpyridine mononucleutide and 
3-trifluoroacetylpyridine adenine dinucleotide.
Component NMN analogue NAD* analogue
3-trifluoroacetylpyridine 0 .8 9 0 .9 4
ribose 1 .0 5 1-95
phosphate 0 .9 3 1 .9 2
adenylic acid - 1 .0 3
Results are given in p-moles of component per ^-mole of analogue
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that it was not recrystallised,-but dissolved in chloroform (1 ml ) 
and applied to a magnesia:celite (3:1 ) column (1 cm x 0.5 cm dia. ). 
The hydrazone was eluted by chloroform (10 ml ), the eluent evaporated 
to 1 ml and the optical density at 375 nm measured.
In later experiments the average yield of the hydrazone, prepared 
from 3“trifluoroacetylpyridine itself (10 p-moles ) and purified by 
the above procedure was 72 % and hence the results of the 
determination of the 3“trifluoroacetylpyridine content of the analogues 
were corrected using this figure.
(b) Ribose.
This was determined using the orcinol procedure (Taylor et. al«;1948 ).
(c) Total phosphate.
This was determined by the method of Bartlett (1959 )•
(d) Adenylic acid.
This was determined on 3-trifluoroacetylpyridine adenine dinucleotide 
only by reaction with 5*-adenylic acid deaminase (Colowick; 1955 ) 
after cleavage of the analogue with NAD* pyrophosphatase from snake 
venom (Shuster et. al.; 1955 )-
(e) Thin layer chromatography.
3-Trifluoroacetylpyridine mononucleotide was chromatographed on CM 
cellulose in a similar manner to that used in the assay of nicotinamide 
phosphoribosyl transferase (see page 83 ).
A single 'spot* (R^ ?= O .8 0 ) was observed when the plate was examined 
under ultra-violet light. This is a similar R^ to NMN. 
3-Trifluoroacetylpyridine adenine dinucleotide was chromatographed:-
(i) on PEI cellulose using an eluent of 1 M-acetic acid. Only 
one 'spot* was found, both by examining the radioactivity profile or 
by examining the plate under ultra-violet light. This 'spot* had an
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of 0.40, which is identical to that of NAD*.
(ii) on PEI cellulose, using the eluent detailed previously 
(see page 89.)» Again only one 'spot' was detected, both by 
radioactivity and by ultra-violet light, and this had an R^ of 0.57» 
which is the same as NAD*.
(f) Nuclear magnetic resonance spectrum.
3-Trifluoroacetylpyridine mononucleotide had a single resonance at 
8.7b p.p.m. upfield from trifluoroacetic acid, whereas 
3-trifluoroacetylpyridine adenine dinucleotide had a single resonance 
at 7 -2 8 p.p.m. upfield from trifluoroacetic acid.
(g) Ultra-violet spectrum.
'3-Trifluoroacetylpyridine adenine dinucleotide had a X at 239 nmmax
and an extinction coefficient of 17*5 cm^ p-mole 
INVESTIGATION OF THE PROPERTIES OF THE ANALOGUES.
Stability of 3-trifluoroacetylpyridine adenine dinucleotide at 
various pH values.
The stability of this analogue was determined at pH 4, 5» 6, 7i 8 and 
9 in aqueous solution, the pH of the solution being kept constant by 
the addition of 0.01 M-NaOH. The amount of analogue hydrolysed was 
determined by t.l.c. under the conditions previously detailed (see 
page 89 )• The radioactivity corresponding to the remaining analogue 
was measured, as was that due to the decomposition products. The 
experiments were all performed at 23°C.
Plots of time against amount of analogue remaining are shown in 
figure 66, as are the half-lifes at the various pH values.
Reaction of the analogues with cyanide ions.
Any changes in the ultra-violet spectrum of a 20 mM solution of the 
analogue (0.2 ml ) and 1 M-KCN, pH 11 (3 ml )were monitored over the
Fig. 66.
Rate of decomposition of 3”trifluoroacetylpyridine adenine 
dinucleotide at various pH values.







T i  = 1 Hr pH 9
Conc.(jjM)
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wavelength range 300 to 700 nm (against 1 M-KCN blank ).
No changes in the spectrum of either 3-trifluoroacetylpyridine 
mononucleotide or 3“trifluoroacetylpyridine adenine dinucleotide 
were noted.
Chemical reduction of the analogues.
Water (1.8 ml ), a 50 mM solution of the analogue (0.2 ml ) and 
0.2 M-sodium cyanoborohydride (100 ̂ 1, in 0.2 M-tris acetate, pH 7 ) 
were mixed, and any changes in the spectrum, over the wavelength 
range 300 to 500 nm noted.
No new absorption, in the specti^um of either analogue was noted. 
Co-enzymic activity of 3-trifluoroacetylpyridine adenine dinucleotide » 
The ability of this analogue to mimic NAD* in several dehydrogenase 
systems was investigated.
Alcohol dehydrogenase from yeast.
A mixture of alcoholic tris buffer (a mixture of 0.1 M-tris(hydroxy- 
methyl)aminomethane and 0.5 M-ethanol ), pH 10.1 (2.5 ml ), a 30 mM 
solution of the analogue (0.2 ml )was prepared and alcohol 
dehydrogenase from yeast (10 ̂ 1, 1:100 dilution ) was added. The 
spectrum over the wavelength range 300 to 600 nm was measured before 
and after the addition of the enzyme.
No changes in the spectrum were noted.
Similarly, no co-enzymic activity was noted with alcohol dehydrogenase 
from horse liver, malate dehydrogenase from pig heart mitochondria, 
lactate dehydrogenase from rabbit muscle or glyceraldehyde-3-phosphate 
dehydrogenase from yeast.
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Investigation of the inhibitory effect of 3-trifluoroacetylpyridine 
adenine dinucleotide.
(a) Alcohol dehydrogenase (from yeast ).
Glycine-sodiura pyrophosphate buffer, pH 9 (2.5 ml, 1.7 g 1 ^glycine 
in 75 mM-sodium pyrophosphate ), 2.2 M-semicarbazide, pH 6.5 (O.l 
ml ), ethanol (O.l ml ), 27-7 mM-NAD* (0.2 ml ) and 0.3 M-glutathione 
(o.l ml, reduced form ) were incubated with alcohol dehydrogenase 
from yeast (10 71I, 1:5000 dilution ) at 25°C, and the initial rate 
of the reaction was measured by monitoring the rate of increase in 
NADH concentration (measured at 3^0 nm ).
The reaction was repeated, except that 3-trifluoroacetylpyridine 
(to a final concentration of 1 mM in the reaction medium ) was 
added.
Result :-
Rate of reaction with the inhibitor added = 89 % of the rate without 
inhibitor (average of 3 determinations ).
(b) Lactate dehydrogenase (from hog muscle ).
0.1 M-Potassium phosphate buffer, pH 7»0 (2 .8 3 ml ), 23 mM-sodium 
pyruvate (O.l ml ) and 12 mM-^ADH (O.O5 ml ) were incubated with 
lactate dehydrogenase (10 pi, 1:1000 dilution ) at 25^C, and the .
initial rate of reaction was measured by monitoring the rate of
/ decrease in NADH concentration (measured at 340 nm ).
The reaction was repeated, except that 3-trifluoroacetylpyridine 
(to a final concentration of 1 mM in the reaction medium ) was 
added.
Result:-
Rate of reaction with the inhibitor added = 78 % of the rate without
inhibitor (average of 3 determinations ).
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(c) Glyceraldehyde-3-phosphate dehydrogenase (from yeast ).
0.1 M-Potassium phosphate buffer, pH 7 .I (2.1 ml ), 27.7 mM-NAD*(0.2m 1 
and glyceraldehyde-3-phosphate (0 .2  ml ) were incubated with 
glyceraldehyde-3-phosphate dehydrogenase (1 0 pi, 1 :1 0 0 dilution ) at 
25°C, and the initial rate of the reaction was measured by monitoring 
the rate of increase in NADH concentration (measured at 340 nm ).
The reaction was repeated, except that 3-trifluoroacetylpyridine 
(to a final concentration of 1 mM in the reaction medium ) was 
added.
Result:-
Rate of reaction with the inhibitor added = 9% % of the rate without 
inhibitor (average of 3 determinations ).
(d) Malate dehydrogenase (from pig heart mitochondria )
100 mM-Sodium malate (10 pi ), 36 mM-NAD* (10 jxl ) and malate
dehydrogenase (10 pi, 1:100 diution, a gift from Dr. G. Smith ) in
50 mM-triethanolamine buffer, pH 7-8 to a total volume of 1 ml were 
incubated at 25^C , and the initial rate of the reaction was measured 
by monitoring the rate of increase in NADH concentration (measured at 
340 nm ).
The reaction was repeated, except that 3-trifluoroacetylpyridine 
(to a final concentration of 0-36 mM in the reaction medium ) was 
added- 
Result; -
Rate of reaction with the inhibitor added = 62 % of the rate without
inhibitor (average of 3 determinations ).







In view of the wide involvement of NAD* in enzymically catalysed 
reactions a fluorinated analogue of this coenzyme was prepared and 
characterised. There are several positions in the NAD* molecule into 
which fluorine could be introduced, but, in view of the direct 
involvement of the nicotinamide moiety in the mechanisms of 
oxidation/reduction reactions involving NAD* it was decided to 
introduce fluorine, in the form of a trifluoroacetyl group, in place 
of the amide grouping of the nicotinamide moiety. The first step 
towards the preparation of this compound, 3-trifluoroacetylpyridine 
adenine dinucleotide (Fig. 6 7 ), involved the synthesis of the 
pyridine derivative, 3-trifluoroacetylpyridine.
Synthesis of 3-trifluoroacetylpyridine.
Initial attempts to prepare 3-trifluoroacetylpyridine were based on 
the route shown in figure 68 (a), this method being chosen in 
preference to the published route (pp 23-24) in order to further 
investigate the fluorinating action of perchloryl fluoride which had 
already been used successfully at Bath University for the fluorinatipn 
of diethyl oxaloacetate-The chosen route (Fig. 68a) involves the 
precursor ethyl nicotinoylacetate which was prepared by the method 
of Strong and McElvain (1933) (see experimental method (b)). This 
method gave a better yield (75%) than did the other methods 
investigated. The spectroscopic data obtained for both ethyl 
nicotinoylacetate and its hydrochloride showed that the desired 
product had been obtained in both cases.
The initial preparation of ethyl difluoronicotinoylacetate








Formula of 3-trifluoroacetylpyridine adenine dinucleotide.
Fig. 68.
Synthesis of 3-trifluoroacetylpyridine















b) Using the published method.
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proposed by Sheppard (I969) (Figs. 14 and I6 ),,which predicts the
formation of ethyl fluoronicotinoylacetate, as well as the difluoro
compound. Spectroscopic data confirmed that this was the case. Although
the initial yield of difluorinated product was, as quoted (p.68)^48%,
subsequent attempts to prepare ethyl difluoronicotinoylacetate by this
method were less successful, although the fluorination, monitored by
g.l.c., did appear to proceed to some extent in most cases. In
several attempted fluorinations a peak with the retention time of the
compound thought to be the monofluoro compound was noted, and this
increased in size with a simultaneous decrease in the size of the peak
attributable to the starting material. Strong absorptions at a
-1frequency of between 1100 and 1200 cm were noted in the I.R. 
spectrum of the product from these reactions, these being indicative 
of the introduction of a — C— F bond into the starting material.
However, a significant amount of the difluoro compound was only 
obtained in one of the subsequent fluorinations-
It has been found that fluorinations using perchloryl fluoride 
sometimes do not proceed (G. D. Smith- personal communication), and 
that the addition of catalytic amounts of water or ethanol have been 
sufficient to initiate the reaction. Effectively these additions are 
the replacement of some of the sodium hydride with'sodium hydroxide or 
sodium ethoxide, but in this case it was found that such additions did 
not cause an increase in the yield of the difluoro compound. The 
replacement of sodium hydride with n-butyllithium did not lead to the 
formation of any difluoro compound.
Although perchloryl fluoride is a surprisingly stable molecule, being, 
for example, thermally stable to 5 0 0°C, it is, as well as being a
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fluorinating agent, a strong oxidant, and has been known to react 
explosively with many organic compounds. In one attempted 
fluorination of ethyl nicotinoylacetate the reaction mixture 
exploded, and subsequent attempts to prepare 3“trifluoroacetylpyridine 
by a route involving fluorination by perchloryl fluoride were 
abandoned for safety reasons.
Preliminary investigations of the further steps involved in the 
route shown in Fig. 68a indicated that ethyl difluoronicotinoylacetate 
could be hydrolysed to give the corresponding crystalline acid 
hydrochloride in 3 0% yield, but the attempted decarboxylation of the 
material was unsuccessful. In view of the problems inherent in the 
preparation of ethyl difluoronicotinoylacetate by the above procedure 
this was abandoned in favour of the alternative approach to 
3-trifluoroacetylpyridine (Fig. 68b) described by Salvador and Saucier 
(1977).
The preparation of N,N-diethyltrifluoroacetamide and of the crystalline
3-trifluoroacetylpyridine gem diol proceeded smoothly and with yields
of 5 2% and 6 0% respectively. It is of interest to note that the CH^
groupings of ethyl groups of N,N-diethy]trifluoroacetamide are in
non-identical environments (n.m.r.) presumably as a result of the
p
inhibited rotation of the — 6— N bond.s,
The 2,4-dinitrophenylhydrazone of 3-frifluoroacetylpyridine was
prepared and was found to have a X of 375nm. This compound wasmax
subsequently used to estimate the 3 -fri f .1 uoroacetylpyridine content 
of the NAD and NMN analogues.
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Incorporation of 3-trifluoroacetylpyridine into NAD* and NMN analogues. 
Both chemical and enzymic approaches to the incorporation of 
3-trifluoroacetylpyridine into NAD* and NMN analogues were investigated. 
Initial studies examined the chemical synthesis of both the natural and 
fluorinated nucleosides and nucleotides.
Chemical synthesis of nucleosides and nucleotides.
The preparation of ribofuranosides by chemical means involves the 
reaction of a base (in this case a substituted pyridine compound) 
with l-chloro-2,3,5-tri-0-benzoyl^D-ribofuranose; which is itself 
prepared from the stable crystalline compound l-O-acetyl-2,3 »5-tri-
0-benzoyl-D-ribofuranose (Fig.6 9 ). The synthesis of these materials 
proceeded as published (see pp 33 to 3 ^)with an overall yield of the 
chloro compound of 7 8%. The spectroscopic datd of both compounds was 
consistent with the proposed structures.
N.m.r. spectra of furanoside and pyranoside ring protons generally 
tend to be complex, containing multiple and overlapping spin-spin 
splitting patterns. Nevertheless,the chemical shifts of the ring 
protons of many sugars and nucleosides have been assigned 
( Varian Associates; Cat. of N.m.r. spectra; I9 6 3 ), and identification 
of the signals in the spectra of compounds in the present synthetic 
sequence was possible by ^nalogy with the published data for 
similar compounds.
The preparation of the benzoylated ribosides of nicotinamide and 
3-trifluoroacetylpyridine was effected with yields of 41% and 42% 
respectively according to the procedure of Haynes et.al, (I9 5 7 ).
In each case nicotinamide(or its analogue) was isolated from the 
reaction mixture as its hydrochloride, suggesting that some 
residual HCl remained in the starting material (l-chloro-2,315“
Fig. 89.






















Proposed route for the chemical synthesis of 3“trifluoroacetylpyridine
adenine dinucleotide.
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tri-0- benzoyl-D- ribofuranose). As attempts to remove this HOI- by 
the application of a vacuum did not. fully succeed, later preparations 
utilised an excess of 3“trifluoroacetylpyridine, which led to an 
increase in yield of 18%.
There was some evidence that the products were not stable for an 
extended period, as evidenced by two peaks in the mass spectrum at 
m/e = 2 3 8 and 2 3 6 . These peaks are also in the mass spectrum of
l-chloro-2,3,5-tri-0-benzoyl-B- ribofuranose, and appear to be derived 
from a chlorine containing fragment. It is unlikely that these reflect 
contamination of the products by the chlorinated starting material, 
since it is soluble in both chloroform and diethyl'ether (the solvents 
from which the benzoylated nucleosides are purified), and it seems 
accordingly that the benzoylated nucleosides are not very stable, the 
glycosidic bond breaking to reform the starting materials. However, 
storage under refridgeration was found to prevent decomposition. The 
spectroscopic data, whilst not of a high standard, was generally 
consistent with the structures proposed for the benzoylated nucleosides.
Débenzoylation of the nicotinamide riboside with a saturated solution 
of ammonia in methanol proceeded as published (Haynes et. al., 1957)  ̂
and in a similar yield (70%). The 3“trifluoroacetylpyridine riboside 
was debenzoylated under the same conditions, but with a much lower 
yield (8%), which was too low to be of practical use. The use of sodium 
methoxide or methanolic HCl as reagents for the débenzoylation met with 
no success, the benzoylated nucleoside being decomposed by both reagents,
Preliminary experiments indicated that the phosphorylation of the 
debenzoylated nicotinamide nucleoside could be effected by o-phenylene
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phosphorochloridate (prepared by the method of Khwaja et.al. (1970) in 
42% yield), a compound with the same R as NMN being separated by 
paper chromatography. However, it is possible that the 2’ and 3' as 
well as the 5' phosphate may have been formed as the instability of 
the glycosidic bond precluded the protection of the 2’ and 3 '-OH 
groups with an isopropylidene residue. In view of the difficulties 
encountered in the preparation of 3-trifluoroacetylpyridine riboside, 
further experiments on the phosphorylation of nucleosides were not 
undertaken and attention was turned to the synthesis of NAD* analogues 
by enzymic means.
Transglycosidation reactions involving NAD* transglycosidase from 
pig brain.
In general, the use of NAD* transglycosidase from pig brain is the 
preferred enzymic method for the preparation of analogues of NAD* in 
which the nicotinamide moiety has been replaced by another substituted 
pyridine compound. The basis of the reaction is shown in figure 70. 
Factors in its favour are:-
i) the ready availability of pig brain 
ii) the ease with which the crude enzyme may be isolated 
iii) the stability of the enzyme 
iv) the fact that further purification of the crude enzyme is 
not required
v) the speed of enzymic transglycosidation 
vi) the large scale on which the reaction may be performed 
vii) the ease of purification and isolation of the product.
NAD* transglycosidase was successfully prepared from pig brain by 
the procedure of Kaplan et. al. (1954), and was used to catalyse the 
substitution of 3-acetyTpyridine for the nicotinamide moiety of NAD*
Fig. 70,
NAD"^ + EnzymeN
-N ic o t in a m id e







0  =  analogue forming base
Formation of NAD* analogues using NAD* transglycosidase,
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according to the method of Kaplan and Ciotti (1954). The resulting 
3-acetylpyridine adenine dinucleotide was obtained as a pale yellow 
powder in 45% yield.
When 3“trifluoroacetylpyridine was incubated with. NAD* and the 
transglycosidase under similar conditions a yellow powder was obtained 
which did not contain fluorine and behaved chromatographically as ADPR. 
Reduction of samples of the reaction mixture by ethanol in the presence 
of yeast alcohol dehydrogenase showed a steady decrease in absorbance 
at 340nm with time, corresponding to the disappearance of NAD* from 
the reaction mixture. However, in contrast to the corresponding reaction 
with 3-acetylpyridine no new absorbance attributable to a reduced NAD* 
analogue could be detected. It appears that in the presence of 
3-trifluoroacetylpyridine the enzyme behaves simply as a glycohydrolase, 
and the resulting ADPR is not linked to the fluorinated pyridine 
derivative. Repeated incubations at a range of pH values similarly 
failed to.,yield the required fluorinated analogue. As the latter was 
subsequently found to be stable under the conditions of the incubation 
it is unlikely that the analogue had been formed and subsequently 
hydrolysed In t^e reaction mixture.
3-Trifluoroacetylpyridine was found to inhibit the transglycosidation 
of NAD* and 3“acetylpyridine, suggesting that 3°trifluoroacetylpyridine 
might well compete for the active site on the enzyme without having 
the ability to form a glycosidic linkage. Such behaviour can be 
rationalised in terms of the negative inductive effect of the 
3-trifluoroacetyl grouping.
Ah alternative approach to the synthesis of a fluorinated NAD*
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analogue was investigated using NAD* transglycosidase in a series of 
reaction analogous to that used successfully by Biellmann et. al.
(1 9 7 1) in the synthesis of the 3-ehloroacetylpyridine analogue of NAD*. 
These workers found that the direct incubation of 3-chloroacetyl- 
pyridine with NAD* in the presence of NAD* transglycosidase failed 
to produce the required NAD* analogue, and used instead 3“diazoacetyl- 
pyridine in the initial transglycosidation. The resulting 
3-diazoacetylpyridine NAD* analogue was then converted into the desired 
monochloro derivative by reaction with chloride ions. It seemed possible 
that, similarly, reaction of the 3-diazoacetylpyridine analogue with 
fluoride ions might lead to a monofluorinated analogue of NAD*. 
3-Diazoacetylpyridine adenine dinucleotide was accordingly prepared 
(in 2 3% yield) by the procedure of Beillmann and his coworkers. The 
3“diazoacetylpyridine analogue was successfully used to prepare the 
monochloro derivative (73% yield) by the published method, but 
corresponding incubations with fluoride ions failed to yield a fluorine 
containing organic product.
In view of the unpromising results obtained using NAD* transglycosidase 
attention was turned to the use of a two stage enzymic preparation of
3-trifluoroacetylpyridine adenine dinucleotide using nicotinamide 
phosphoribosyl transferase and NAD* pyiophosphorylase.
Two-stage enzymic preparation of NAD* analogues.
Phosphoribosyl transferase from Lactobacillus fructosus is known to 
catalyse the transfer of ribose-5“phosphate from PRPP to nicotinamide 
(Ohtse and Nishizuka, 19^7) and the resulting NMN reacts with ATP in 
the presence of hog liver NAD* pyrophosphorylase to give NAD^ (Fig. 71)? 
The system was accordingly investigated as a route to the preparation 
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Synthesis of NAD^ or a NAD^ analogue using a phosphoribosyl
transferase.
(3 -Trifluoroacetylpyridine is used as the substituted pyridine
in this example.)
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Nicotinamide phosphoribosyl transferase, was prepared from Lactobacillus 
fructosus according to the procedure of Ohtsu and Nishizuka (1 9 6 7) with 
a specific activity of O.OO9 units mg  ̂ (Ohtsu and Nishizuka quote 
0.01 units mg )̂ . Incubation of 3~trifluoroacetylpyridine with PRPP 
in the presence of the enzyme led to a fluorine-containing compound
19with an value (t.l.c.)similar to that of NMN and with a F n.m.r. 
signal having a chemical shift different from that of 3 ^trifluoroacetyl­
pyridine or its gem diol. Experiments in which 3~trifluoroacetylpyridine
14was incubated with the enzyme and PRPP in the presence of 7- C-nicotin- 
amide showed that the fluorinated pyridine analogue did not inhibit 
incorporation of labelled nicotinamide into NMN to an extent greater 
than that caused by unlabelled nicotinamide itself.
In view of the apparent success of these preliminary attempts to
synthesise 3“trifluoroacetylpyridine mononucleotide, the crude product
3 +was incubated with 2- H-ATP in the presence of hog liver NAD
pyrophosphorylase. Thin layer chromatographic analysis of the products
showed the presence of two radioactive spots having R^ values consistent
with their identification as ATP and the required NAD* analogue. The
yield of NAD* analogue in this reaction was apparently some seven times
higher than the corresponding yield of NAD* itself when NMN was used
as starting material.
The two enzymic steps were combined in an experiment in which 
3-trifluoroacetylpyridine was incubated with PRPP and ATP in the 
presence of both nicotinamide phosphoribosyJ transferase and NAD* 
pyrophosphorylase. Again chromatographic evidence indicated that 
the required NAD* analogue had been obtained.
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The suspected 3“trifluoroacetylpyridine adenine dinucleotide was then 
prepared on a 50 ̂ -mole scale by the single incubation procedure. The 
product was purified on a Dowex 1X8 column to give a white amorphous 
powder in an overall yield of 7 5% from 3 ”trifluoroacetylpyridine.
In view of the similar retention volumes of the product and AMP it 
was found necessary to destroy the latter compound by the addition 
of alkaline phosphatase prior to the ion-exchange chromatography 
stage.
3“Trifluoroacetylpyridine mononucleotide was also prepared on a 
5 0  ̂ -mole scale, by scaling up the initial incubations in the presence 
of phosphoribosyl transferase.
Ohtsu and Nishizuka (I9 6 7 ) reported that phosphoribosyl transferase 
from Lactobacillus fructosus is specific for nicotinamide, and does 
not utilize nicotinic acid. In view of the apparent activity of 
3 -trifluoroacetylpyridine as a substrate for this enzyme a number 
of other 3 ”substituted pyridine derivatives were tested for substrate 
activity. From these incubations compounds having similar thin layer 
chromatographic mobility to NMN were detected when nicotinamide,
3-trifluoroacetylpyridine, 3-acetyTpyridine and pyridin-3-al were 
used as the starting materials. Nicotinic acid, etby] nicotinoylacetate 
and 3 “bromopyridine, on the other hand, failed to yield the 
corresponding products.
In the cases when an NMN analogue was detected in the above studies, 
further incubations in the presence of NA]/ pyrophosphorylase yielded 
the corresponding NAD* analogues as judged by thin layer chromatography. 
It appears, therefore, that the combined use of phosphoribosyl
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transferase and NAD* pyrophosphorylase can serve as a useful 
alternative to the method using NAD transglycosidase from pig brain 
in the synthesis of NAD* analogues, although the latter method is 
generally preferred for the reasons already given.
Characterisation of fluorinated analogues of NMN and NAdT 
The identities of the trifluoroacetylpyridine analogues of NMN and NAD* 
were confirmed in a number of ways. Thus hydrolysis of the glycosidic 
linkages yielded in each case trifluoroacetylpyridine which was 
quantified by determination of the absorbance of its 2,4-dinitrophenyl- 
hydrazone derivative. Ribose and phosphate contents were measured by 
standard colourimetric procedures and, in the case of the NAD* 
analogue, adenylic acid was determined by the use of NAD* pyrophosphatase
tfollowed by 5 -adenylic acid deaminase. In all cases the expected molar 
contents were found to be present. The homogeneity of the analogues 
was confirmed by thin layer chromatography.
19 4-F N.m.r. analysis of the NMN and NAD analogues showed in each case
a single fluorine signal well resolved from that of the starting material,
trifluoroacetylpyridine. The presence of a single peak representing all
three fluorine atoms is clearly an advantage in the possible application
19of the analogue to enzyme active site studies by F n.m.r. spectroscopy.
19While this is the most likely spectrum it is conceivable that the F 
signal could have been split by non-equivalence of the fluorine atoms 
within the dinucleotide complex and such splitting would lead to 
diminished sensitivity in its use as a moIecu]ar probe.
The fluorinated analogues were found to be similar to the naturally 
occuring compounds in a number of respects. Thus t.I.c. analysis of 
3-trifluoroacetylpyridine adenine dinucleotide in two different
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chromatographic system in each case a single zone with value 
identical to that of NAD*. Moreover the u.v. spectrum of the NAD*
2 , -1 
\ mi
260nm and E- l8.0cm^ mole  ̂for NAD* itself.
analogue showed A 259nm and E - 17»5cm^ ole compared with Amax max
The stability of 3“trifluoroacetylpyridine adenine dinucleotide at a 
range of pH values was investigated by t.I.c. analysis of the radio­
labelled analogue. Like NAD* itself and many of its derivatives, the 
fluorinated analogue was found to be increasingly unstable as the pH 
value of the incubation mixture rose. At pH 9 the analogue was found 
to have a half life of only 12 minutes. The half life at pH 7 on the 
other hand was 12 hours which supports the point made earlier that 
failure of the incubations using pig brain NAD* transglycosidase 
cannot be attriuted to decomposition of the product at the pH value 
(7-5) employed.
Activity of 3-trifluoroacetylpyridine adenine dinucleotide as an 
NAD analogue.
Activity as a substrate.
NAD* and some of its analogues form addition products with cyanide 
(fig. 4 5 ) 1 having A i n  the 3 2 0 to 340 nm region; indeed^ this has 
been used to monitor the extent of the reaction in many 
transglycosidation reactions using the pig brain enzyme (Biellmann 
et. al., 1 9 7 4). The other characteristic reaction of NAD* is its 
reduction to a 1,4-dihydro adduct by reducing agents such as 
dithionite, bisulphite and cyanoborohydride. However,
3-trifluoroacetylpyi'idine adenine dinucleotide failed to react with 
cyanide, nor was it reduced chemically, these judgements being based 
on u.v. spectroscopy. Examination of the data in figure 43 shows that 
those analogues that react with cyanide or form 1,4-dihydro adducts
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under reducing conditions contain a carbonyl group in the 3-position 
of the pyridine ring. The effectiveness of the carbonyl grouping in 
this context can be rationalized in terms of the resonance 
stabilisation of the addition product. The NMN analogue was also found 
to be inert under these conditions.
In view of the propensity of a-gem-difluoromethyl ketones, for example 
difluorooxaloacetate (Kun and Dummel,I9 6 9 ), to form hydrates and the 
ability of 3-trifluoroacetylpyridine to exist as a stable hydrate, it 
seems highly likely that the 3-trifluoroacetylpyridine NAD* analogue 
exists in aqueous solution largely as 3-&,&-dihydroxy-P,P,P-trifluoro- 
ethylpyridine adenine dinucleotide. This substituent clearly does not 
contain a carbonyl group and it may be that this provides an explanation 
for the lack of reactivity of 3-trifluoroacetylpyridine adenine 
dinucleotide with either cyanide or cyanoborohydride.
3-Trifluoroacetylpyridine adenine dinucleotide is not reduced by 
ethanol, malate, lactate or glyceraldehyde-3-phosphate in the presence 
of the corresponding dehydrogenase. This behaviour is likewise 
consistent with the existence of the analogue as its hydrate. It may 
be noted that 3“chloroacetylpyridine adenine dinucleotide is also 
inert as a coenzyme in several dehydrogenase systems (Beillmann et. 
al., 1 9 7 4).
Activity as an inhibitor.
Inhibitors are substances which form enzyme complexes which are 
catalytically inactive, or less active than the enzyme-substrate 
complex. If the binding of the inhibitor and substrate to the enzyme 
ismutually exclusive, the inhibitor is classed as competitive. The 
structure of a competitive inhibitor usually resembles that of the
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substrate, and thus competitive inhibitors are usually assumed to
interact with the enzyme at the substrate binding site. In the
presence of a competitive inhibitor, at concentration I , the rate of
an enzyme catalysed reaction, v^, is given by:-
Vm





where, is the dissociation constantof the enzyme-inhibitor complex,
is the maximal velocity,
S is the substrate concentration, and o
K is the Michaelis constant, m
Although 3-trifluoroacetylpyridine adenine dinucleotide inhibited the 
rate of all four dehydrogenases investigated, insufficient kinetic 
data was obtained to show conclusively that the analogue is a 
competitive inhibitor of NAD or NADH. However, if the assumption is 
made that the analogue does act as a competitive inhibitor, which is 
a reasonable assumption on the basis of the structural..similarity, 
it is possible to estimate the binding constants of the analogue with 
these enzymes.
For all the enzymes tested the rate equation is:-
VmV =*=o -(2)
—  +  —  +    +1
M [ f
where, [a] is the concentration of the coenzyme,
[b] is the concentration of the substrate, and
K , K and are the kinetic parameters. In all the casesA B AB
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studied the concentration of the substrate, B, was saturating, and 




which is the Michaelis-Menton equation for the cosubstrate. A, with 
Michaelis constant K^. In the presence of a competitive inhibitor this
becomes : -
VV. = m1
-^(1 + +  1
1
following equation (l). The fractional inhibition, »i, at a given
[a ] elicited by a competitive inhibitor is given by:-
Lil
i = _____ ^ _____  -(3)
1 A
where, i = 1 - v.1
V o
Solving equation (3) for K. gives:-
K. = [I] (1 - O  .(4)
6
which allows an estimate for K, to be obtained. The values found are1
given in figure 72.
The values of the binding constants are all within the experimentally
19detectable range of concentrations for F n.m.r. spectroscopic 
investigation using reasonably obtainable enzyme concentrations. This, 
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tool for investigating the coenzyme binding site of NAD* dependent
dehydrogenases a promising direction for future studies.
C O N C L U S I O N S
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Conclusions
The use of perchloryl fluoride to prepare ethyl difluoronicotinoyl­
acetate, an intermediate in the synthesis of 3“trifluoroacetylpyridine 
was unsuitable for two reasons. Firstly, the yield from the reaction 
was variable, and secondly the reaction was found to be hazardous.
This method of synthesis had been chosen, in preference to the 
published method, to further explore the use of perchloryl fluoride 
as a fluorinatingagent, perchloryl fluoride already having been used 
at Bath University to prepare diethyl difluoro-oxaloacetate. However, 
the published method for the synthesis of 3-trifluoroacetylpyridine, 
involving the reaction of 3-lithiopyridine and N,N-diethyl 
trifluoroacetamide, was found.to be satisfactory.
Chemical nucleoside synthesis was found to be unsatisfactory for 
several reasons. The method followed was that used in Todd's 
laboratory and involved the reaction of a substituted pyridine with 
an acylated haloribofuranose. The number of stages involved in the 
synthesis is large, and hence the overall yield is poor, and the 
synthesis lengthy. In the preparation of 3-trifluoroacetylpyridine 
ribofuranoside the step in which the substituted nucleoside is 
deacylated proceeded with a yield of only 8%, making the synthesis 
impractical. The n.m.r,spectra of these compounds was very poor. The 
signals were very broad and unresolved, this being due, in part, to 
the insolubility of several of these compounds.
2 -Phenylene phosphorochloridate was found to be a suitable 
phosphorylating agent for the phosphorylation of nicotinamide 
nucleoside, but the position of phosphorylation was not investigated. 
Although NAD* transglycosidase from pig brain was found to be a useful 
enzyme for substituting some pyridine compounds into NAD*
3-trifluoroacetylpyridine was unfortunately not a substrate, but was
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found.to inhibit the incorporation of 3-acetylpyridine into NAD*. In 
the presence of 3-trifluoroacetylpyridine and NAD* the enzyme acted 
simply as an NAD* glycohydrolase.
Nicotinamide phosphoribosyl transferase from Lactobacillus fructosus 
was found to be less specific in its base requirements than had been 
published. The enzyme accepted 3-trifluoroacetylpyridine as a substrate 
and was not inhibited by this compound. 3-Tr ifluoroacetylpyridine 
mononucleotide was isolated from this enzyme system.
Enzymic pyrophosphorylation of the above compound and ATP proceeded 
to give 3-trifluoroacetylpyridine adenine dinucleotide.
The NAD* fluoroanalogue was found to be stable in aqueous solution at 
pH 5» Neither fluoroanalogue formed an addition product with cyanide, 
nor were they reduced by cyanoborohydride.
The NAD* analogue did not exhibit coenzymic activity with alcohol, 
lactate, malate or glyceraldehyde-3-phosphate dehydrogenases. It was, 
however, found to be an inhibitor of all of these enzymes. Approximate 
values of were determined for the binding of the inhibitor to each 
enzyme.
Suggestions for further work.
(a) Further and more detailed enzyme kinetic experiments are required
in order to determine accurate values of K^.
19(b) F N.m,r; spectroscopy should be used to investigate the binding of 
3-trifluoroacetylpyridine adenine dinucleotide to the enzyme in various 
dehydrogenase systems, and thus learn more about the active sites of 
these enzymes.
(c) An investigation into the specificity of NAD* kinase with regard to
3-trifluoroacetylpyridine adenine dinucleotide should be undertaken 
with a view to preparing a fluorinated analogue of NADP*.
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46, 2 9 1 7.
Buffa, P. and Peters, R.A. (1950). 2" Physiol., 110, 488.
Burger, A. (1970). ed. Medicinal Chemistry, Vols. 1 and 2. (Wiley 
Interscience, 3 *̂̂ * Edition).
Burns, H-D. and Powell, G. (1945). jl- Amer. Chem. Soc., 6 7 , 1468.
Bush, I.E., Hunter, S.A. and Meigs, R.A. (I9 6 8). Biochem. J.,107, 239- 
Bush, I.E. and Mahesh, V.B. (1964). Biochem. Ĵ ., 3̂,» 2 3 6.
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